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Factors Associated with Delay of Breast Cancer Diagnosis among Palestinian Women 
Who Are Treated at Beit Jala Governmental Hospital 
Prepared by: Abdel Naser Mahmoud Hasan Badawi 
Supervisor: Dr. Sumaya Y. Sayej    
Abstract: 
Introduction: Breast cancer is the most common cancer in women and the sole greatest 
cancer killer among women across the globe; Breast cancer is also the most common cause 
of cancer death among women there were 522 thousand deaths in 2012. Breast cancer 
comes in the first place of cancer among Palestinian women, which has amounted to 
(35.4%) of total cancer cases in 2013, most of these women seeking medical attention in 
late stage.                                                                                          
Objectives: To determine if there is any delay of BC diagnosis among targeted women. To 
assess all possible factors/barriers associated with delay of breast cancer diagnosis. To 
identify the relationship between, socio demographic status, health seeking behavior, 
family history, type of initial symptoms and patient delay. To identify the relationship 
between the stage of breast cancer; tumor size and the delay of diagnosis. 
methodology: A cross sectional study conducted among 194 Palestinian women with 
confirm breast cancer at any age, sample was selected from the Biet Jala Government 
Hospital, at day care ward, outpatient clinics. A face to face interview using a structured 
questionnaire. Which included demographic data, patient and family health history, breast 
screening and periodic follow-up to detect breast cancer, initial symptoms of breast cancer, 
the way it was discovered, the reason of diagnosis delay. the cause of the delay between 
the discovery of these symptoms and visiting the doctor and the reason for the delay in a 
final diagnosis after visiting the doctor. And lastly, the patients‘ records were investigated 
by the researcher identify the stage of breast cancer for each woman participated in the 
study. 
 
Results:  Our study conclude, 17.0% consulted within the first three months a. 37.1% 
waited for more than three months (patient delay).  Provider delay was found in 46.9% of 
all women participant (over one months).  Total delay was found in 60.8% of all women 
participant (over three months). 
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Many reasons for delay in seeking treatment were found; 98% of women did not consider 
symptoms were serious, 94.2% reported embarrassment of visiting the doctor and breast 
examination. women don‘t receive support from the spouse, family 93%, 77.8% 
respectively. 91.4% The economic situation of the family. Fear of, diagnosis of breast 
cancer, surgery, mastectomy or part thereof 90.8%, 88.6%, 74.2% respectively. 83.4% The 
impact on my status as a female or spouse.  80.6 % The presence of one of the family 
members suffering from breast cancer. 79.8 % belief that the therapy available for breast 
cancer leads to rapid death. 77.2% use alternative therapies such as herbal medicine. 72.8%   
refusal to go to a doctor and leaving to fate as whatever the outcome of breast cancer could 
be. 72.8%   The lack of adequate time do I have. 70.6 % The lack of a woman doctor or a 
specialist. Diagnosis delay was significant association with age between (46-60) years (p 
value 0.010), lower educational level (p value 0.018), Married women (p value 0.001), low 
income level, (p value 0.046), presence of fibrous mass, milky secretions or inflammation 
in the breast in the period before the discovery of the disease (p value 0.022). Shorter delay 
significant association with visited one of the doctors During the five years preceding the 
discovery of the cancer (p value 0.039). family members (mother, sister) has or had breast 
cancer (p value 0.023). Women with Know how to perform BSE (p value0.035) and 
women practicing BSE (p value 0.028). initial breast symptom(s) that include a lump 
(0.011).  
Our Study Findings Most of the patients (52.7%) had early stage BC (Stages I and II). And 
revealed the high proportion (47.3%) of women BC had advanced-stage (stage 3 and 4). 
This study found strong a significant association between patient delayed presentation, 
provider delayed and advanced stage at presentation was observed. 
Conclusion: A complex matrix of factors was identified that contribute to the late 
presentation or delayed diagnosis of breast cancer among Palestinian women how treated 
at BJGH. In the sample studied, the majority of patients with breast cancer began treatment 
after a delay. Both patient delays and provider delays were associated with advanced 
disease, Breast awareness and education are required to promote early detection, this study 
recommended an establishment of a national program for early diagnosis and treatment 
before the tumors enlarge and metastasis. Health policy reform related to breast cancer 
delay diagnosis in Palestine.   
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CHAPTER ONE 
Introduction  
 
1.1 Introduction  
 
Breast cancer is the most common cancer in women and the sole greatest cancer killer 
among women across the globe (Hirko, 2013). Globally, breast cancer incidence is on the 
rise, especially in developing countries where more than 1.2 million women are diagnosed 
with breast cancer annually worldwide (American Cancer Society, 2015). 
 
According to International Agency for Research on Cancer (2013), breast cancer is the 
most common cause of cancer death among women there were 522 thousand deaths in 
2012 and the most frequently diagnosed cancer among women in 140 of 184 countries 
worldwide, and represents one in four of all cancer types in women. 
 
In addition, breast cancer is the most common cancer in women in the Eastern 
Mediterranean Region and the leading cause of cancer mortality worldwide (Khatib, 2006). 
In the Arab world breast cancer is the most common type of cancer among women that 
constitutes 13-35% of all female cancer, with a young age around 50 years, and over 60% 
of cases are with an advanced stage of the disease (El Saghir et al., 2007). 
 
The Palestinian Ministry of Health report (2013) indicated that the number of the new 
cases of all cancer types for the year 2013 among females was 1127 (51.5%) of all new 
cases, and the number in males was 1062 (48.5%). The same report also mentioned that 
401 breast cancer cases have been recorded. Thus, breast cancer comes in the first place of 
cancer among Palestinian women, which has amounted to (35.4%) of total cancer cases in 
2013 (MOH Report, 2013). 
 
From the statistics mentioned in the report one can conclude that there is a clear significant 
increase in cancer cases in the West Bank, and there is a bad need for more studies and 
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researches to be carried out especially breast cancer as the Palestinian ministry of health 
indicated. 
Studies confirms that the percentages of breast cancer in Palestine is part of global 
proportions especially in neighboring countries, but what distinguishes the situation in 
Palestine is the late discovery of it. Darweesh study (2009) of Palestinian women with 
breast cancer in North West bank revealed that 60.7% of these women were diagnosed 
with advance stage of cancer at the time of diagnosis.  The Palestinian Ministry of Health 
regretted the fact that most cases are discovered to be late, and related this delay to cultural 
and social barriers that prevent women to seek advice at the proper time. The same report 
further reiterated that early discovery of the breast cancer reduces breast cancer deaths of 
two thirds (Bitar in MOH Report, 2011). 
The data mentioned in previous studies has also shown that in many Arab countries 
including Palestine that 50-80% of breast cancer women at presentation are with advanced 
stage of the disease. It is striking that more than 50% are with stage 2 and stage 3 (ElSaghir 
and Abulkhair, 2010). Besides, tumors in Palestinian women were generally detected by 
physical examination rather than by the widely screening mammography (El Saghir et al., 
2007). This indicates that Palestinian women with breast cancer don't come to consultation 
in an early stage. 
 
Based on these previous findings, one of these studies concludes that as a result of lack of 
awareness of early screening for breast cancer programs. Donnelly et al. (2013) revealed 
that among 397 Palestinian women aged 50 years and more found more than 60% of them 
had never attended mammography, and further elaborated that a large proportion of 
Palestinian women may attend for treatment in advanced stages, and this usually happens 
after three months of initial symptoms. McLaughlin et al., (2012) reported; a delay of 
breast cancer diagnosis of more than 60 days‘ results in cancer spreading to lymph node or 
distant sites and linked with an 85% of breast cancer death compared with women who 
were treated sooner. 
Breast cancer total delay is classified in two types; patient's delay and provider's delay. The 
majority of studies have considered patient's delay for more than three months, which 
mean between the discovery of symptoms and the first medical consultation. Saldana and 
Castaneda (2009) reported that provider‘s delay is considered between the first medical 
consultation and the start of definitive treatment, the most accepted span is one month.  
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Some studies assure that there should be a number of factors associated with diagnosis 
delay. Some are referred to the provider delay such as negligence, postponing 
appointments or misdiagnosis (Goncalves et al., 2014; Poum et al., 2014; Abu-Helalah et 
al., 2016). Other reasons are associated with the patient delay as for example; symptoms 
were not considered serious, alternative therapy was applied in the patients and fear or 
shame prevents women from visiting the doctor (Khazaee et al., 2014; Alhurishi et al., 
2011).  
The studies also mentioned that initial breast symptom(s) without a lump was strongly 
associated with diagnosis delay (Meechan et al., 2003; Elobaid et al., 2014; Innos et al. 
2013; Burgess et al; 1998). Lack of knowledge about breast cancer and screening 
activities, fear of breast cancer diagnosis, inability to provide financially and place of 
residence are factors expected to be major barriers for many Palestinian women to have 
treatment in the proper time (Qabaha et al., 2015; Tfayli et al., 2010; Azaiza et al., 2010). 
 
Therefore, this study was conducted at Beit Jala Governmental Hospital in Bethlehem city, 
the only hospital treating cancer in the southern West Bank aiming at identifying the 
average time period for the delay of breast cancer diagnosis and treatment among women 
being treated for breast cancer in this hospital. Also, the study identified the factors and 
reasons that prevent these women from visiting a doctor for care and treatment in the 
proper time in order to lessen the opportunities of delay. Here comes the importance of the 
study which aims to recommend on adding more emphasis on screening through increased 
awareness and education among Palestinian women to avoid the advanced stages of breast 
cancer.  
 
1.2 Research problem  
 
The Palestinian Central Bureau of Statistics-PCBS (2013) reported that Breast cancer 
comes in the first place of cancer among Palestinian women which has amounted to 
(35.4%) of total cancer cases in 2013. The World Health Organization states (2014) 
reported that 40% of breast cancer cases are curable if they are exposed to an early 
diagnosis with enough detection and less metastasis. Taha et al., (2012) elaborated that the 
5-year survival rate reaches 88% -93% when breast cancer is detected in its earliest stages 
(0 and I) respectively compared to 15% in stage IV.  El-Saghir et al. (2007) commented 
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that late diagnosis is a major factor related to the higher mortality among Palestinian 
women with breast cancer.  
 
Understanding the factors and barriers that are associated with breast cancer delay are 
important issues to the development of strategies for shortening this delay. In Palestine, 
there are no mature studies to clarify the causes of delay to an early breast cancer diagnosis 
and whether these reasons are related to the patient herself or to health care provider. 
According to Arndt et al. (2002), patient's delay is defined as the period from first onset of 
symptoms to first medical consultation, while provider's delay covers the period from first 
consultation to definite diagnosis and treatment. Delayed presentation of symptomatic 
breast cancer of three months or more is associated with lower survival rate from the 
disease (Richards et al., 1999). 
 
Several studies have shown that the delayed presentation of symptomatic breast cancer is 
associated with worse prognosis and tumor progression meaning an increase in mortality 
rate (Arndt et al., 2002; Ermiah et al., 2012). When breast cancer is detected early 
(localized stage), the 5 years‘ survival rate is 98 % (National Breast Cancer Foundation, 
2014). This concludes that breast cancer mortality could be reduced if the disease was 
detected at an early stage by the implementation of proper awareness and screening 
programs.  
 
Therefore, to improve breast cancer care, one must understand the causes of the delay in 
diagnosis and therefore the treatment. Early detection of breast cancer is considered as an 
important issue for intervention to reduce disease advancement and mortality rate. 
 
Unfortunately, there are a few marginal studies concerning breast cancer delay of diagnosis 
in the West Bank. After reviewing some studies worldwide on the subject, the possible 
barriers to breast cancer detection and early diagnosis are due to; financial shortcomings, 
misconception about breast cancer screening related to social norms and its implications 
such as shyness and fear of cancer, wrong beliefs and fatalistic attitudes and lastly, could 
be the lack of health care facilities (Alhurishi et al., 2011; Ermiah et al., 2012; Elobaid., 
2014). In developing countries, the literature shows that negative socio-cultural perception 
of breast cancer, strong beliefs in traditional medicine and perhaps strong religious beliefs 
are the main reasons for the delay in presentation (Hadi et al., 2010). 
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Thus, reducing the time between the onset of the first symptoms of B.C and the first 
consultation, and reducing the time between first consultation to start effective treatment is 
essential to improve disease prognosis and improve quality of life.  
 
Therefore, identification of barriers to an early diagnosis of breast cancer and finding 
means to facilitate early detections in order to avoid advance stages of cancer at 
presentation among Palestinian women is of major concern of the researcher and health 
care professionals as well. 
 
1.3 Justification of the study  
This study will create a better understanding of the factors associated with the delay for 
seeking cancer treatment which is important in order to increase overall cancer survival 
rate among breast cancer Palestinian women. In addition, the study will be of value to 
public health professionals, physicians and other health care providers as it will identify 
knowledge and perception towards occurrence, symptoms, risks, survival, progression and 
treatment of breast cancer. Also, the study will support the global and national efforts 
aiming at reducing premature deaths among Palestinian women with breast cancer.                                                                                                                        
 
The expected results will help in both ways: informing and promoting optimal early 
diagnosis and treatment among the breast cancer patients. It will generate a better 
awareness and a keen insight that can support programs in developing effective strategies 
for addressing the challenges that hinder the early detection and treatment of breast cancer 
as well as inform future health care policy and practice that will increase an early diagnosis 
and optimal utilization of facilities.  
 
Besides, the study aims to recommend for mechanisms to be stimulated for early detection 
and treatment of breast cancer women, create awareness of breast screening and reduce the 
incidence of late breast cancer diagnosis. It will also engender information for the Ministry 
of Health to promote early breast cancer detection among women and men as well to 
reduce accessibility obstacles to medical care.   
Moreover, the study is expected to assist the Ministry of Health in the formulation and 
implementation of national cancer control in the long-term future strategy. Relevant sectors 
in the Ministry of Health and Medical services are also expected to benefit from this study 
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in coming up with the best methods of breast cancer prevention and control among women 
in general and low resource areas in specific.  
 
In addition, the study will be beneficial to the governmental and non-governmental 
organizations which have an interest in cancer control and prevention. It promotes the best 
methods of increasing breast cancer awareness among women in low resource areas and 
ways of improving access to breast cancer screening and diagnostic services. It will 
encourage the endorsement of other preventive measures and also inform them of how 
women in low resource areas perceive breast cancer. This study also aims to inform the 
health service providers on women expectations in order to encourage breast cancer 
screening and diagnosis attendance as well as being used as ground for further research. 
 
1.4 Breast Cancer; identification, pathological changes, manifestation and staging   
 
1.4.1 Identification and background  
 
Breast cancer has become one of the defying public health problems in many developing 
countries including Palestine as the mortality and incidence rate are increasing. The PCBS 
(2013), reported that breast cancer among Palestinian women was 18.3%, rated third 
among factors that lead to death and occupied the first and the most common type of 
cancer. The report also mentioned that breast cancer represents 35.4% of all cancer cases, 
and 60% of the affected age group was between the 15-60 years old.   
This indicates that breast cancer cases have been diagnosed at a later stage or discovered 
cases are not adequately treated. Therefore, this study was conducted on confirmed breast 
cancer women being treated at Beit Jala Hospital to determine the factors and barriers 
associated with their delay for their breast cancer diagnosis and treatment. Also, the study 
aimed to determine the reasons for delay whether referred to patient himself or to health 
care providers and to explore relationship between the stage of breast cancer and delay of 
diagnosis. Beit Jala Hospital receives cancer cases from southern West Bank, Bethlehem 
and Hebron, and it sometimes receives cases of cancer from the middles region (Ramallah 
and Jericho).                                   
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According to Hazboun and Glennon. (2011), Palestinians have limited health awareness 
regarding breast cancer because of limited resources; the economic status of population 
discourages breast cancer screening, the Palestinian life in general relates to culture, 
methods of early breast cancer detection such as clinical breast exams are rarely performed 
and screening with mammogram is only available at Bethlehem primary care center. They 
further commented, the majority of Palestinians does not have appropriate health insurance 
and cannot afford to seek health care because 60% of population is poor and unemployed. 
 
1.4.2 Pathological changes and manifestations  
 
To be more precise and to address the topic from a medical point of view one can argue 
changes in the breasts may be caused either by benign (non-cancerous) conditions or 
malignancy (cancerous). Benign breasts have many of the same symptoms as breast 
cancer; benign breast condition often causes lumps, which mostly aren‘t breast cancer 
(American Cancer Society, 2016). The only safe way to distinguish between benign lump 
and cancer is by the tissue examined, biopsy (WebMD, 2014).  
 
Breast cancer is characterized by an uncontrolled growth of abnormal cells. There are two 
types of breast cancer; non-invasive breast cancer where abnormal cells grow inside the 
lobules or grow inside the milk ducts. This means cancer cells do not spread to other 
tissues in the breast or other parts of the body. Invasive breast cancer can start in the milk 
ducts or the lobules, but the cancer cells spread to other breast tissues or parts of the body 
(Davis etal., 2010). 
 
Most breast cancers are commonly formed in the inner lining of milk ducts or the lobules 
that supply the ducts with milk. Cancer originates from lobules that are known as lobular 
carcinoma, and those originating from ducts are known as ductal carcinoma (Parkash, 
2014).   
 
Ermiah et al. (2012) reported that the most frequent symptoms of breast cancer are a 
painless breast lump, or a lump under the arm pit, nipple discharge, and it can be a change 
in the shape of breast, lumpiness in breast or skin irritation or itching.  
 
Cancer Research UK (2014), reported, the initial symptom of breast cancer in many 
women is a lump. On the other hand, many women have breast lumps but 9 out of 10 
8 
 
(90%) are benign (Cancer Research UK, 2014). Diagnostic mammography is usually used 
to assess possible breast cancer in women who present with disease (Barlow et al., 2002). 
The sign and symptoms include, breast mass or lump, swelling of all or part of the breast, 
skin irritation, breast or nipple pain, redness or thickening of the nipple or breast skin, a 
nipple discharge, also it is possible that breast cancer can spread to lymph nodes under the 
arm (American Cancer Society, 2016).  
 
 
The diagnosis of breast cancer depends on clinical, radiological and pathological 
examination. Clinical examination includes palpitation of the breast and regional lymph 
node while radiological examination includes mammography and ultra sound of breast; 
pathological examination when used is based on core needle biopsy (Aebi et al., 2011).  
 
Mammography is an x- ray which detects 85% of BC. A distinction should be made 
between diagnostic mammography and screening mammography, 45% of BC can be seen 
by mammography before they are palpable (Abu Shmais, 2010). 
 
The treatment is usually determined by the size, stage and other characteristics. Such 
treatment may include surgery, drug (hormonal therapy and chemotherapy), radiation or 
immune therapy (Parkash, 2014). 
 
 
1.4.3 Staging  
 
Many studies argue that the initial breast symptoms without lump were strongly associated 
with diagnosis delay. When breast cancer diagnosis is established, the staging of the 
disease provides the basis of best choice of treatment. According The American Joint 
Committee on Cancer (AJCC) and the International Union for Cancer Control (UICC); 
(ACS, 2015)  
 using information about tumor size, how far it has spread within the breast and 
organs (T),  
 lymph nodes involvement (N),  
 and the presence or absence of distant metastasis (M).  
 
Once the T, N, and M are determined, a stage of I, II, III, or IV is assigned, where stage I 
an early stage and stage IV the most advanced one. Early breast cancer diagnosis refers to 
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breast cancer in stage, 0, I and II at the time of diagnosis (American cancer society, 2014). 
Stage is described as how wildly the disease spreads, the disease stage is usually described 
by using the number 0-4, low number indicates the earlier stage of cancer, Staging the 
disease clarifies the way the disease progresses (National Breast Cancer Foundation, 2015)  
 
There are many risk factors of breast cancer that were suggested in previous studies. The 
most important of these factors are ewer births, later age at first full-term pregnancy, not 
having breastfed, early age at menarche, irregular menses, late menopause, the use of 
exogenous hormones (e.g., oral contraceptives), obesity, physical inactivity and the family 
history of breast cancer (Canadian Cancer Society, 2014).  
Although most studies clarify many risk factors of breast cancer, but primary prevention is 
still not available (Caplan, 2014). Therefore, the main effective ways to control the disease 
and reduce the incidence of morbidity and mortality from breast cancer is to promote early 
diagnosis through screening and awareness and early treatment of breast cancer.   
 
1.5 Goal and objectives of the study  
 
To identify factors associated with delay of breast cancer diagnosis among Palestinian 
women being treated for B.C at Biet Jala governmental hospital. These factors include the 
patient perception and practices toward B.C and health care services provider for her.  To 
achieve this goal, the following measurable objectives are set. 
 
 To determine if there is any delay of BC diagnosis among targeted women. 
 To assess all possible factors/barriers associated with delay of breast cancer 
diagnosis. 
 To identify the relationship between, socio demographic status, health seeking 
behavior, family history, type of initial symptoms and patient delay.   
 To identify the relationship between the stage of breast cancer; tumor size and the 
delay of diagnosis. 
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1.7 Research question 
 
 What are the factors associated with delay of breast cancer diagnosis among 
women with breast cancer treated at BJGH? 
 is there a delay between the presence of symptoms and medical consultation, and 
the first visit the doctor to final diagnosis and treatment? Are there relationships 
between this delay and stage of B.C? 
 what are the reason (barrier) that prevent patients to seek medical consultation after 
discovery of symptoms? 
 what are the reason that difficult health care provider to early diagnosis of B.C? 
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1.8 LIST OF DEFINITIONS 
Breast Cancer Delay (diagnosis delay or total delay): A lapse of more than three months 
between symptom discovery by the patient and the beginning of definitive treatment. 
Patient Delay: An interval longer than three months between symptom discovery by 
patient and first medical consultation. 
Provider Delay: A period of more than one month between the first medical 
consultation and confirm diagnosis to initiation of treatment. 
Breast Self-examination (BSE): done by the woman every month in order to detect any 
changes in the breasts and beginning in 20s (WHO, 2016) and (Mayo clinic, 2016) 
A mammography: is a kind of test that produces an image of the inner breast tissue on a 
film. It uses x-rays to visualize normal and abnormal structures within the breasts (WHO, 
2016), (ACS, 2014). 
A Clinical Breast Exam (CBE): is a physical exam of the breasts which is normally done 
by a health care provider such as a doctor, nurse practitioner, nurse, or physician assistant 
as part of a regular medical examination; the health professional carefully feels both the 
breast and the underarm for abnormalities (WHO, 2016) and (National Breast Cancer 
Foundation. 2015) 
The Health Belief Model (HBM): is a psychological model that attempts to explain and 
predict health behaviors. This is done by focusing on the attitudes and beliefs of 
individuals. 
palliative care: is specialized medical care focused on relief of the pain, symptoms and 
stress of serious illness. The goal is to improve quality of life for both patents and family. 
It is appropriate at any age and at any stage in your illness and can be provided along with 
treatment meant to cure (Center to Advance Palliative Care,2011). 
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CHAPTER TWO 
Literature Review 
2.1 Introduction  
This chapter will present studies related to breast cancer starting with; epidemiology of 
BC, early detection of BC followed by diagnosis delay (patient and provider delay). 
Obstacles which hinder patients from visiting the health care providers and reasons which 
make it difficult for the health care provider to an early diagnosis. Lastly, studies on the 
relationship between diagnosis delay and tumor staging.        
2.2 epidemiology of breast cancer   
The global burden of breast cancer in women is measured by incidence, mortality, and 
economic costs as public health data indicates. The World Health Organization (WHO) 
estimated over 508, 000 women died in 2011 due to breast cancer. Almost 50% of breast 
cancer cases and 58% of deaths occur in less developed countries.                                                                                   
Breast cancer is the most common cancer in women (Tfayli et al., 2010) reviewed the 
challenges of epidemic breast cancer and he concluded that   around 45% of breast cancer 
cases and 55% of breast cancer deaths occur in low and middle income countries; 
accounting for 23% of all female cancers around the globe. It is estimated that 45% of the 
1.35 million new cases are diagnosed each year, and more than 55% of breast cancer 
related deaths, occur in low and middle income countries, an estimated 1.7 million women 
will be diagnosed with breast cancer in 2020—a 26% increase from current levels, mostly 
in the developing world. 
 
 In Arab countries, the data also shows that similar trends with a rate of advanced or 
metastatic stage reaching 60 to 80% of cases. In Egypt for example, stages III and IV 
constitute 68% of all breast cancer cases. As for Saudi Arabia, stages III and IV constitute 
about 46% of cases. Also in Oman the rates are high amounting to 50.8%. Efforts aimed at 
early detection can decrease stage at diagnosis and potentially improve the probability of 
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survival and cure. The mastectomy rates in Arab countries are high amounting to 79.9%–
82% in Egypt, 65% in Oman, 70% among Palestinians, 88% in Syria, and 82.4% in 
Tunisia. In general, the majority of patients present with stage IIIa and IIIb tumors 
reaching levels of 62% in the Arab world (Tfayli et al., 2010). 
 
Worldwide, breast cancer is the third most frequent cancer in the world (796,000 cases in 
1990) and by far the most common malignancy of women (21% of all new cases), breast 
cancer ranks as the fifth cause of death from cancer overall. Although it is still the leading 
cause of cancer mortality in women. There are 314,000 annual deaths which represent 
14.1% of cancer deaths in females (Parkin et al., 1999). 
 
Jemal et al. (2011) clarify Breast cancer is the most frequently diagnosed cancer and the 
leading cause of cancer death among females, accounting for 23% of the total cancer cases 
and 14% of the cancer deaths. In general, breast cancer incidence rates are high in Western 
and Northern Europe, Australia/New Zealand, and North America; intermediate in South 
America, the Caribbean, and Northern Africa; and low in sub-Saharan Africa and Asia.  
 
Qabaha et al. (2015) Clarify Breast cancer is a major threat for Palestinian women and 
healthy living. breast cancer amounted to 35.4% of all types of cancers among Palestinian 
women. The percentage of incidence is 1 out of every 13 women. In 2013, 401 cases were 
diagnosed with breast cancer compared to 292 cases that were diagnosed with breast 
cancer in 2012.  
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Table 2.1 Clinical stage of breast cancer patients by country 
 
 
 
 
The table summarizes the clinical stage data reported for different countries. As shown, 
while the majority of breast cancers are diagnosed in localized stages in HICs, most are 
detected in regionally spread stages in LMICs. In HICs, more than 70% of breast cancer 
patients are diagnosed in stages Ⅰand Ⅱ; Sweden and Norway have proportions above 
90%. In contrast, in LMICs, only between 20 and 60% of patients are diagnosed in these 
earlier stages, while between 30 and 80% are diagnosed in stages Ⅲand Ⅳ. (Saldana, 
2014).  
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2.3 Early detection of breast cancer  
Early detection refers to the notion of "using an approach that let‘s breast cancer gets 
diagnosed earlier than otherwise might have occurred (ACS, 2012). 
The main goal of breast cancer screening program is detection of breast cancer at early 
stage, Breast cancer screening can reduce morbidity and mortality and improve the 
survival rate for this malignancy (Seif and Aziz, 2000; Otaghvar et al.,2015).   
Johnson, (2006) Reported that Early detection methods, such as mammography, clinical 
breast examination and breast self-examination, can play an important role in the reduction 
of deaths from breast cancer in the absence of primary prevention strategies.  
Rezaianzadeh et al. (2009) clarify the results demonstrate that survival is relatively poor 
and is associated with diagnosis with late stage disease. that this is due to low level of 
awareness, lack of screening programs and subsequent late access to treatment. 
Khokher et al. (2015) that awareness activities about breast cancer screening are effective 
to increase the knowledge of women and better impact is associated with higher education 
and younger age of women. 
Elobaid et al. (2014) reported Common barriers towards screening included fear of pain 
and embarrassment, fear of radiation causing cancer, and perceived inadequate facilities. 
Knowledge of breast self-examination increased the likelihood of women to present in 
early stages. Lack of knowledge about BSE and not having a previous CBE or a 
mammogram were also associated with late stage at presentation (Stapleton et al. 2015). 
In the study conducting among Malaysian women the study showed awareness of breast 
cancer and practice of screening procedures increases with higher education and urban 
living. Therefore, there is an urgent need for an intensive breast cancer awareness 
campaign and availability of screening centers prioritized in rural areas (Kanaga et al., 
2011)  
Radi, (2013) reported that age, marital status and level of education as significant factors 
associated with BSE practice. 
Women with low educational attainment, low cancer knowledge, and no usual source of 
care were less likely to be CBE or mammogram compliant. Socioeconomic differences 
were larger for the two clinical tests than for BSE (Harris et al., 2003). 
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A study conducted among Muslim Arab women in Israel to assess explanatory factors of 
mammography screening behavior. the study concludes That women who were 
significantly more likely to undergo mammography were those who received a 
recommendation from a health professional or from family/friends, perceived themselves 
as vulnerable to getting breast cancer, believed in the efficacy of the test, perceived it as 
not painful, were younger, were more educated (Soskolne et al, 2006).  
 
ACS. (2015) guidelines for the early detection of breast cancer vary depending on a 
woman‘s age and include mammography and clinical breast examination (CBE), as well as 
magnetic resonance imaging (MRI) for women at high risk. Mammography should begin 
annually at age 40 with no specific age to stop. Clinical breast examination should be done 
every 1–3 years for women aged 20–39 years and annually for women aged 40 years and 
older, prior to mammography. Magnetic resonance imaging is recommended for women 
with a 20%–25% or higher lifetime risk for developing breast cancer. MRI should be 
performed annually beginning at age 30. Although the (ACS) no longer recommends that 
all women perform monthly breast self-exams (BSE), women should be informed about 
the potential benefits and limitations associated with BSE 
A study conducted among 397 Palestinian women in the West Bank aged from 30-60 
years, the study showed   that   more   than (70   %) of the participants never applied 
mammography or CBE, and 62% of the participant applied BSE (Azaiza et al., 2010). 
A study conducted among 519 Jordanian women in order to examine the factors and 
beliefs that have a kind of relation to the practice of BSE, the study found that (67%) had 
heard of and/or read about breast self-examination, and only (7%) of them had done self-
breast examination monthly (Petro-Nustus and Mikhail, 2002). 
A study conducted among 1,315 Saudi adult females with no previous history of breast 
cancer, the results found that CBE performed by less than (5%) and mammography by 
only (3%) of the participants (Amin et al., 2009)   
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2.4 Diagnosis delay, patient and provider delay 
 
The first study on cancer delay where these two types of delay are described was done by 
Pack and Gallo in 1938. They defined "undue patient delay" as "three months or more 
elapsed time between discovery of symptoms and a visit to a physician, Provider delay 
refers to a prolonged period of time between the initial medical consultation and the 
beginning of definitive treatment. It is also known as system or doctor delay. Pack and 
Gallo defined one month as "adequate time for the physician to take appropriate action. 
This first definition has been surprisingly preserved for 70 years in most studies of patient 
delay and provider delay (Saldana and Castaneda, 2009).   
cross-sectional study 180 patients with invasive breast cancer were interviewed about 
potential risk factors and markers of delayed presentation. Patient delay was defined as 
time from onset of symptoms to first consultation with a health care provider, and doctor 
delay was defined as time from first consultation with a health care provider to diagnosis 
of breast cancer, 17% delayed seeking consultation for longer than 3 months, and 42% 
reported a doctor delay of longer than 3 months, the study conclude Hospital referral from 
a health care provider was a major contributor to delayed diagnosis. Breast cancer 
awareness campaigns in Thailand should target individuals in low- and high-income 
groups, as well as practitioners (Poum et al., 2014)  
 
A cross-sectional study on female breast cancer patients in Jordan. The total number of 
participants was 327. The proportion of patients with presentation delay, diagnosis delay, 
and treatment delay was 32.2%, 49.1%, or 32.4%, respectively. The main reported reasons 
for delay in presentation were ignorance of the nature of the problem (65.6%), limited/lack 
of knowledge that symptoms were suggestive of cancer diagnosis (16.7%), and 
misdiagnosis (16. 7%).study conclude advanced stages at diagnosis and poor outcomes for 
breast cancer patients in Jordan. We recommend revising the current early detection and 
down-staging programs in Jordan (Abu-Helalah et al., 2016).  
Odongo et al., (2015) conducted a study among162 patients with newly discovered B.C in 
low income countries –Uganda, 139 (89 %) patients delayed by more than 3 months after 
noticing symptoms of breast anomaly. Patients with no social support from spouses and 
family were more likely to delay (OR = 7.1, 95 % CI 2.4–21.5, p = 0.001), those who 
perceived the symptoms as very serious were less likely to delay (OR = 0.2, 95 % CI 0.1–
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0.6, p = 0.007). There was a significant association between delayed presentation and 
advanced stage at presentation (p = 0.006).   
 
The delay in diagnosis and treatment is categorized into patient or provider.  Arndt et al. 
(2002) conducted a study among two hundred and eighty-seven Germany women in 
Saarland, a state with about 1 million inhabitants in Western Germany, aged 18 to 80 years 
with newly diagnosed invasive symptomatic breast cancer, were interviewed to the 
diagnostic process. Patient delay was defined as time from the onset of the first symptoms 
to the first consultation of a doctor. Eighteen per cent of all breast cancer patients waited 
longer than 3 months before consulting a physician.  The most common reasons for patient 
delay symptoms as harmless was the most important reason for more than half of the 
patients (55.3%) to delay seeking doctors‘ advice for more than 1 month. Time constraints 
(14.6%), considering symptoms as temporary (13.6%), and older women tended to 
consider their symptoms as temporary more often than middle aged or younger women 
(20.5% vs 11.6% vs 4.8%), a strong association between age and patient delay, the late 
stage breast cancer was found in 51.6% of all patients. It tended to be more frequent among 
women with patient delay of 43 months‘ delay (58.0%) than among women who consulted 
a doctor within 1 month after onset of symptoms (48.9%; Ptrend=0.22).                                                                                   
Pineros et al. (2009) conducted a study among Colombian women with breast cancer to 
assess characterized diagnosis and treatment of breast cancer in Bogota, Colombia and 
examine the extent and determinants of patient delay. The majority (65.9%) of 
symptomatic women consulted within the first month, 13.8% consulted within the first 
three months and 20.3% waited for more than three months. The most frequent reasons for 
delay among women with a more than 3-month-delay were: not considering symptoms to 
be important (32.9%), a lump that did not hurt (28.2%), fear of cancer diagnosis (7.9 %) 
and time constraints (7.6%). Analysis showed the following socio demographic variables 
as statistically associated with delay: older age (>65 years) (p= 0.019), lower education 
level (p= 0.000), poorer housing conditions (p= 0.011) and no affiliation with the health 
care system (p= 0.005). Diagnosis at advanced stages was also associated with delay (p= 
0.000).  
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Poum et al. (2014) conducted a study among 180 Thailand women factors associated with 
delayed first consultation for breast symptoms (patient delay), delayed diagnosis after first 
consultation (doctor delay), the study concludes 17% delayed seeking consultation for 
longer than 3 months, and 42% reported a doctor delay of longer than 1months. In 
multivariate linear analysis, a significant increase in patient delay was associated with 
higher family income and smoking; factors associated with increased doctor delay were 
previous breast symptoms, self-treatment, and travel time to the hospital.  
2.5 Obstacles which hinder patients from visiting the health care provider 
Several studies had been conducted on patient delay focusing on different factors affecting 
the delay. Norsa‘adah et al. (2011) conducted across sectional study   among breast cancer 
women in Malaysia, in this study diagnosis delay was defined when there was more than 6 
months from the recognition of symptoms to the histological diagnosis, consultation time 
is measured by the time from the first recognition of symptoms to the first general 
practitioners. 328 respondents were included in the study; most respondents had ductal 
carcinoma (89.3%), The frequency of diagnosis delay of more than 3 months was 72.6% 
and delay of more than 6 months occurred in 45.5% of the cases, the factors significantly 
associated with diagnosis delay were the use of alternative therapy, breast ulcer, palpable 
axillary lymph nodes, false-negative diagnostic test, non-cancer interpretation and a 
negative attitude tow treatment.  
Ermiah et al. (2012) conducted a study among 200 Libyan female breast cancer. The study 
concluded a number of factors associated with diagnosis delay: Symptoms were not 
considered serious in 54 (27%) patients. Alternative therapy was applied in 13.0% of the 
patients. Fear and shame prevented the visit to the doctor in which 10%respectively of the 
patients. 31 patients (15.5%) were inappropriately reassured after first medical visit that the 
lump was benign. Initial breast symptom(s) without a lump was strongly associated with 
diagnosis delay (p <0.0001).                                                                      
In a study conducted among Palestinian women in the West Bank , to assess screening 
behaviors in relation to cultural and environmental barriers with low screening for breast 
cancer , participant were 397 Palestinian women residing in the West Bank including 100 
from each district in the West Bank districts ; Bethlehem ,Hebron, Nablus, and Ramallah , 
the study shows greater than 70% of the women had never undergone mammography or 
clinical breast examination (CBE), whereas 62% performed self-breast examination 
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.Women were more likely to undergo mammography if they were less religious , and if 
they expressed lower personal barriers .Women were more likely to perform clinical breast 
examination if they were more educated, resided in cities, were Christian, were less 
religious, had a first degree relative with breast cancer, perceived higher effectiveness and 
benefits of clinical breast examination(Azaiza et al., 2010).  
 
Meechan et al. (2003) in a study to assess the relationship between delay and the type of 
breast symptom, women who had a breast lump waited a significantly shorter time period 
before visiting the doctor than those without a breast lump.  
 
Shaheen et al. (2011) conducted a study to investigate barriers and opportunities for breast 
cancer screening, the invited Palestinian women were divided into two groups. Group 
1women living in the Gaza Strip (WIG), and group 2 Palestinian women from Gaza who 
had been living outside the Gaza Strip for at least one year. The WOG group was 
comprised of women living in 9 different countries (Canada 19, Jordan 18, Saudi Arabia 7, 
United Arab Emirates 5, Egypt 2, United States 1, Kuwait 1, Japan 1, and Sweden 1). The 
survey data were organized into five categories: Demographics and risk factors, women‘s 
attitudes toward breast health, knowledge and misconceptions about breast cancer, cultural, 
religious and societal values, and resources and accessibility of medical services. The 
survey found that over 90% of both groups were willing to undergo a diagnostic 
mammogram for a breast complaint and 86% of WIG and 85% of WOG believed survival 
was increased with early detection. Only 27% of WIG and 50% WOG were willing to 
undergo screening mammography. Religion and culture were not barriers to 
mammography for over 94% of WIG and 98% of WOG. Limited resources and lack of 
access to medical facilities were identified as barriers in up to 55% of WIG compared to 
15% of WOG. Misconceptions about breast cancer were reported more frequently by WIG.  
Another study conducted among Arab Women in the United Arab Emirates to evaluate 
breast cancer awareness, knowledge, and practice, the study shows Women easily fall in 
misconceptions about breast lumps, nearly one third of the participants interpreted the 
presence of a breast lump, women who did not interpret as threatening or alarming sign of 
breast cancer. Nearly 57% of participants misunderstood screening as seeking medical 
attention only when having symptomatic breast complaint, Common barriers towards 
screening included fear of pain and embarrassment, fear of radiation causing cancer, and 
perceived inadequate facilities (Elobaid et al., 2014).  
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Neal and Allgar. (2005) conducted study among 65192 patients in England with one of six 
types of cancer (female breast, colorectal, prostate, NHL, lung, and ovarian in England, 
Various components of delays (patient and primary care delays, referral delays, secondary 
delays, and total delays) were calculated from answers to questions about their cancer, the 
study concluded. These were as follows: sex – female subjects had longer delays than 
males; age – younger people had longer delays than older people; marital status – single 
and separated/divorced people had longer delays than married people; social class – lower 
social class groups had longer delays than higher social class groups; and ethnic group – 
Black and south Asian people had longer delays than white people.                                                                            
Another study conducted among British women to assess knowledge and beliefs regarding 
breast cancer, the study concluded that poorer knowledge of symptoms and risks among 
older women may help to explain the strong association between older age and delay in 
help-seeking. In the current sample, women aged 35 – 59 years were perceived to be most 
at risk of developing breast cancer. Breast cancer is the single commonest cause of death 
among women aged40 – 50. However, in absolute terms advancing age is the greatest risk 
factor for developing breast cancer. approximately one-third of all breast cancers occur in 
women aged over 70.  The Knowledge of symptoms was poorer among older women and 
women who had never been employed. Older women were less likely to perceive nipple 
eczema, changes in the shape or size of the breast and nipple retraction as symptoms of 
breast cancer. It is possible that older women attribute such symptoms to the ageing 
process (Grunfeld et al., 2002).  
 
However, in absolute terms advancing age is the greatest risk factor for developing breast 
cancer Approximately one-third of all breast cancers occur in women aged over 70 
(Partridge et al., 2012).  
 
Another study carried out  among Arab women living in  Qatar , to assess Beliefs and 
attitudes about breast cancer and  screening practices , the study concluded that the main 
reasons given for not planning BCS were lack of a doctor‘s recommendation, fear, and 
embarrassment , the study indicated that a variety of channels (health care providers, 
media, breast cancer survivors, community leaders) should be utilized to create culturally 
appropriate breast cancer intervention programs and increased awareness of breast cancer 
(Donnelly et al., 2013).  
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2154 Nigerian breast cancer patients of all ages and socio-economic groups, 87% 
presented in Stages III or IV and only 13% in Stages I or II. All were questioned on their 
reasons for not attending hospital sooner. The most common reason for delay (963 
patients, 44.7%) was fear of mastectomy. Other reasons given include preference for 
prayer houses or spiritual healing homes in 291 patients (13.5%) a belief that the lesion 
was inflammatory in 183 (8.5%), preference for native doctors or herbalists in 497 (23.1%) 
and economic reasons in 220 (10.2%) (Ajekigbe, 1991). 
2.6 Patient delay. 
 2.6.1 Socio economic variables and patient delay   
The social and the culture role that women play in the Arab community and the social 
stigma around breast cancer may have prevented the early detection of the disease. Many 
factors play a role in creating cancer disparities. Some of these factors are socio-economic 
status, culture, and social injustice, with poverty being the dominant factor (Elobaid, 
2014).  
 
In the study occur among Iranian B.C women the study clarifies that the age of the higher 
risk of age group 40–49 years and the advent of advanced breast cancer (Otaghvar et al., 
2015). 
 
Innos et al. (2013) clarify the risk of prolonged delay of breast cancer diagnosis was 
significantly associated with age 65 years and over (OR 2.27, 95% CI 1.23–4.20), the same 
study clarify Non-significant risk increase was seen with lower education. 
 
Linsell et al. (2008), Rauscher etal. (2010) Clarify that older women they are more at risk 
of breast cancer and more likely to delay seeking help with breast cancer symptoms than 
younger women. 
 
Najjar and Easson. (2010) clarify the impression among Arab Physicians dealing with 
breast cancer is that it presents at an earlier age and at a more advanced stage as compared 
to western countries. However, the statistical data to support this impression is remarkably 
scarce, twenty-eight articles were identified and reviewed, we performed a comprehensive 
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literature review of reports of breast cancer in Arab countries. Articles were identified from 
Saudi Arabia, Bahrain, Qatar, Kuwait, Emirate, Oman, Yemen, Iraq, Syria, Jordan, 
Lebanon, Egypt, Libya, Algeria, Tunis, Morocco, and Sudan. the average age was 48 (SD 
¼ 2.8), range 43e52, median 48.5 and mode 45 years among the 7455 patients included. 
 
Alhurishi et al. (2011) assess Factors Influencing Late Presentation for Breast Cancer in 
the Middle East, the study revealed Older age and lower educational level, Un married 
were found to have strong effects in explaining late presentation. 
In the study conducted among Iranian women, the study showed the association between 
the delay diagnosis and embarrassments, there is a powerful cultural belief that breasts are 
sexual organs that should not be discussed publicly (Khazaee et al., 2014). 
Although breast cancer historically has been more common in industrialized, affluent 
countries and among more affluent women in any given country (i.e., a positive 
socioeconomic gradient), incidence rates in poorer countries and among poorer women in 
more affluent countries (Krieger, 2002). 
Osborne et al. (2004) Clarify married women less delay and were at decreased risk for 
mortality after a diagnosis of breast cancer. Many of the health benefits enjoyed by married 
women are likely derived from increased social support and social networks. 
Burgess et al. (1998) Clarify the risk factors for patient delay included not disclosing the 
discovery of a symptom and needing to be prompted to attend the GP by someone else 
suggest that women's' help-seeking behavior is responsive to social influences. 
 
Chintamani et al. (2011) clarify factors that are responsible for the patient or provider 
delays in the diagnosis of breast cancer. The Literacy rates and rural background were 
found to be significant factors leading to a delay in reporting to a qualified doctor. 
 
Elzawawy et al. (2008) clarify Breast cancer problems are multi complex. Hence, there is 
no one single cause for the delay in seeking consultation. However, the main cause for 
delay is Fear of the socioeconomic consequences of the diagnosis of cancer, fear of therapy 
(chemo therapy) fears of pain and death and fear of disfigurement and mastectomy. 
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Rauscher et al. (2010) clarify Longer patient delay has been associated with low 
socioeconomic status, low income and low educated. 
 
Rauscher  et al. (2010) that married women and those with a negative family history of 
breast cancer waited longer than others before seeking care, Delay was associated with: 
older age, being married, lower income, unemployed women ,less education, place of 
residence (small cities), negative family history of breast cancer, belief in the fatality of 
breast cancer, lack of access to healthcare services, lack of knowledge of breast cancer 
symptoms, and denying the importance of breast self-examination. The main reasons given 
for the delay were: lack of knowledge regarding the necessity of such a visit, fear, 
negligence, lack of access to physicians, and poverty. 
 
Mclafferty et al. (2010) clarify Lack of transportation, long distances and travel times, and 
other spatial barriers reduce opportunities for early breast cancer detection. In the Arab 
world, culture and religion play a major role in facilitating or hindering screening and early 
detection of breast cancer (Elobaid, 2014).  
 
2.6.2 Health characteristics and patient delay 
Elobaid et al. (2014); Innos et al. (2013); Burgess et al. (1998) Clarify the risk of 
prolonged delay of breast cancer diagnosis was significantly associated with symptoms 
other than painless breast lump or breast pain.  
Stapleton et al. (2011) Pain is a very common symptom of any disease that draws attention 
to the site of the disease. In case of breast cancer, pain is most likely to occur in case of 
large tumors or ulceration, both of which are indicative of late-stage disease. In settings 
with low screening or early detection, lack of pain will delay a patient‘s attention toward a 
growing tumor and delay the process of. A history of past benign breast problems became 
associated with prolonged patient delay (Rauscher et al., 2010).  
2.6.3 Health seeking behavior and patient delay  
the results of lack of awareness about breast cancer either the knowledge of breast cancer 
symptoms or attitudes towards help-seeking or both, taken together increased delay time 
for the diagnosis of breast cancer (Nurleli et al., 2014; Montazeri et al., 2008; Gilani et al., 
2010). 
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Innos et al. (2013) Clarify the risk of prolonged delay of breast cancer diagnosis was 
significantly associated with no history of mammograms (OR 1.83, 95% CI 1.13–2.95), 
having received no information on breast cancer during past year (OR 1.77, 95% CI 1.05–
2.99), and previous benign breast problems (OR 1.65, 95% CI 1.01–2.67).  
 
2.7 Reasons which make it difficult for the health care provider to an early diagnosis 
Many studies discuss the patient delay factors, however, provider delay from diagnosis to 
start of treatment has not been fully examined. Delays in the diagnosis process, referral of 
women after diagnosis or delay in treatment initiation is likely to result in tumor 
progression and poor prognosis (Arndt et al., 2003). 
 
In a study to assess factor associated with provider delay. study conclude In univariate 
analysis, delay was significantly associated with higher parity (P < 0.05), early age at first 
birth (P < 0.01), previous breast symptoms (P < 0.01), first consultation at a general health 
care center (P < 0.05),first consultation with a doctor rather than another type of health 
care worker (P < 0.05), inconclusive initial diagnosis (P < 0.05), longer distance to hospital 
(P < 0.05), longer travel time to hospital (P < 0.01), and higher number of consultations 
with a surgeon before diagnosis (P < 0.01)(Poum et al., 2014). 
 
Goncalves et al. (2014) reported at least a barrier in the trajectory of care for breast cancer. 
The organizational and health services barriers, were the most reported in the periods of 
investigation and treatment of breast cancer.  the barriers should be considered in public 
health policies and programs for the control of breast cancer. 
 
The early diagnosis and determination of the exact size of the tumor before surgery is 
important in choosing a therapy plan. The decision on the therapy of invasive breast cancer 
depends on several factors such as cancer stage, tumor size and type, pathological and 
cytological status of the tumor, the patient's opinion, the presence or absence of estrogen 
and progesterone receptors in the cytoplasm of tumor cells and so on (Otaghvar et al., 
2015).  
 
 
26 
 
Burgess et al. (1998) Clarify Presenting women with breast cancer to the GP with a breast 
symptom that did not include a lump independently predicted general practitioner delay. 
Delay in diagnosis of breast cancer is the most common clinical scenario resulting in 
malpractice litigation. Tartter et al. (1999) clarify Physician delay in the diagnosis of breast 
cancer is common, and patients with delay are similar to patients without delay, the 
consequences of physician delay in terms of stage at diagnosis, treatment and outcome 
were not statistically significant. 
 
The one reason for late stage of breast cancer, is the absence of the proportion women who 
obtain screening mammography. Taplin et al. (2002) conducted this study among seven 
health care plans participating in the Cancer Research Network Among all screening 
women, the odds of having late-stage cancer were higher among women with an absence 
of screening (OR _ 2.17, 95% CI _ 1.84 to 2.56; P<.001). Among case patients, women 
were more likely to being the absence-of-screening group if they were aged 75 years or 
older (OR _ 2.77, 95% CI _ 2.10 to 3.65), unmarried (OR_ 1.78, 95% CI _ 1.41 to 2.24), or 
without a family history of breast cancer (OR _ 1.84, 95% CI _ 1.45 to 2.34). A higher 
proportion of women from census blocks with less education (58.5% versus 49.4%; P _ 
.003) or lower median annual income (54.4% versus 42.9%; P _ .004). The study also 
concluded to reduce late-stage breast cancer occurrence, reaching unscreened women, 
including elderly, unmarried, low-income, and less educated women. 
 
Jassem et al. (2013) conducted a study among 6588 female breast cancer patients from 12 
countries were surveyed, based on a questionnaire survey conducted in 2011. The majority 
of patients were aged 40–69 years. The most common first sign of BC detected by self-
examination was a breast lump (>65% in all countries). Less frequent symptoms included 
breast pain, nipple or skin changes and nipple discharge. Several studies reported, 
diagnosis delays in the range of 3–6months between the onset of symptoms and the start of 
treatment had a significantly adverse impact on survival. In this study delay in medical 
advice and diagnosis of breast cancer remains a serious problem and breast health 
awareness and education may positively impact early detection, diagnosis and treatment. 
The study recommended identifying groups of women with an increased risk of a delay 
and building programs that promote timely access to care. 
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Arndt et al. (2003) conducted a study among Germany breast cancer women to assess 
provider delay. Provider delay was defined as the duration from first consultation of index 
disease until start of treatment. In this study, it was found a median delay of 15 days 
between first consultation and onset of treatment. Provider delay over 3 months was found 
in 11% of all breast cancer cases and was associated with patient characteristics, higher 
education (odds ratio_ 2.6; 95% confidence interval, 1.3 to 5.4), full-time employment (OR 
_ 2.5; 95% CI, 1.1 to 5.5), family history of breast cancer (OR _ 2.8; 95% CI, 1.2 to 6.2), 
and presenting with a non–breast symptom (OR _ 4.3; 95% CI, 1.7 to 10.9).  
 
2.8 Diagnosis delay and tumor stage  
The impact of breast cancer delay on survival and clinical staging, differs on study 
conclusion.  may be due to differing sample characteristics including patients in all clinical 
stages or only patients with specific staging cancer, differences in the delay interval studied 
(patient, diagnostic, treatment, provider, total delay or different combinations, differences 
in time periods used to define delay e.g. 1, 2, 3, 6 months (Saldana, 2009).    
In the same study which was conducted on 200 Libyan female breast cancer, the study also 
conclude late clinical stage of breast cancer was found in 65.5% of all patients and it 
tended to be more frequent among women with diagnosis delay >6 months (89.3%) than 
among women who had diagnosed < 3 months after onset of symptoms (23%; p < 0.0001). 
Diagnosis delay was significantly associated with large tumor size (T3 and T4; p < 0.0001) 
and with positive lymph nodes (N2, N3; P < 0.0001). 23 patients presented with metastasis 
at time of diagnosis, 91.3% of those had diagnosis delay >6 months (Ermiah et al., 2012).                  
In a study conducted in turkey breast cancer women to identify factors affecting the total 
delay time (TDT) in Turkish BC patients, 1031 patients with BC were surveyed. The time 
between discovering the first symptom and signing up for the first medical visit (patient 
delay time; PDT) and the time between the first medical visit and the start of therapy 
(system delay time; SDT). The relationship between TDT and cancer progression 
indicators (tumor size, nodal spread and metastasis) was analyzed. Findings showed that 
for all three indicators there were statistically significant differences (P < 0.001) in mean 
TDT depending on how advanced the symptoms were. Specifically, longer diagnostic 
times were associated with larger tumor sizes, affected lymph nodes and metastasis 
(Ozmen et al., 2014).  
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Montazeri et al. (2003) conducted a study in Tehran Iran to examine the extent of patient 
delay and associated factors in the presentation of breast cancer. The study concludes a 
Significant association were found between delay presentation and the late stage disease (P 
= 0.01) and bigger tumor size (P = 0.004). 
 
 
Table 2.2 Association between Iranian patients delay diagnosis and stage 
 
2.8.1 Staging process  
National Cancer Institute in 2009 defined staging as the process where breast cancer spread 
within or to other parts of the body. 
• Early breast cancer 
o Stage 0: Carcinoma in situ or disease that has not invaded the basement 
membrane. 
o Stage I: Small primary tumor without lymph node involvement. 
o Stage II: Involvement of regional lymph nodes. 
• Locally advanced breast cancer 
o Stage III: Usually a large tumor with extensive nodal involvement in which 
node or tumor is fixed to the chest wall; also includes inflammatory breast 
cancer, which is rapidly progressive. 
• Advanced or metastatic breast cancer 
o Stage IV: Metastases in organs distant from the primary tumor. 
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2.8.2 Stages and survival rate 
 
American Cancer Society, (2014) clarify that Stages and survival of breast cancer The five-
year survival rate can be calculated. Based on the prognostic factors the survival rate 
increases or decreases. 
 
 
 
 
 
Table 2.3 Stages and survival of breast cancer according ACS 
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CHAPTER THREE 
Conceptual framework 
3.1 introduction 
In this chapter the study major definition, theoretical framework, and study conceptual 
framework will be presented.   
 3.2 Breast cancer definition:  
Breast cancer is a malignant (cancer) tumor that starts in the cells of the breast. It is found 
mostly in women, but men can get breast cancer (American cancer society,2014). Breast 
cancer occurs when malignant tumors develop in the breast.  These cells can spread by 
breaking away from the original tumor and entering blood vessels or lymph vessels, which 
branch into tissues throughout the body (National Breast Cancer Foundation, 2015).                                                                                     
3.3 Diagnosis delay: 
Delay in  this context  is used to describe the waiting time in the diagnostic process , 
usually delay is divided into patient and provider delay (Facione,1993) 14 , The full period 
of delay usually refers  to total delay and includes the period from first symptoms until the 
start of treatment.  
Delay is often defined and measured in several different ways, Pack and Gallo (1938) 
originally defined two main types of delay. (1) Patient delay and (2) Provider delay. Patient 
delay is defined as the time elapsed from the discovery of symptom by the patient to first 
medical consultation m, three months or more elapsed time between discovery of 
symptoms and a visit to a physician. Provider delay is defined as more than one month 
between the first medical consultation and the initiation of definitive treatment, Provider 
delay, sometimes referred to as system or clinical delay. 
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Breast cancer delay or total delay is defined as ―more than three months between symptom 
discovery by the patient and the beginning of definitive treatment )Pack & Gallo, 1938) 
Finally, as literature clarify on this topic Diagnostic delay is a variation of patient delay or 
provider delay or sum of these total delay.   
 
 
 
 
Figure 3.1Types of delay along the breast cancer are continuum (Pack & Gallo, 1938).  
3.4 Staging and tumor size:  The stage is usually described as the extent of the cancer in 
the body. It is based on whether the cancer is invasive or non-invasive. The size of the 
tumor and of how many lymph nodes are involved and if it has spread to other parts of the 
body.  In this study breast cancer stage is one of the important factors to determine the 
effect of diagnosis delay (American Cancer Society. 2014). Also stages of cancer have 
been categorized into two groups, Early Stage (I & II) and Late Stage (III & IV) (Breast 
cancer organization 2012). 
3.5 Stage and Delay  
In one reason for studying delay to know the effects on breast cancer stage at diagnosis. 
all; patient delay, provider delay, total delay over three months are associated with poor 
survival and worse prognosis (Arndt et al., 2002; Gullatte et al., 2006; Partridge et al, 
2012; Ermiah et al., 2012).  
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3.6 Theoretical Framework of the study  
The Health Belief model formed the theoretical basis for this study. 
3.6.1 The Health Belief Model (Wikipedia. 2016) 
One can define "The Health Belief Model" is a model which assumes that people who 
dread diseases and so the health actions are motivated by the degree of the perceived fear 
or threat and the estimated fear decreased action. This possible decrease prevails over both 
the physical and the physiological barriers and takes action to enable participation in 
productive health actions. In sum, it stresses the hypotheses of a health belief model. It 
includes and uses four concepts. The chart above may facilitate the concepts. 
Perceived susceptibility: This is obvious with women who could be at risk of developing 
breast cancer and that motivates them to run breast screening. When women perceived that 
they might be subject to breast cancer, they are expected to take up early breast detection 
in the event that they suspected any breast changes.  
Perceived severity: This is the women‘s attitude on the gravity of developing fatal breast 
cancer. Women would change their health behavior and take up breast early detection and 
take advice from the health provider depending on how serious they consider the 
consequences of developing deadly breast cancer.  
Perceived benefits: This is the women‘s estimation of the efficacy of early breast 
diagnosis as a procedure of reducing the effects of later stage of breast cancer. Women 
would early seek help for breast cancer when they are sure that early diagnosis would be 
viable and helpful.  
Perceived barrier: This is the women‘s belief of the physical and psychological cost of 
running an early breast diagnosis against not taking it up. These comprised the physical, 
psychosocial, economic and demographic variables that would inhibit breast early 
diagnosis acceptance.  
Cues to action: The woman‘s own integrity could internally drive her to accept early 
breast diagnosis to lessen risks of developing lethal breast cancer. Outer factors like media 
ads, awareness campaigns and posters would apt the women to take up early diagnosis to 
enable women to overcome the psychosocial, demographic and physical barriers and bring 
about early diagnosis approval. 
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This study assumes this model because it explains certain health behavior; it has also helps to 
escort the search for "why" these behaviors arise and to plug for possible change. Using this 
structure, change plans that can be intended such as developing messages that are possible to 
convince women to make healthy decisions. Using the HBM, messages that are suitable to 
health education for breast self-examination and early diagnosis other positive behavior change 
can be developed. 
 
3.7 Conceptual Framework of the Study  
 
 
Figure 3.2: Study conceptual framework (self-developed) 
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3.8 Socio demographic status                                                  
To investigate the socio demographic aspect we have to take into consideration some 
important factors such as the place of residence; rural or urban .In a study conducted in 
Egypt to determine the breast cancer survival time and explore the association between the 
breast cancer survival and socio-demographic of diagnosis in El-Minia Governorate, the 
study shows a statistically significant relation between breast cancer survival and lower 
education and occupation with low income and with a residence in rural areas (Seedhom 
and Kamal, 2011).  
 
Life satisfaction may have buffering effect on delay in seeking medical help for breast 
cancer, so high level satisfaction may be associated with shorter delay and low life 
satisfaction with longer delay (Ruddy et al., 2014).  
 
The conflicting finding about the influence of age on delay. Some of studies suggest that 
younger women more likely to delay than older women (Gnerlich et al., 2009). 
It is likely that younger women fear that her body image may distort as a result of surgery 
to remove her breast or part of it. Consequently, they postpone early diagnosis. 
 
On the other hand, most of studies reported that older women delayed seeking help 
significantly longer (Partridge et al., 2012; Macleod et al.,2009). Older women may 
attribute their breast symptoms due to physiological change related to aging process, or nit 
possible older women interpreted that due to medical problem such as chronic disease.  
Poorer knowledge of symptoms and risks among older women may help to explain the 
strong association between older age and delay in help-seeking (Grunfeld et al., 2002).   
 
Some study explores the relation of education women and delay of breast cancer diagnosis 
(Marcus et al., 2013) the study reported education women less likely to delay. It possible 
educated women more health awareness, and better informed about breast symptoms.  
 
Some study explores the relation of marital status and delay, the study revealed widowed 
and divorced women had a higher risk of delay. Perhaps one might argue that this could be 
explained by the fact that widowed and divorced women do not have enough motivation to 
seek help or care about themselves and lack support (Montazeri et al., 2003). 
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The financial status plays a decisive role in seeking health care. Many studies confirm that 
low-income women are more likely to wait a longer period of time following the onset of 
breast cancer symptoms before seeking medical treatment (Ruddy etal., 2014). 
study clarify that cost and not having a health insurance prevented women from 
performing breast cancer screening or early diagnosis B.C in Turkey, Jordan, Israel and 
Iraq (Donnelly et al., 2013). 
 
Altaf et al. (2011) clarify the factors responsible for late presentation of breast cancer 
revealed that most cases of breast cancer presented in advanced stage probably due to poor 
economic status, illiteracy and negligence by patients or their family members and general 
practitioners.            
3.9 Family health history.  Patient health history. Using of screening method. 
Meechan et al. (2002) reported that having family history with breast cancer was 
associated with shorter delay, may be due to fear from seeing family member suffering 
breast cancer. Memon et al. (2013) reported that the Most common reason for patient‘s 
delay in diagnosis of breast carcinoma is negative family history of breast cancer and 
vague attribution of the symptoms. 
 
The International Agency for Research on Cancer (IARC, 2012) concluded that the 25% 
reduction in mortality seen in the trials of mammographic screening and implies a 
reduction in breast cancer mortality of about 35% for women who are screened regularly. 
Several research has reported that previous general help- seeking habit is significant 
associated with decreased delay in seeking help, when the actual breast symptoms occur 
(Montazeri et al., 2008) 
In addition, a number of studies have shown the relationship between shorter delay and 
regular practices of self- examination, and mammogram screening (Naroozi and 
Tahmasebi, 2011; Weller and Campell, 2009) prospectively. These studies show that most 
women are not taking up breast cancer screening due to high illiteracy level and lack of 
knowledge about vital issues related to breast cancer and prevention measures. increasing the 
time interval of periodic mammography diminished the mortality reduction by allowing undetected 
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growth of interval cancers. Increasing the screening interval of women in their forties from annual 
to every 2 years or to every 3 years would diminish mortality reduction rates from 36% to 18% and 
to 4%, respectively (Tabar, 1996) 
3.10 Factors affecting women seeking care  
3.10.1 Symptoms of BC                                                   
One of the important factors affecting help seeking is to identify the symptoms variation of 
breast cancer. The nature of symptoms with lump or without it is important and affects the 
proper diagnosis in the right time. Meechan et al. (2003) clarifies that women who 
experience a breast lump are less likely to delay than women who experience other breast 
symptoms such as nipple discharge or a change in shape of the breast. 
 
Some women interpret their symptoms to breast disease other than breast cancer, and these 
symptoms would go away, women initially tended to evaluate and attribute breast 
symptoms as a non-serious cause as seen in other types of cancer (Khakbazan et al., 2014).  
 
In a study conducted among Iranian women to know the causes of delay in seeking 
treatment in patients with breast cancer the study suggests that women and even physicians 
need further information about breast cancer symptoms. Women need encouragement to 
seek medical advice when they encounter suspicious symptoms (Rastad et al., 2002). 
Knowledge of breast cancer symptoms play an important role in this point. 
 
It was reported by Norsa‘adah et al., (2011) that Perception of the seriousness of a 
symptom of breast cancer is dependent upon the first symptom and how fast the symptom 
changes and multiplies 
 
3.10.2 Emotional response 
                             
Women with breast symptoms have feeling with negative emotion such as fear and anxiety  
Fear of breast cancer is variously described as a facilitator or mostly it can be a barrier to 
seek medical advice. some studies stress that fear of breast cancer detection, fear of 
abandonment by spouse, fear of diagnosis, fear of mastectomy, pain mammography, fear 
of radiation, fear of disease, or fear of hospitalization and/or surgery have been reported as 
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barriers (Consedine et al., 2004; Jones et al., 2004). In addition to other factors such as 
shyness, embarrassment or thinking that the symptoms are not serious, studies have shown 
that it may be cause of the delay of an early diagnosis (Altwalbeh et al., 2015).  
The impact of various types of fear on the help seeking is not entirely clear, perceived 
seriousness of the symptom and fear about the consequences of delay such as the 
symptoms become worse or fear of death, this motivated woman to seek help (Khakbazan 
et al., 2014).  
 
3.10.3 Belief and knowledge                                            
 
The degree of belief about cancer, early detection, and early treatment are important for to 
improve prognosis. This varies from community to another. In the Arab country cancer is 
believed to be a stigma, both men and women who often try to conceal their diagnosis and 
avoid discussing it. If cancer is discussed, it often receives a label of ―that disease '' 
(Hazboun and Glennon, 2011). It is reported by Magrath, (2010) that an unknown number 
of patients in LMIC with overt cancer remain undiagnosed and untreated for various 
reasons ranging from wrong beliefs about the causes of cancer (e.g., evil spirits) and 
consequent stigmata, especially with genital cancers. Many studies clarify that there is a 
strong association between lower education and delay to seek health care. Educated people 
who are high school graduates or have completed higher levels of education have more 
control of their own healthcare decisions and seek health care earlier than people with 
lower education levels (Montazerietal, 2003). 
 
Seedhom and Kamal, (2011) Clarify that education may result in a higher degree of health 
awareness, better perception of breast cancer, related symptoms.  All will result in less 
delay in seeking medical care.  
 
In a study conducted among breast cancer patients in the UK to assess knowledge about 
breast cancer and preventive measures, the study revealed that most patients were 
unfamiliar with the subject of cancer. They expressed lack of knowledge of cancer as a 
disease and its symptoms. They identified a painless lump in the breast as sign of 
abnormality, but not cancer. They also did not know any non-lump breast symptoms 
(Karbanetal, 2011). Lack of knowledge about breast cancer was mentioned as an important 
factor delay in Iran (Montezeri et al., 2003). 
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3.10.4 Cultural dimension    
 
Nobody can overlock the cultural values which play a large role in seeking health care. 
Many women tend to keep their condition secret and thus their cancer may remain 
undiagnosed especially in the Arab countries. One can argue that the Middle Eastern Arab 
culture affects women‘s behavior by stating that Arab women have restricted access to 
health information outside their community because of traditional norms which are taken 
as a taboo that can't be violated which respects the high value placed on the role of women 
as mother and homemaker. Cancer is perceived as latent killer that is incurable and cause 
much suffering pain and fear. The disease was seen as part of one's destiny or god's will 
and therefore little could be done to change it. In addition, modesty and embarrassment in 
exposing one‘s body to strangers, religious practice, and gender preference are cultural 
barriers to seeking health care (Hazboun and Glennon, 2011).  
 
Ismail et al., 2013 conducted a study among females at Cairo University Hospital to 
explore the relation to factor that hinder early detection of breast cancer, findings indicate 
that the one most common factor is denying breast cancer, thinking it is only a simple 
mass.  
 
Lamptey et al. (2009) clarify Ignorance about breast cancer, fear of mastectomy, use herbal 
treatment, and perceived hastening of death were reported as among the commonest causes 
of delay for breast cancer patients. 
 
There are three major socialization blocks in Arab/Muslim culture that could impact the 
delivery of healthcare significantly. These are the family system, the role of the individual 
relative to social organization and the assignment of primary gender roles (Hammoud et 
al., 2005). 
Some Arab women believe that they are not at risk from breast cancer. Many of them feel 
uncomfortable about the idea of telling cancer of the breast by touching them. Cancer 
about symptoms is often shared only with their family to seek their support, although they 
would not talk about them with those outside the family. Such women believe it is not wise 
to keep bad feelings inside. These attitudes affect women's confidence and competence 
related to breast health practices include, breast self-examination, clinical breast exam and 
help seeking in the case of any breast symptoms.  
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3.10.5 Relationship status 
 
Relation status can be important for women with breast cancer .in appositive sense it can 
provide emotional support, material aid, advice and information, positive feedback, 
physical assistance. It also enhances the extent of encouragement to go for breast 
screening, early assessment and diagnosis. 
Marital status in women is possible to be a guiding role in influencing the Palestinian 
women in the early detection of breast cancer, especially in the eastern communities which 
follow the customs and traditions and the opinion of the partner (the husband) (Hazboun 
and Glennon, 2011). 
To be employed or unemployed is essential to influence the chances of an early detection. 
Whereas working women have the opportunity to express the symptoms of the disease to 
their colleagues who may suggest creative ideas to diagnose the disease, such as having 
early screening which could lead to an early detection. Unemployed women lack this 
opportunity (Hammoud et al., 2005). 
3.10.6 Physician and hospital service  
Most cancer in low- and middle-income countries (LMC) are detected at later stages than 
in high-income countries. It is commonly assumed that this late diagnosis is due to the 
population‘s lack of information and to deficient coverage of screening programs (Saldana 
and Castaneda, 2009).  
Health service is an important factor in the study of BC delay. Factors mentioned in 
previous studies such as the quality of health service, distant residence to the cancer center, 
administrative barriers to health care, medical error in diagnosis, the miss diagnosis such as 
mastitis, infections and other condition could lead to a delay to detect the disease and 
therefore a delay in treatment breast signs or symptoms other than lump. All these together 
are real problems in perusing early detection. Healthcare providers play an important role 
as enablers and facilitators for effective utilization of screening techniques and early 
detection of B.C. Not receiving a recommendation by healthcare provider to perform 
screening has been found to be a barrier for participation in screening (Azaiza& Cohen, 
2006) 
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CHAPTER FOUR 
Methodology 
 
4.1 Introduction in this chapter, research design, study setting, study population, inclusion 
criteria, sampling method, sample size, Data sources and study tools, questionnaire 
validation, reliability, piloting, fieldwork techniques, method of data analysis, ethical 
consideration and study variable. 
4.2 Research design                                                                                                         
 
This study adopts a descriptive cross sectional study design, the design was preferred to 
obtain and investigate the factors affecting BC diagnosis delay among women treated at 
the BJGH. utilizing the quantitative data methods, targeted women were interviewed from 
day care ward, oncology ward and outpatient clinics, data about tumor size and cancer 
staging were collected from medical records.     
The advantages of this type of study design are that it is straightforward, relatively 
inexpensive, and could be conducted quickly. Thus, this type of design facilitated the 
completion of this study 
4.3 Study setting: 
BJGH was established in 1908. It is located in Beit Jala city – Southern West Bank. It is a 
central hospital in the southern West Bank and the only referral hospital for all patients 
with cancer particularly from that area. It is the first place to be contacted for the diagnosis 
and treatment of cancer patients. 
The oncology ward provides healthcare services for cancer patients including; diagnostic 
procedures such as; medical imaging, laboratory testing, histopathology and therapeutic 
care such as surgery and chemotherapy. Also cancer patients come to day care ward for 
patients when admitted to receive chemotherapy treatment. Cancer patients are followed up 
in the outpatient oncology clinics. 
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4.4 Study population                                                                                                      
 
The study population involved all women with confirm breast cancer, at any stage, 
attending BJGH, who treatment at day care cancer ward or oncology ward, besides women 
who come to follow –up in outpatient oncology clinic, during the study period. 
 
4.5 Study period 
The study was carried out during the period November 2015to May 2016. The 
questionnaire, the consent form, Ministry of Health approval and permission, and the 
logistic preparation were all ready by the end of January 2016. Data collection and the 
study population interviews started in November 2015. Three months later, the number of 
eligible participants that were included in the study was 194. 
 
4.6 Inclusion criteria                                                                                                       
 Any patient women diagnosed with breast cancer of any aged, being treated in day 
care cancer ward or oncology clinic or admitted to oncology ward during the 
research period.  
 confirm breast cancer diagnosis and is documented in medical record.                        
 participants consent to participate in the study was required.                                        
 4.7 Sampling method and Sample size 
 
There is no official statistics that show the total number of women with breast cancer 
attending BJGH. When reviewing the annual report of MOH for the years 211-2013 the 
number of new diagnosed breast cancer cases in west bank was 375 cases, so 60% of the 
total population all be included in the study as the following:357*60\100= 214 participants 
will be selected. Those patients have to attend the clinics for follow up or the day care 
ward for chemo therapy at least once monthly. In addition to cases seen in the oncology 
department. Therefore, Convenience sampling will be utilized on all breast cancer patients 
attended BJGH during the study period were included in the study sample. The total 
number of the study cases was diagnosed by histo- pathological examination was 194 
participants. 
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4.8 Data sources and study tools 
 
4.8.1 Participants medical record  
After selecting the study case participant, his medical record was explored to ascertain the 
TNM classification of each participant.  
 
4.8.2 The Questionnaire  
The questionnaire was developed using several previously validated questionnaires. 
Especially the questionnaire of the study done by faired. (2009) among Jordanian women 
in the King Hussein Cancer Center. The questionnaire consisted of four parts (Annex 1) 
 
Part 1: the social and demographic characteristics of the patient such as, age, place of 
residence, educational level, marital status, career and economical and financial situation.  
 
Part 2: is concerned Information related to patient and family health history, and the 
occurrences of breast screening and periodic follow-up to detect breast cancer. This part 
suggests question as if any of the family member had ever had breast cancer, if she has 
complained of abreast lump, if she has run breast self-exam, mammogram or breast clinical 
exam. 
 
Part 3: is concerned with the initial symptoms of breast cancer, the way it was discovered, 
the reason of diagnosis delay. This part concentrate on question such as; the first sign 
which motivates the patient to visit the doctor, the first time visiting the practitioner, the 
time it takes between the first visit to the practitioner and the final diagnosis confirming the 
disease through histopathology examination.  
 
Part 4: And lastly, the patients‘ records were investigated by the researcher to identify the 
stage of breast cancer for each woman participated in the study. Here the researcher refers 
to medical record file stored in the computer after taking the permission from the 
specialist. The researcher concentrated on the following issues to identify; the stage of 
breast cancer, lymph nodes if affected, the tumor size and finally if cancer is metastases or 
not  
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3.9 Questionnaire validation, reliability and piloting  
A. Validity 
  
The validation of the questionnaire proceeded in two forms. The first was after the 
questionnaire has been distributed and has been reviewed by three specialists in the field 
who provided some comments on the tool. The second form involved the implementation 
of a pilot study (N=20) to validate the survey using exploratory factor analysis.   The Table 
(2.3) shows the exploratory factor analysis of all the paragraphs of the table (The reasons 
of patient delay) is statistically significant, enjoying an acceptable degree of validity, and 
they share together in measuring the associated factors in breast cancer diagnosis. 
 
B. Reliability 
 
In order to check the reliability of study questionnaire a Cronbach's Alpha coefficient test 
was done on the section of the questionnaire (The reason of patient delay). the result 
showed 0.93, indicating very good reliability in the study questionnaire.  
 
C. Pilot study  
 
A pilot study for the questionnaire was conducted before collecting the results of the 
sample. The sample for pilot study will be chosen in the same way we choose the sample 
for the study as it has been chosen from BJGH. 10% out of 194 breast cancer female will 
be chosen, 20 subjects will be chosen to have a preliminary test for the questionnaire This 
helped in checking whether the tool used was reliable and valid. The pilot study is 
important here to evaluate the questionnaire. The results will clarify the women 
understanding and the rate of acceptance of the questionnaire.  
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3.10 Data collection procedure  
The data was of two parts; the first part was performed through a constructed questionnaire 
where the data was collected from interviewed women directly. The questionnaire was 
carried out by a trained nurse, who was supervised by the study researcher.  
The second part was a revision of each target woman's medical records to collect data 
about staging and tumor size.       
 In order to minimize recall bias, the study participants were asked to remember the onset 
of symptoms and the day of first consultation with the help of a calendar and files.    
 
3.11 Method of data analysis  
Each participant was identified by a medical serial number. also used this medical serial 
number to refer to the participant's file stored in the pc to know the staging of the disease 
for each participant. The data collected was analyzed using the Statistical Package for 
Social Sciences (IBM SPSS 20). Frequent cheeks were made throughout the process of 
data entry.  Descriptive statistics include means and standard division were used for 
quantitative data. We use Chi – Square test to determine the association between dependent 
and independent variables. if the p- value of the test was ≤ 0.05, the association was 
considered significant at the 0.05 level.  
4.12 Ethical consideration  
The approval of this study from AL- Quds University – school of public health research 
committee and Al-Quds University Graduate study committee. Permission was granted 
from MOH to access the patients and their records and only by the researcher. For the 
participants; the study goal was explained, privacy and confidentiality was maintained and 
the women were informed that their participation would be voluntary and their withdrawal 
from the study at any time would not be a problem. 
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4.13 Study variable: 
 
A. Dependent variable: 
1. Breast cancer women treated at BJGH.  
2. Diagnosis delay; patient delay and provider delay  
3. Stage of breast cancer 
 
B. Independent variable: 
The independent variables for this study were;  
1. Socio demographic status (age, place of residence, educational level, Marital 
Status, age at marriage, occupation, Monthly income)                                                                                           
2. Patient health history, Family health history, Using of screening method. 
3. Factors affecting women seeking care (Symptoms of BC, Emotional response, 
Belief and knowledge, Cultural, Relationship status, Physician and hospital service) 
 
4.13 Limitations of the study 
 
 The study result cannot be generalized to Palestinian women with BC, because the 
study limited at women who were diagnosed at BJGH. 
 
 Recall bias, especially question related to recall of the duration from onset of 
symptoms to the first medical visit and question related to patients first visit the 
doctor to final diagnosis, it may have been wrongly estimated, especially in case 
with longer delay. And question related to behavior of breast screening, type of 
initial symptoms. 
 
 Information bias, it could be women provide inaccurate information especially 
question related to, reasons for delay, some women consider that as privet 
information.            
 
 
 
 
 
46 
 
 
 
Chapter Five 
 
 The Results 
 
 
5.1 Introduction  
 
In this chapter, study results will be presented, Study population characteristics will be 
shown in descriptive analysis. Univariate and multivariate analysis will be presented in this 
chapter.  
 
5.2 characteristics of participants 
 
Table 5.1 shows that 36.1 % of the study population was age between 46-60 years. Of 
them, 80.8 % were married and 34.0% their age of marriage was between 18-25 years old. 
Of the study population, 20.7 % was secondary school, Also, 71.1 % of study population 
lived in a city. While 91.7 % were housewife and 63.5% had a monthly income less than or 
equal 1000 NIS.   
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Table 5.1 Characteristics of participants 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Total 
N=194 
%(N ( 
Age 
≤ 45 years 59 30.4 
46-60years 70 36.1 
≥60 years 65 33.5 
 
Place of 
residence 
City 138 71.1 
Village 51 26.3 
Camp 5 2.6 
 
Governorate 
Hebron 136 70.1 
Bethlehem 32 16.5 
central provinces 
Ramallah. Jarico 
22 11.4 
Northern 
provinces 
4 2.0 
 
Educational 
level 
 
not (reads and 
writes 
19 9.8 
Primary 35 18.1 
Preparatory 40 20.7 
Secondary 30 15.5 
Diploma 
Average 
37 19.2 
bachelor degree 
or high 
32 16.6 
Marital Status 
Single 8 4.1 
Married 156 80.8 
Divorced 29 15.0 
Age at 
marriage 
Widow 92 47.4 
18-25 years 66 34.0 
>25 years 29 14.9 
Occupation 
Housewife 177 91.7 
Retired 5 2.6 
Employee 11 5.7 
Monthly 
income of the 
family NIS 
 
<1000 122 63.5 
1001 -2000 37 19.3 
>2000 33 17.2 
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Table 5.2 The numbers and percentages of participant's chronic diseases.    
 
 
Yes No 
Do not 
know Total 
N 
# % # % # % 
High blood pressure 
36 0623 101 3422 1 322 161 
Diabetes 23 6226 110 4121 - 323 160 
Asthma 
60 1126 136 5423 1 322 160 
Any type of allergies 16 625 142 6326 - 323 161 
Chronic arthritis or acute 
 
63 1321 140 5623 - 323 161 
Digestive Disease 
 
10 324 153 6020 - 323 160 
Cardiovascular disease 
 
10 324 153 6020 - 323 160 
Self-immune system diseases. (Such as 
systemic lupus erythematous, rheumatic 
arthritis, etc.) 
 
61 1326 141 5523 1 322 160 
Recurrent infections 64 1123 131 5223 6 123 160 
Neurological or psychiatric disease 
 
66 1122 134 5423 0 123 166 
 
The table above shows that (62) patients have hypertension, and (50) patients have 
diabetes, and (23) have asthma, and (19) have various types of allergy, and (20) of chronic 
or cute arthritis (13) have digestive tract diseases, and (13) of cardiovascular disease, (21) 
suffer from the self-immune diseases, and (27) of repetitive infectious diseases, and (22) 
have neurological or psychological diseases. 
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Table 5.3 Medical history of patients and their families. 
 
 
Yes No 
Do not 
know 
Total 
N 
# % # % # % 
In the period before the discovery of the 
disease have you had the presence of mass, 
fibrous bags, milky secretions or 
inflammation in the breast? 
176 90.7 18 9.3 - - 194 
During the five years preceding the discovery 
of the cancer have you visited one of the 
doctors / physicians in order to carry out 
comprehensive checks to your body 
66 34.0 128 66.0 - - 194 
Is there anyone of the family members 
(mother, sister) has or had breast cancer? 33 17.1 160 82.9 - - 193 
Is there anyone of the relatives (Aunt, aunt, 
grandmother, uncle girl / H, girl Khal / e) 
suffering from breast cancer? 
23 11.9 171 88.1 - 0 194 
Is there anybody of the family members or 
relatives who suffers from any other type of 
cancer. 
43 22.3 150 77.7 - 0 193 
 
The data in the above table shows that the (176) of the women were suffering from a mass 
or fibrous bags or secretions, or inflammation of the breast, and (66) of the cases visit the 
doctor to do a comprehensive check-up for their bodies during the past five years, and (33) 
show that their mothers or sisters have /had breast cancer, and the results indicate that the 
(23) have it in their relatives and (43) have relatives who have grades cancer of different 
types and levels. 
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Table 5.4 Usages of breast self- examination(BSE)   
 
 
Yes No 
# % # % 
Before the diagnosis of the disease you have, 
do you know how to perform a breast self-
examination? 
79 40.7 115 59.3 
 
The data in the above table shows that the (79) cases only know how to BSE and that 
equals (40.7%) of the cases, compared with 115 cases who does not know about BSE, the 
following table shows the source of the patient's information and knowledge of BSE. 
 
Table 5.4.1 The source of information about BSE.  
 
 N % 
Awareness provided by the medical staff 50 63.3 
Online 6 7.6 
Television  8 10.1 
Family members  10 12.6 
Otherwise, 5 6.3 
Total N 79 100 
 
 
The previous table shows that 50 of the cases have received the knowledge of how to 
perform BSE from the medical staff, and (6) from the internet, and (8) from television, (10) 
from one of family members, (5) various sources. This shows the importance and the role 
of medical staff in educating women about cancer, also it shows the little the role of the 
family's in raising awareness about breast cancer. 
 
Table 5.4.2 The numbers and percentages of participants who took up BSE. 
 
 
Yes No 
# % # % 
Before the diagnosis of the disease 
you have, have you ever thought of 
Breast self-examination?  
67 34.5 127 65.5 
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The table shows that (67) cases carried out self-examination of the breast, a rate of 
(23.3%), before the discovery of the disease, the disease.  The following table shows how 
breast screening is done. 
 
Table 5.4.3The number of times that have made BSE. 
 
 N % 
I run breast self-examination once a month. 35 52.2 
.I run breast self-examination of three to four times a year. 12 17.9 
.I run breast self-examination once a year. 10 14.9 
Others 10 14.9 
Total N 67 100.0 
 
The above table shows that the (35) of the cases run BSE once a month.  We can also see 
that (12) of women have BSE three to four times a year, (10) of women have BSE once a 
year, (10) others. 
 
Table 5.5 Numbers and percentages of participants with previous knowledge about 
mammograms.  
 
 
Yes No 
Do not 
know 
# % # % # % 
Before the diagnosis of the disease you have, 
have you known what a mammogram is? 
21 10.8 172 88.7 1 0.5 
 
The above table shows that the (21) cases have knowledge about mammography before the 
discovery of the disease a rate of (10.8%). This a small percentage. Work should be done 
to raise awareness among women about mammography for breast. 
 
Table 5.5.1 Numbers and percentages of who performed a mammogram. 
 
 
Yes No 
# % # % 
Before the diagnosis of the disease you have, have you 
ever performed a mammogram? 
20 10.3 174 89.7 
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The table shows that the (20) cases only have mammography of the breast which equals 
(10.3%) of women with cancer. The following table shows the number of times women of 
breast cancer have mammography before the discovery of the disease. 
 
Table 5.5.2 Numbers and percentages of times that participants took up 
mammograms. 
 
 N % 
I took up mammogram everyone years. 16 80.0 
I took up mammogram every two years. 2 10.0 
I took up mammogram once every three to four years. 2 10.0 
Total N 20 100.0 
 
 
It is clear to us through the data in the table above that (80.0%) of cases is doing a 
mimeograph of the breast once a year. 
 
Table 5.6 Numbers and percentages of clinical breast examination(CBE).   
 
 
Yes No 
Total N 
# % # % 
Before the diagnosis of the disease you have, 
have you ever visited the doctor / before you 
run clinical breast examination? 
7 3.6 186 96.4 193 
 
The table shows that (7) cases visit the doctor to have clinical examination of the breast 
which equals (3.6%). The following table shows the number of times they visit the doctor. 
 
Table 5.6.1 Number of times participants took up CBE 
 
 N % 
I Perform the clinical breast examination once a year 5 71.4 
Other 2 28.6 
Total N 7 100.0 
 
 
The table shows that the (5) cases only visit the doctor to have clinical examination once a 
year. One case visits the doctor once in two or three years or more. 
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Table 5.7 The marks that appeared which urges you to search for health advice. 
(Warning symptoms of breast cancer). 
 
 
Yes No 
Do not 
know 
Total N 
# % # % # % 
Does the emergence of an un painful lump in 
one of breasts urge you to visit the doctor? 
175 90.2 19 9.8 - 0 194 
Were there changes and problems in the 
nipple? 
91 47.2 102 52.8 - 0 193 
Was there a pain in the breast? 
65 33.9 126 65.6 1 0.5 192 
Was there a change in the shape and size of 
breast? 34 17.5 160 82.5 - 0 194 
Was there a enlargement of the lymph nodes 
under the armpit? 35 18.2 156 81.3 1 0.5 192 
Was there a strange nature of secretions from 
the breast 40 20.8 152 79.2 - 0 192 
Was there a swilling in the breast itself? 
53 29.3 127 70.2 1 0.5 181 
 
The data shows that (175) cases appeared to have a painless mass in one breast. The lower 
marks were such a change in breast shape and size, a rate of 29.3%. 
 
 Table 5.7.1 The initial symptoms the participants have noticed 
 
 N % 
Un painful lump in one of breasts 132 71.0 
Nipple changes 19 10.2 
Breast pain 17 9.2 
lymph nodes enlargements   9 4.8 
Others  9 4.8 
Total N 186 100.0 
 
The table above shows that the most important first symptoms of the disease was the 
emergence of a painless mass in one of the breasts 71%. 
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Table 5.7.2 Who was the first to discover the symptoms that participants have 
mentioned in the previous answers, (i.e. the first sign of breast cancer you have) 
 
 N % 
 (the patient himself)  129 66.5 
The physician / doctor 51 26.3 
Through X-ray (mammography) and without conversing with the doctor 14 7.2 
Total N 194 100.0 
 
The table above shows that (66.5%) of the women figured out the signs of the disease 
themselves, and (26.3%) detected signs of the disease by visiting a doctor. And (7.2%) 
detected only signs of the disease through the x-ray images without conversion from a 
doctor. 
 
Table 5. 7.3 Upon the emergence of these previous symptoms you talked to.  
 
 N % 
I have not spoken to anyone. 96 50.0 
I told my husband. 69 35.9 
 I told a family member. 23 12.0 
Others 4 2.1 
Total N 192 100.0 
 
The data shows that (50.0%) of the cases didn't tell anybody about these signs and (35.9%) 
told their husbands about these signs, and (12.0%) told one of the family members. 
 
Table 5.8 The intervals between the firsts symptoms and visiting the doctor.   
 
 
 N % 
≤ 1 months 89 45.9 
≤3 months, > 1months  33 17.0 
> 3 months 72 37.1 
Total N 194 100.0 
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The table above shows that (45.9%) of the cases visit the doctor in less than a month period 
since the emergence of symptoms of breast cancer, and that (17.0%) during the period of 
between one month and three months, and (37.1%) visit the doctor after more than three 
months from the emergence of signs of illness. 
 
 
 
 
 
Figure 5.1Time interval between the first symptoms to first seek medical advice   
 
 
Table 5.9 The reasons for the delay to visit a doctor since the onset of symptoms. 
 
 
 Mean 
S.deve
ation 
% 
Did not take things seriously, believing that these symptoms will 
go away? 
4.90 0.417 98.0 
The embarrassment of visiting the doctor and breast 
examination 4.71 0.846 94.2 
Do not receive support from the spouse 
4.65 0.715 93.0 
The economic situation of the family does not allow it 
4.57 0.853 91.4 
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Fear of diagnosis of breast cancer 
4.54 0.821 90.8 
Fear of surgery 
4.43 0.990 88.6 
The impact on status as a female or spouse, loss of breast or part 
of it 4.17 1.021 83.4 
one of the family members suffering from breast cancer and I 
do not want to I suffer like her 4.03 0.919 80.6 
Belief that the therapy available for breast cancer leads to rapid 
death 3.99 0.896 79.8 
Do not receive support from the family 
3.89 0.912 77.8 
Seeking to use alternative therapies such as herbal medicine 
3.86 0.924 77.2 
Fear of mastectomy or part thereof 
3.71 0.863 74.2 
The refusal to go to a doctor and leaving to fate as whatever the 
outcome of breast cancer  3.64 0.737 72.8 
The lack of adequate time  
3.64 0.612 72.8 
The lack of a woman doctor or a specialist who can run breast 
examination? 3.53 0.627 70.6 
 
The table shows that the most important reason for the delay in the visit to the doctor was 
not taking the disease seriously, believing that it will disappear as an arithmetic mean 
(4.90) with a standard deviation (0.41), then followed by the shame to visit the doctor's and 
run a breast examination with a mean ( 4.71) with a standard deviation (0.84), followed by 
the lack of support from the spouse with a mean (4.65) with a standard deviation 
(0.71).The comes the economic situation of the family with a mean (4.57) and with a 
standard deviation (0.85) after that the fear of the diagnosis of the disease with a mean 
(4:54) with a standard deviation (0.82)Next, comes the lack of a doctor or specialist 
women for breast screening with a mean (3.53) and with a standard deviation (0.61). 
Finally comes the lack of time with a mean (3.64) with a standard deviation (0.62).  
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Table 5.12 Reasons that urged the participants for medical consultation after the 
delay.  
 
 
Yes No 
Do not 
know 
Total N 
# % # % # % 
symptoms persist. 163 84.9 27 14.1 2 1.0 192 
The feeling of fear that the 
symptoms of breast cancer may 
become worse if left untreated. 
160 84.2 27 14.2 3 1.6 190 
Curiosity if they are the symptoms 
of breast cancer. 117 62.9 62 33.3 7 3.8 186 
Advice from family and relatives. 87 55.1 97 43.7 2 1.3 158 
Symptoms become serious. 50 26.5 137 72.5 2 1.1 189 
Other reasons / Mention!................ 17 50.0 17 50.0 - 0.0 34 
 
 
The table above shows that (163) of cases were pushed to visit doctor because of the 
continuation of symptoms, and (160) cases were pushed because of fear that the symptoms 
of the disease become worse, and (117) were pushed to visit the doctor because of curiosity 
as to whether the symptoms are the symptoms of breast cancer, and (87) had been advised 
by family and relatives to visit the doctor, and (50) of the case visited the doctor after 
symptoms of the disease become more serious. 
 
Table 5.13 visit one of the doctors / physicians prior to the visit of BJGH.  
 
 
Yes 
# % 
Since the onset of symptoms, you have, did you visit 
one of the doctors / physicians prior to the visit of Beit 
Jala Governmental Hospital? 
 
193 100 
 
The table shows that patients had visited the doctor since the emergence of the symptoms 
of cancer have. 
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Table 5.13.1 The doctors the patients have reviewed since the onset of symptoms and 
before visiting BJGH the first time.  
 
 N % 
A general practitioner  32 16.6 
A gynecologist 60 31.1 
An oncologist 32 16.6 
A Surgeon 64 33.2 
Others!! Mention! 5 2.6 
Total N 193 100.0 
 
The table shows that (16.1%) of the cases had visited a GP once a year, and that the doctor 
(31.1%) visited (a gynecologist, and (16.6%) visited Oncologist, and (33.2%) visited a 
doctor surgery, and (2.6%) had visited other doctors. 
 
Table 5.13.2 The doctor's advice before being directed to BJGH. 
 
 
 N % 
I was asked to have a mammogram  51 26.4 
I have been transferred to BJGH / Oncology Clinic, to complete the 
tests. 
132 68.4 
I have been transferred to other Hospital to complete the tests. 4 2.1 
Being diagnosed as non-breast cancer case, it is only inflammation of 
the breast (mastitis)  
6 3.1 
Total N 193 100.0 
 
The table above shows that (26.4%) of the cases were requested to have an x-ray of the 
breast after the emergence of the first symptom, and (68.4%) were directed to Beit Jala 
Hospital and (2.1%) were transferred to other hospitals for testing, and that (3.1%) were 
diagnosed with breast cancer. 
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Table 5.16 The time took the patient to have an appointment for the oncology clinic 
 
 N % 
Less than a week 186 95.9 
Less than a month 7 3.6 
More than a month 1 0.5 
Total N 194 100.0 
 
 
5.17 The interval between the first visit and the final diagnosis.  
 
 N % 
≤ 1week 23 11.9 
≤ 1month, > 1 weak 80 41.2 
>1month 91 46.9 
Total N 194 100.0 
 
 
The table above shows that (11.9%) of the cases took less than a week between the first 
visit to the doctor and the final diagnosis of the disease, and (41.2%) took less than a 
month's period, and (46.9%) took them a period more than a month from the first visit and 
the final diagnosis of the disease. 
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Figure 5.2 Time interval between first visit to final diagnosis 
 
 
 
Table 5.18 Total delay includes the period from first symptoms till the confirmation 
of the B.C to start the treatment (patient and provider delay). 
 
 N % 
≤ 1 months 10 5.2 
≤ 3moths, > 1 months 66 34.0 
3> 118 60.8 
Total N 194 100.0 
 
 
The table above shows that (5.2%) of the cases have reached the final diagnosis of the 
disease in less than a month's period from the emergence of symptoms of breast cancer, 
and it took (34.0%) period of between one month and three months, and (60.8%) have 
reached the final diagnosis of the disease after more than three months. 
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Table 5.19The treatment that has undergone since the time was diagnosed as breast 
cancer.  
 
 
Yes No 
Total N 
# % # % 
Mastectomy. 52 98.1 1 1.9 53 
Partial mastectomy.  89 100.0 - 0.0 89 
Lumpectomy 
121 98.4 2 1.6 123 
Radiotherapy 
136 99.3 1 0.7 137 
Chemotherapy. 
159 99.4 1 0.6 160 
Hormonal therapy. 
76 97.4 2 2.3 78 
Immunotherapy. 
6 85.7 1 14.3 7 
 
Table 5.19.1 Guidance to Palliative Care 
 
 
Yes No 
Total N 
# % # % 
Were you guided to the Palliative Care 69 35.8 124 64.2 193 
 
The table above shows that (69) cases have been transferred and guided to Palliative Care. 
 
Table 5.19.2 The place of palliative care 
 
 N % 
Part of the treatment performed in the hospital 36 52.2 
Home care (home) 31 44.9 
Others 2 2.8 
Total N 69 100.0 
The table shows that (52.2%) of the cases receive part of the treatment in the hospital, and 
(44.9%) receive home care, and (1.4%) receive different care, as well (1.4%) receive 
treatment part in hospital and the other part through homecare. 
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Table 5.20 Staging and TNM classification of participants  
 
 
 
 
N % 
Stage 
 
Stage 1 44 23.9 
Stage 2 53 28.8 
Stage 3 49 26.6 
Stage 4 38 20.7 
T  
T1 52 8.1 
T2 68 36.8 
T3 52 28.1 
T4 13 7.0 
N 
N0 81 43.8 
N1 48 25.9 
N2 47 25.4 
N3 9 4.9 
M 
M0 147 79.5 
M1 37 20.0 
MX 1 0.5 
 
 
The table shows that, 52.7% of cases have Early stage (stage 1and 2), 47.3% of cases have 
Late stage (stage 3and 4). The study showed that 20% of women with breast cancer have 
metastasis. 
 
Table 5. 21 The association between socio demographic status and delay to visit a 
doctor to tell him about those symptoms 
 
 ≤ 1 months 
≤ 3moths, > 
1 months 3months> Total N df P 
value # % # % # % # % 
Age 
≤ 45 years 29 32.6 13 39.4 17 23.6 59 30.4 
4 0.010 46-60years 27 30.3 6 18.2 37 51.4 70 36.1 
≥60 years 33 37.1 14 42.4 18 25.0 65 33.5 
 
Place of 
residence 
City 62 69.7 20 60.6 56 77.8 138 71.1 
4 0.238 Village 24 27.0 13 39.4 14 19.4 51 26.3 
Camp 3 3.4 0 0.0 2 2.8 5 2.6 
Educational 
level 
not (reads 
and writes 
15 16.9 2 6.1 2 2.8 19 9.8 
10 
0.018 
Primary 13 14.6 4 12.1 18 25.4 35 18.1  
Preparatory 23 25.8 6 18.2 11 15.5 40 20.7  
Secondary 13 14.6 7 21.2 10 14.1 30 15.5  
Diploma 
Average 
10 11.2 7 21.2 20 28.2 37 19.2 
 
bachelor 
degree or 
high 
15 16.9 7 21.2 10 14.1 32 16.6 
 
Marital 
Status 
Single 4 4.5 1 3.0 3 4.2 8 4.1 4 
0.001 
Married 79 88.8 30 90.9 47 66.2 156 80.8  
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Divorced 6 6.7 2 6.1 21 29.6 29 15.0  
Age at 
marriage 
Widow 40 46.5 14 43.8 38 55.1 92 49.2 
4 0.301 
18-25 
years 
36 41.9 11 34.4 19 27.5 66 35.3 
>25 years 10 11.6 7 21.9 12 17.4 29 15.5 
Occupation 
Housewife 80 90.9 31 93.9 66 91.7 177 91.7 
4 0.206 Retired 1 1.1 0 0.0 4 5.6 5 2.6 
Employee 7 8.0 2 6.1 2 2.8 11 5.7 
Monthly 
income of 
the family 
NIS 
<1000 52 59.1 18 56.3 52 72.2 122 63.5 4 
0.046 
1001 -2000 14 15.9 9 28.1 14 19.4 37 19.3  
>2000 
22 25.0 5 15.6 6 8.3 33 17.2 
 
 
 
The table indicates that there were no statistically significant differences at the level of 
(α≤0.05) in the associated factors in the postponement of the diagnosis of breast cancer 
with the Palestinian women who are being treated at Beit Jala Governmental Hospital 
according to variables of (place of residence, age at marriage and profession) and the time 
of delay since the onset of symptoms and until the doctor's visit, while showing that there 
are statistically significant differences at the level of (α≤0.05) in the associated factors in 
the diagnosis of breast cancer postponement in women by variables (age, education level, 
marital status, educational level) The time of delay since the onset of symptoms till seeing 
the doctor. 
The differences were according to the age variable in favor of women who are more than 
60 years of age, in the category of less than a month and the category between the ages of 
2-3 months. The differences were in favor of women whose ages ranged from 46-60 years 
old in more than 3 months‘ category, according to the level of education. The differences 
were also in favor of women who have the preparatory educational level, and with the 
variable of marital status differences were in favor of married women, and when the 
variable of income, the differences were in favor of the ladies who have income less than 
1,000 shekels. 
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Table 5. 22 The association between Health history of patients and the delay to visit a 
doctor to tell him about those symptoms. 
 
 
 
 
≤ 1 months 
≤ 3moths, > 
1 months 
3 months> Total N 
Df 
P 
value # % # 
%   # % 
In the period before the 
discovery of the disease 
have you had the presence 
of mass, fibrous bags, milky 
secretions or inflammation 
in the breast? 
Yes
  
84 94.4 32 97.0 60 83.3 176 90.7 
2 0.022 
No 5 5.6 1 3.0 12 16.7 18 9.3 
During the five years 
preceding the discovery of 
the cancer have you visited 
one of the doctors / 
physicians in order to carry 
out comprehensive checks 
to your body. 
Yes
  
38 42.7 11 33.3 17 23.6 66 34.0 
2 0.039 
No 51 57.3 22 66.7 55 76.4 128 66.0 
Is there anyone of the 
family members (mother, 
sister) has or had breast 
cancer 
Yes
  
8 9.1 7 21.2 18 25.0 33 17.1 
2 0.023 
No 80 90.9 26 78.8 54 75.0 160 82.9 
Is there anyone of the 
relatives (Aunt, aunt, 
grandmother, uncle girl / 
H, girl Khal / e) suffering 
from breast cancer? 
Yes
  
10 11.2 6 18.2 7 9.7 23 11.9 
2 0.447 
No 79 88.8 27 81.8 65 90.3 171 88.1 
Is there anybody of the 
family members or 
relatives who suffers from 
any other type of cancer2 
Yes
  
18 20.2 8 24.2 17 23.9 43 22.3 
2 0.817 
No 71 79.8 25 75.8 54 
76.
1 
150 
77.
7 
 
The table shows that there are statistically significant differences at the level (α≤0.05) in 
the associated factors in the delay of the diagnosis of breast cancer in women according to 
variables (in the phase leading up to the discovery of the disease to the presence of mass, 
fibrous bags, secretions milky or inflammation in the breast. Did you visit the doctor 
during the five years preceding the discovery of the cancer in order to carry out 
comprehensive checks to your body, is there anyone of the family members (mother, 
sister) suffered breast cancer)? while showing that there are no differences statistically 
significant at the level of (α≤0.05) in the associated factors in the postponement of the 
diagnosis of breast cancer in women by variables (Is there one of the relatives: aunt, 
grandmother suffered breast cancer. 
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The differences were in favor of women who have suffered from the presence of mass, 
fibrous bags, secretions milky or inflammation of the breast. According to visiting the 
doctor in order to carry out comprehensive checks, the differences were in favor of women 
who did not see a doctor. As for if one of the family members has /had the disease the 
differences were in favor of families with none of the members (mother, sister) has 
suffered from breast cancer. 
 
 Table 5. 23 The association between BSE and delay to visit the doctor to tell him 
about these symptoms. 
 
 
 
≤ 1 months 
≤ 3moths, > 1 
months 
3> Total N 
df 
P 
value # % # % # % # % 
Before the diagnosis of 
the disease you have, 
have you ever thought 
of Breast self-
examination 
Yes
  
45 50.6 10 30.3 24 33.3 79 40.7 
2 0.035 
No 44 49.4 23 69.7 48 66.7 115 59.3 
Before the diagnosis of 
the disease you have, 
have you ever thought 
of Breast self-
examination 
Yes
  
34 38.2 16 48.5 17 23.6 67 34.5 
2 0.028 
No 55 61.8 17 51.5 55 76.4 127 65.5 
Before the diagnosis of 
the disease you have, 
have you known what a 
mammogram is? 
Yes
  
8 9.0 4 12.1 9 12.5 21 10.8 
2 0.749 
No 81 91.0 29 87.9 63 87.5 173 89.2 
Before the diagnosis of 
the disease you have, 
have you ever 
performed a 
mammogram 
Yes
  
7 7.9 3 9.1 10 13.9 20 10.3 
2 0.444 
No 82 92.1 30 90.9 62 86.1 174 89.7 
Before the diagnosis of 
the disease you have, 
have you ever visited 
the doctor / before you 
run clinical breast 
examination 
Yes
  
1 1.1 0 0.0 5 6.9 6 3.1 
2 0.057 
No 87 98.9 33 100.0 67 93.1 187 96.9 
 
 
The table indicates that there are statistically significant at the level of differences (α≤0.05) 
in the associated factors in the diagnosis of breast cancer postponement in women as 
variables (before the diagnosis of disease. You know how to perform breast self-
examination. Before the diagnosis of disease, you have, have you ever performed self-
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examination of the breasts), while showing that there were no statistically significant 
differences at the level of (α≤0.05) in the associated factors in the postponement of the 
diagnosis of breast cancer in women by variables (usages in breast screening and the time 
of delay since the onset of symptoms and to till visiting the doctor. The differences were in 
favor of women with knowledge of breast self-examination, and then the differences were 
according to women who did not take breast self-examination. 
 
Table 5. 24 The association between staging (TNM) and delay to visit the doctor to tell 
him about these symptoms. 
 
 
 
≤ 1 months ≤ 3moths, > 
1 months 3 months> Total N df 
P 
value # % # %   # % 
Stages 
 
Stage 1 42 48.8 1 3.3 1 1.5 44 23.9 6 0.000 
Stage 2 35 40.7 15 50.0 3 4.4 53 28.8 
Stage 3 7 8.1 10 33.3 32 47.1 49 26.6 
Stage 4 2 2.3 4 13.3 32 47.1 38 20.7 
T  
T1 48 55.8 3 9.7 1 1.5 52 28.1 6 0.000 
T2 30 34.9 19 61.3 19 27.9 68 36.8 
T3 8 9.3 8 25.8 36 52.9 52 28.1 
T4 0 0.0 1 3.2 12 17.6 13 7.0 
N 
N0 66 76.7 8 25.8 7 10.3 81 43.8 6 0.000 
N1 17 19.8 11 35.5 20 29.4 48 25.9 
N2 3 3.5 11 35.5 33 48.5 47 25.4 
N3 0 0.0 1 3.2 8 11.8 9 4.9 
M 
M0 85 97.7 26 83.9 38 54.4 149 79.5 2 0.000 
M1 1 2.3 5 16.1 30 45.6 36 20.5 
          
 
The data indicates that there are statistically significant differences at the level of (α≤0.05) 
in the associated factors in the diagnosis of breast cancer in women who postponed by a 
variable of stage, tumor size, lymph node and metastasis. 
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Table 5. 25 The association between Warning symptoms of breast cancer and delay to 
visit the doctor to tell him about these symptoms. 
 
 
 
≤ 1 months ≤ 3moths, > 1 
months 3months> Total N 
df 
P 
value # % # % 
  # % 
Does the emergence 
of an un painful 
lump in one of 
breasts urge your t 
to visit the doctor? 
 
Yes
  
84 94.4 32 97.0 59 81.9 175 90.2 
2 0.011 
No 5 5.6 1 3.0 13 18.1 19 9.8 
Were there changes 
and problems in the 
nipple? 
Yes
  
35 39.3 14 51.5 39 54.9 91 47.2 
2 0.125 
No 54 60.7 16 48.5 32 45.1 102 52.8 
Was there a pain in 
the breast? 
 
Yes
  
23 26.1 13 39.4 29 40.8 65 33.9 
2 0.179 
No 65 73.9 20 60.6 42 59.1 127 66.1 
Was there a change 
in the shape and 
size of breast? 
Yes
  
12 13.5 6 18.2 16 22.2 34 17.5 
2 0.347 
No 77 86.5 27 81.8 56 77.8 160 82.5 
Was there a 
enlargement of the 
lymph nodes under 
the armpit? 
 
Yes
  
18 20.5 2 6.3 15 22.2 35 18.7 
2 0.244 
No 70 79.5 30 93.8 57 77.8 157 81.3 
Was there a strange 
nature of secretions 
from the breast 
Yes
  
18 20.2 7 21.2 15 21.4 40 20.8 
2 0.981 
No 71 79.8 26 78.8 55 78.6 152 79.2 
Was there a 
swilling in the 
breast itself? 
Yes
  
21 25.6 8 25.0 24 35.8 53 29.3 
2 0.148 
No 61 
74.
4 
24 75.0 4
3 64.2 128 70.7 
 
 
The data indicates that there are statistically significant differences at the level (α≤0.05) in 
the associated factors in the diagnosis of breast cancer postponement in women as a 
variable (mass painless appearance in one of the breasts. The differences were in favor of 
women who appeared to have lumps are painless in one breast. 
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Table. 26 The association between the first visit to the doctor and staging(TNM). 
 
 
≤ 1week ≤ 1month, > 
1weak 
>1month Total N 
df 
P 
value 
weak % # %   # % 
Stages 
Stage1 9 40.9 23 30.3 12 14.0 44 23.9 6 0.021 
Stage 2 7 31.8 17 22.4 29 33.7 53 28.8 
Stage 3 6 27.3 20 26.3 23 26.7 49 26.6 
Stage 4 0 0.0 16 21.1 22 25.6 38 20.7 
M 
M0 22 95.5 61 80.3 66 74.7 149 79.5 2 0.096 
M1 0 4.5 15 19.7 21 25.3 36 20.5 
 
The table indicates that there are statistically significant differences at the level of (α≤0.05) 
in the associated factors in the diagnosis of breast cancer in women postponing variables 
(stage that the disease has been diagnosed in the patient, and the spread of the disease). 
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CHAPTER SIX 
 Discussion 
 
6.1 Introduction 
The study results are summarized and compared to the results of other studies worldwide. 
Also, the results are interpreted and discussed. In the final part of the chapter, the study 
conclusions and recommendations are presented. 
6.2 Summary of the results 
The study analyzed 194 breast cancer cases registered at BJGH with confirm diagnosis of 
B.C, the majority of the cases 36.1 % fell between the ages of 46-60 years old, and 33.5% 
were above 60 years old, and 30.4 % were below 45 years old. 
Before the diagnosis of B.C, the study clarifies the low rate of participant women to BSE, 
Mammography and CBE, 34.5%, 10.3%, 3.7% prospectively.   
The majority (45.9%) of symptomatic women consulted within the first month, 17.0% 
consulted within the first three months a. 37.1% waited for more than three months (patient 
delay).  Provider delay was found in 46.9% of all women participant (over one months).  
Total delay was found in 60,8% of all women participants (over three months).  
The first sign or symptom of cancer was a self-detected 66.5%.   breast lump was the most 
frequent symptom (71%), followed by nipple change and discharge (10.2%), breast pain 
(10%), lymph node enlargement under the arm pit (4.8%) and other symptoms (4.8%).  
This Study clarify 71.0% of women participant who have abreast lump as initial signs, 
these results could indicate that women recognize breast cancer symptoms only a late. 
 
In the present study, the majority of women sought medical advice after identifying the 
symptoms of BC, most commonly with breast lump (90.2%). Such a high proportion may 
be explained by the fact that there is no organized breast cancer screening program; 
nevertheless, it has been established that symptom-based detection of breast cancer is still 
very important in countries where an organized screening program (Musmar and Shmais, 
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2010). The most vulnerable group is still not doing it frequently, older women and younger 
ages, less educated, single, and women from refugee camps need to be reached out to 
increase their awareness to go for screening mammography. This study clarifies 84.2 % of 
the women participants did not want to consult a healthcare provider Only after symptoms 
have become worse, table 5.12 clarify this.  
 
TNM classifications are summarized in table 5.20. Most of the patients (52.7%) had early 
stage BC (Stages I and II). And the study revealed the high proportion (47.3%) of women 
BC had advanced-stage (stage III and IV). A strong association between patient's delay, 
provider's delay and stage at diagnosis are obvious in the study.            
Women BC treatment summarized in (table 5. 19) Surgical treatment are wildly among 
women participants in the study, whereas 52 of women participants have undergone to 
total mastectomy beside radio and chemotherapy. This study shows just 35.5% of all 
women participant who guided to palliative care, our study found the palliative therapy it is 
not included as a part of treatment among B.C women who treated at BJGH.                                                     
This study shows that cultural and societal beliefs have a great effect on Palestinian 
women‘s attitudes and behaviors towards symptom recognition, and presentation for 
medical treatment.                                                                                                  
Delay in the diagnostic work-up after the first consultation of a physician may arise from 
patient, provider misdiagnosis, or long waiting times for diagnostic or therapeutic 
procedures because of the limited capacities in the health care system in BJGH.                    
6.3 Diagnosis delay or total delay. patient's delay and provider’s delay  
6.3.1 Patient's delay 
As mentioned in the previous study patient‘s delay (the interval between first detection of 
symptom to first medical consultation), an interval longer than three months between 
symptoms discovery by patient to first medical consultation) (Saldana and Castaneda, 
2009; Arndt et al., 2002; Norsa‘adah et al., 2011; Ermiah et al. 2012; Pineros et al., 2009; 
Poum et al., 2014).  
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The study reveals as shown in the table 5.10 the 37.1% of sample delay more than three 
months from discovered symptoms to see medical consultation, these results in the same 
line of the study conducted among Jordanian female 32.2%(Abu-Helalah et al., 2016) 
which is slightly higher compared to the 14 to 19% range observed in developed countries 
(Freitas and Weller, 2015). Poum et al., (2014) clarify that 17% delayed seeking 
consultation for longer than 3 months in Thailand. but lower than low income countries 
such as Uganda (89 %) patients delayed by more than 3 months after noticing symptoms of 
breast anomaly (Odongo et al., 2015), One explanation for such a difference might relate to 
the patients delay related behaviors and the social context they live in. 
 
This delay of BC diagnosis lead to worse health outcome and lower overall survival 
(Kothari &Fentiman, 2003) Delay in seeking medical advice has been established as one of 
the reasons for increased cancer mortality in developing countries (Pineros etal., 2009).                                                                                                                      
6.3.2 Provider delay  
Provider delay can be defined as the duration from first consultation of index disease until 
the start of treatment (i.e. delay in confirming diagnosis, delay in surgery and delay in 
starting adjuvant treatment). In this study, an interval longer than one month is considered 
provider delay (Pack&Gallo, 1938; Saldaña and Castañeda, 2008). 
Our study reveals as shown in the table 5.10, the provider delay over 1 months was found 
in 46.9% of all breast cancer cases. which is slightly higher compared in Jordan 49.1% 
(Abu-Helalah et al., 2016), Germany 11% (Arndt et al., 2003). And 42% reported a doctor 
delay of longer than 1 month in Thailand (Poum et al., 2014).  Arndt et al. (2002) clarifies 
delay diagnosis over one months is associated with more advanced stage among B.C 
women. Delay of therapy also has impacts on medical burden. 
 
6.3.3 Total Delay  
The interval between a patient‘s first noticing symptoms and starting specific treatment 
more than three months (Ozmen et al., 2014), this delay has been associated with poorer 
survival, late stage and tumor progression (Williams, 2015).  
 
In this study the total delay (patient delay and provider delay) is 60.8% from total patient‘s 
samples. This study shows that the proportion of delaying is high comparing study 
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conducted in developing countries such as, Germany 42% of the patients had a TDT 
(Ozmen et al., 2014).  
 
6.4 Factors related to breast cancer delay 
6.4.1 Factors related to patient delay 
The most frequent reasons for delay among women with a more than 3-month-delay were 
summarized in (table 5.9). The main reasons for patient delay found in this study. These 
findings together with late stage of diagnosis. (98.0%) of women participant delayed 
medical advice over three months is due to the thought of ignoring the seriousness of a 
painless lump, women who are not considering symptoms to be important, it is one of the 
factors that are associated with delay of BC, the previous Literature confirm these result 
(Ermiah et al., 2012; Pineros et al., 2009; Norsa‘adah et al., 2011; Elobaid et al., 2014). 
When Patients‘ interpretation of their symptoms as a sign of cancer had an important 
influence on whether they sought medical help immediately (Odongo et al., 2015). Many 
studies clarify the evaluation of breast symptoms is based on the pre-existing knowledge, 
experience, self-education and observation of individuals (Seedhom and Kamal, 2011; 
Montezeri et al., 2003; Karbanetal, 2011).                                                                 
The health belief model interprets that when the patient perceived risk and seriousness of 
BC and this influence the women to seek medical advice. The Model in an attempt to 
understand women‘s beliefs and perception of risk with regard to delay the diagnosis, 
when women perceived the seriousness of the condition go early to seek help.                                                                                                                 
Shyness and personal modesty are common among participant women. This study reveals 
(94.2%) Women are embarrassment when visiting the doctor and when having breast 
examination. It is one of the factors that associated with delay of BC, this barrier is found 
in many studies (Altwalbeh et al, 2015; Ermiah et al., 2012). An explanation of this breasts 
are sensitive parts of a woman‘s body which have to be concealed all the time and a 
powerful cultural belief that breasts are sexual organs that should not be discussed publicly 
(Khazaee et al., 2014).   
 
The study also clarifies the role of the husband with a woman diagnosed with breast cancer 
is a very sensitive issue. The study findings (93.0%) show that women delay seek medical 
help over three months is due to not receive support from the spouse. A study supports 
73 
 
these findings (Odongo et al., 2015,). Thus the support of the husband, play an important 
role in making breast cancer patients strong in winning the battle. 
 
In this study 91.4% women delayed to seek medical advice and interpret that the economic 
situation of the family is barrier of an early detection of BC. Many Studies confirm these 
result (Pineros et al., 2009; Elobaid, 2014; Elzawawy et al., 2008; Rauscher et al., 2010; 
Ruddy et al., 2014; Altaf et al., 2011). As mentioned in previous studies that is due to their 
lack of ability to pay for a doctor‘s visit or treatment, and thus these women were forced to 
wait until their health had deteriorated to a point where medical attention was of absolute 
necessity. 
Many types of fear that prevent women to early B.C diagnosis. In this study refer to the 
Fear of diagnosis of breast cancer (90.8%), Fear of surgery (88.6%), Fear of mastectomy or 
part thereof (74.2%), all these considered a factor for delay of diagnosis over three months. 
Many studies talk about fear as barrier for early detection (Elzawawy et al., 2008; 
Rauscher et al., 2010; Ajekigbe. 1991).   
The women fear of breast diagnosis may due to fear of the unknown, a fear that stemmed 
from a lack of knowledge and information about what to expect during diagnosis, another 
fear of Breast surgery the interoperation of this, women believed B.C surgery is associated 
with death,  some interoperation associated with fear of mastectomy  they believed 
mastectomy was associated with death , passionately was the diminished sexuality a 
woman experiences after mastectomy, "Fear" of sexual relation disturbances with 
husband" and "Fear" of being abandoned by husband, mastectomy causes disfigurement 
and Disability. 
 
In addition, the study finds that (83.4 %)of women interpret the impact on her status as a 
female or spouse, loss of breast or part of it as a barrier to early detection may be due to the 
traditional woman‘s role in the family of taking care of children and the husband. Donnelly 
et al. (2013) pointed in a study in Israel that ―Fear of losing traditional role as woman‖ was 
one of the fears but it was not a barrier, this different may due to cultural values. 
This study clarifies the following two points as barriers to an early B.C diagnosis.   women 
in the study interpreted the presence of one of the family members suffered from breast 
cancer as barrier to early detection (80.6%), The belief that the therapy available for breast 
cancer leads to rapid death (79.8%). This becomes more sensitive if one of the relatives 
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had died or suffered from breast cancer before. So that it was looking to the topic in a 
negative perspective. All this is due to the lack of knowledge and awareness to B.C 
(Montezeri et al., 2003; Norsa‘adah et al., 2011; Elzawawy et al., 2008). This study 
supports this view as barrier.    
 
This study demonstrates that (77.2%) seeking treatment at the tradition healer is among the 
reasons for delay in seeking treatment. This is similar to the results of study conducted by 
(Ermiah et al., 2012) whereby13.0% of the study participants delayed because they were 
seeking treatment from the traditional healers. 
In this study (77.8%) of women delayed to seek medical advice is due to lack of family 
support. One interpretation of this is that BC is not openly discussed with mothers, 
daughters, or other extended family members in Palestinian community.  
In this study (70.6%) of women participant delayed seeking medical help over three 
months because of the unavailability of a female healthcare provider. Studies among Arab 
community clarify that healthcare provider gender is an important factor in attracting 
women to presenting earlier for diagnosis, Arab and Muslim women prefer female 
healthcare providers (Elobaid et al., 2014). 
 
This study revealed 50% of women participant do not tell anyone when symptoms appear 
and keep their disease as a secret, therefore this fear holds the women to seeking medical 
advice and imposes silence, (Hazboun and Glennon, 2011) discussed social stigma 
surrounding breast cancer. This might be due to the fact that the breast is attached to the 
sexual and reproductive system. 
 
6.4.2 Factors related to provider delay                                                                    
Provider delay has been studied less than patient delay and there is a difference between 
the literature on this topic, in particular related to clinical and system factors that impact 
provider delay. This study shows that there is a delay by a health care provider. This reason 
is not discussed extensively in this study. This study focuses on the most important reasons 
that prevent health care provider to early B.C diagnosis. 
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This study clarifies 66.5% of patients discover breast cancer themselves.  Such a high 
proportion may be explained by the fact that there are no organized breast cancer screening 
programs.         
Where the study indicates that only 10.3% of women are doing mammogram, the absence 
of organized screening programs and lack of accessible and effective treatment for BC are 
cited as reasons for delays in treatment.  There is no organized nationwide mammographic 
screening in Palestine.                                                       
Six women experienced delays because of errors in diagnosis and inaction by healthcare 
providers. The study also shows that the majority of women ask to visit the hospital. As 
68.4% were ask to review the oncology clinic in Beit Jala Hospital. This is a good ratio 
indicates the awareness of a health care provider in out clinic in Palestine. Tertiary care 
and health system needs more highlight to know the reasons for the delay health care 
provider for diagnosis. 
 
6.5 Diagnosis delay and Socio Demographic Status                                                      
This study clarifies that there is an association between age of the patient and patients 
delay, (p value 0.010). Linsell et al. (2008); Rauscher et al. (2010) These studies found a 
significant association between age and patient delay, and clarify age between (46-60) 
years is a risk factor for both developing breast cancer and subsequent delayed 
presentation.  Grunfeld et al., (2002) clarifies that the age of the higher risk for delay of age 
group 46–60 years, may be the old women interpret the change occur in the breast due to 
aging process.  Therefore, this study suggests any intervention program should target older 
women in particular. 
These age results are similar to those derived from the literature of neighboring countries, 
the average age at presentation of breast cancer in Arab countries appears to be a decade 
earlier than in western countries. Breast cancer that presents at a younger age generally has 
more aggressive cellular features resulting in more advanced stage at presentation and 
treatment strategies are also more aggressive, this has important implications for early 
detection and cancer management strategies in Arab countries including Palestine and the 
ideal age at which to begin screening (Tfayli et al., 2010, Najjar and Easson., 2010). 
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This study also clarifies that there is no association between place of residence and patients 
delay (p value 0.238). These findings contrast the results done by Rauscher et al. (2010); 
Seedhom and Kamal, (2011). The study found that women who live in cities are more 
likely to have breast cancer more than women who live in villages and camps, 71.1%, 
26.3%, 2.6% respectively.  The study shows that women live in cities have more delay 
over three months than women who live in villages and camps, 28.9%, 7.2%, 1.0% 
respectively.                                                                                
This study clarifies that there is a significant association between educational level and 
patients delay (p value 0.018). Alhurishi et al. (2011); Rauscher et al; (2010); Altaf et al. 
(2011) These studies clarify that the association between educational level and delay, and 
show that less education was a significant predictor of patient delay. The role of education 
and knowledge in decreasing delay has been confirmed in other studies (Montazerietal, 
2003, Seedhom and Kamal, 2011).                        
This study clarifies that there is a significant association between marital status patients 
delay (p value 0.001). this study shows that married women delay to seek help are more 
than (single, divorced or widowed). This also reflects that the Palestinian women who do 
not receive support from husbands, or it may be due to the husband‘s lack of knowledge 
about B.C signs and symptoms, and the importance of early detections. Previous studies 
done by Osborne et al. (2004), Alhurishi et al. (2011) showed that is association between 
marital status and delay and shows widowed and divorced women had a higher risk of 
delay. that this could be explained by the fact that widowed and divorced women do not 
have enough motivation to seek help or care about themselves and lack support.                                                                                
The study clarifies that there is no association between occupation and delay by patients, (p 
value 0.206). These findings contrast the study conducted by Rauscher et al. (2010). This 
study clarifies that the majority of women are housewives 91.7% Therefore it can be 
normal the majority of delayed women are among this group.       
The study also clarifies that there is significant association between income level and 
patients delay (p value 0.046), women with low income have more delay to seek medical 
advice. Elzawawy et al. (2008); Rauscher et al. (2010); Ruddy et al. (2014); Altaf et al. 
(2011) all these studies confirm that there is a strong association between level income and 
delay, and shows that women with low level income were more likely to experience delays 
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in seeking medical attention. In this study (63.5%) of women who were less financially 
comfortable. This suggests an economic disparity that deserves further attention.                                                                                     
6.6 Diagnosis delay and health history 
This study clarifies that there is a significant association between presence of fibrous mass, 
milky secretions or inflammation in the breast in the period before the discovery of the 
disease and patient's delay (p value 0.022), and the study shows women appear these signs 
more than to delay. Arndt et al. (2002); Rauscher et al. (2010) found association between 
fibrous and benign breast disease with delay.  Explanation is that former episodes of breast 
tissue alterations, if benign is also later considered as benign by their doctors. Thus, it 
might be worthwhile to encourage women with known benign breast disease to present 
new breast symptoms promptly. Additionally, doctors should understand that new 
symptoms should be evaluated as potential new risks for breast cancer.                                                                                                  
This study finds out that there is significant association between the ones who visited the 
doctors During the five years preceding the discovery of the B.C and decreased patients 
delay (p value 0.039). Previous studies done by Nurleli et al. (2014); Montazeri et al. 
(2008) showed that there is a significant associated between general help- seeking habit 
and decreased patients delay.                                                                                                   
This study finds out a significant association between the family members (mother, sister) 
has or had breast cancer and patients delay (p value 0.023). Previous studies done by 
Meechan et al. (2002); Memon et al. (2013) found the same results and showed that family 
members with a history of breast cancer was associated with shorter delay, may be due to 
fear from seeing family member suffering from breast cancer.           
6.7 Diagnosis delay, patient’s knowledge and practice of B.C                                     
In this study, the lack of knowledge of breast cancer reported by the study, participants 
show low adherence to breast cancer screening. 
 
6.7.1 Breast Self-Examination (BSE)  
The study findings showed that only 34.5% of the study participants are practicing BSE. 
However, 127 (65.5%) had never practiced BSE from all participant. still the rates are low 
compared to developed countries (Stapleton et al. 2015).   
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6.7.2Clinical Breast Exam (CBE) and/or Mammography                                           
Women in the study reported low participation rate in breast cancer screening activities 
before the discovery of B.C signs and symptoms. This study revealed 10.8% of women 
participants have an adequate level of knowledge for Mammography.  Our findings 
showed that 3.6% and%10.3 of women who reported having a history of CBE and/or 
Mammography respectively. Johnson (2006) Reported that Early detection methods, such 
as mammography, clinical breast examination and breast self-examination, can play an 
important role in the reduction of deaths from breast cancer in the absence of primary 
prevention strategies.  
 
The lower participation rate in mammography is clear in the study. These results are 
obvious in the study conducted in west bank. The study shows   that   more   than (70 %) of 
the participants have never applied for mammography or CBE (Azaiza, et al., 2010). A 
study in Gaza conducted by Shaheen et al. (2011) shows also a low percent (17%) 
performed a mammography at least once during their lives.  This rate of participation is 
lower than Arab Women in the United Arab Emirates. The study clarifies that 58% of 
women are reported to have a history of CBE or a mammography in the past few years 
(Elobaid et al, 2014). 
 
Still these participation rate are very low compared in to the ones in the developed 
countries. 72% of the target population in Canada reported to have had a mammogram in 
the past two years (Statistics Canada, 2009). In the UK more than 80% of women are 
reported to have had mammography in the previous three years (WHO, 2008). 
 
EL saghir. (2008) clarifies that randomized trials of mammographic screening of average-
risk women above 50 years reduced breast cancer mortality by more than 36%.  According 
to MOH recommendations in 2005, women from age 35 -40 must do it every three years; 
women over 40 years should do it every two years, and after they are 50 years or more, 
they should apply it once every year. 
 
In Palestine, there are clinical screening program for breast cancer screening, but the use 
and implementation of the program are weak as the result of this study shows. More 
widespread implementation of these screening may increase the quality of care for breast 
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cancer patients and shorten the diagnosis delay. Health care providers play a major role in 
delivering the message of the necessity of regular breast cancer screening. 
 
A) The study finds a link between BSE and delay in seeking medical advice (p value  
The study clarifies that women who know how to perform BSE and women practicing BSE 
tend to seek medical care more rapidly. Many studies have the same findings (Johnson. 
(2006); Stapleton et al., (2015); Naroozi and Tahmasebi, 2011).        
B) The study finds an association between patients who do CBE, Mammography and 
delay in seeking medical advice.  
 
These contrasts are shown in many studies (Naroozi and Tahmasebi, 2011; Weller and 
Campell, 2009) The negative association may be due to the very low participants who 
attend mammography and CBE.  
 
6.8 Diagnosis delay, signs and symptoms of B.C                                                           
In the current study, the result showed that the delay to be significantly related to the type 
of breast symptom, with women who experienced a breast lump being less likely to delay 
(p value 0.011). 
 
In the present study, the nature of the first symptom other than lump had no association 
with patient delay. It is argued that discovery of a breast lump reduces the patient delay 
and an association has been suggested in other studies (Meechan et al., 2003; Ermiah et al., 
2012; Meechan et al., 2003). The lack of knowledge about common symptoms of breast 
cancer might explain why there was no association between the nature of the first symptom 
and delay in this study. The longer delay in women with other breast symptoms highlights 
the fact that future health screening program should encourage women who discover other 
abnormal breast symptoms to also seek attention promptly. The study reveals that 71% of 
women participants have a lump the first signs and symptoms appear, Women need to be 
educated about the different types of breast cancer symptoms, especially the most frequent 
symptom (breast lump). 
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6.9 Impact of breast cancer delay on clinical stage                                                      
TNM classification are summarized in table (5.20) Most of the patients (52.7%) had early 
stage BC (Stages I and II). And the study reveals the high proportion (47.3%) of women 
with BC are in advanced-stage (stage 3 and 4). This result is consistent the study conducted 
in Gaza, data from the Palestinian Cancer Registry (PCR) in Gaza suggest that breast 
cancer is diagnosed at an advanced stage of the disease; 42.2% of reported cases had 
regional lymph- node involvement (stage III) and 17.8% had distant metastases (stage IV), 
(Musmar and Abu Shmais, 2010).  
Some of a study consistent of this result. In a study conducted among Arab women 
compared with Jewish women in the greater Jerusalem area, the pathological classification 
of these as follow, Ashkenazi Jews 76%% early stage (stage I and II) and 18% late stage 
(stage III and IV), Sephardic Jews 61% early stage and 30% late stage, Palestinian Arabs 
65% early stage and 35% late stage (Nissan et al., 2004). A study conducted among 
Egyptian women with newly diagnosed breast cancer patients at the Tanta Cancer Center, 
the study reveals that 39.1% of women have an early stage, 60.9% have late stage (Mousa 
et al., 2011). The study conducted by Norsa‘adah. (2011) in Malaysian women, the study 
result was 43.9% in an early stage (stage I and II), the study reveals the majority of women 
have an advanced stage 56. % (stage III and IV).  A study conducted by Ermiah et al. 
(2012) among 200 Libyan females with breast cancer, women the study results are 34.5% 
early stage (stage I and and 65.5% are in (stage III and IV).  Ozmen et al. (2014) conducted 
a study among 1031 patient‘s Turkish women with BC. Study results   are 67.1%% early 
stage (stage I and II) and 20.9% in an advanced stage (stage III and IV). 
 
6.9.1 Patients delay and influences of staging (TNM classification)                                  
The relationship between patient's delay, staging and cancer progression indicators (tumor 
size, nodal spread and metastasis) was also analyzed. Findings show that for all three 
indicators there were statistically significant differences (P value 0.000). It means the 
patient delay of more than 3 months was closely associated with increased tumor size and 
advancement in the disease stages. Many studies explore the relation between patents delay 
and staging (Ermiah et al., 2012; Simon. 2012; Montazeri et al., 2003; Arndt et al., 2003; 
Saldana et al. 2015) a result of these studies are consistent with the results of this study. 
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6.9.2 Provider delay and influences of staging (TNM classification) 
The relationship between provider delay and staging, was also analyzed. Findings show 
that there are statistically significant differences (P < 0.05), longer provider‘s times were 
associated with advanced stage. A few studies explore the relation between provider delay 
and staging (Jassem et al., 2013; Arndt et al., 2003; Saldana et al., 2015) a result of these 
studies are consistent with the results of this study. 
 
6.10 Conclusion  
 
This study is the first in Palestine (up to my knowledge) that investigates the factors 
associated with delay of breast cancer diagnosis and the effects of the delay on staging and 
tumor progression. Most of the outcomes of this study are expected with the same line of 
the most international studies results. This study indicates a complex medium of factors 
which were identified and that contribute to the late presentation or delayed diagnosis of 
breast cancer among Palestinian women who were/are treated at BJGH, i.e. the lack of 
knowledge of B.C signs and symptoms, cultural traditions, social support, socio-
demographic factors, accessibility, screening behavior, doctor recommendations, health 
system, environmental aspects. These factors are associated with breast cancer delay 
diagnosis either positively or negatively. This study provides a better way of understanding 
the acceptable time interval between presentation of symptoms to seek medical advice, and 
time interval to reach the final diagnosis and treatment. The majority of patients with 
breast cancer began treatment after a delay. Both patients' delays and providers' delays 
were associated with advanced disease. Breast awareness and education are needed to 
reduce breast cancer mortality by promoting early detection, diagnosis and treatment 
before the tumor enlarges and spreads to lymph nodes and metastasis.   
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6.11 Recommendation  
The findings suggest that patients and health care provider need to be educated about the 
different types of breast cancer symptoms. 
 
For provider’s delay, can be suggested at the primary, secondary and tertiary levels 
by;  
 
 Integrating BC as public health issue within sexual and reproductive health 
programs for to increase awareness and reduce the delays of women in seeking 
health care services regarding investigating BC.  
 Implementing organized population-based screening programs within accessible 
health care facilities as well as founding cancer centers. 
 
 It must be stressed that the entire civil organizations and bodies must be mobilized 
and involved in a wider campaign for an effective awareness. Religious leaders can 
play a major role in this respect through their encouragement to women for early 
diagnosis and screening of BC since such issues don't contradict with religious 
teachings. Such campaigns can be carried out through seminars and speeches.  
 Palliative care should be emphasized and integrated within the tertiary health care 
system 
  To know the reasons of health care provider delay for diagnosis and to highlight 
this gap in order to correct this delay  
 There is an urgent need for constructing a national program to overcome the 
difficulties and barriers faced by breast cancer patients. 
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For patient’s delay 
 
 Women need encouragement to seek medical advice when they encounter 
suspicious symptoms through different channels particularly mass media and 
medical campaigns. 
 Husbands should be included within the education/awareness programs and 
encouraging them to attend with their wives for successful breast cancer screening 
promotion and early detection.  
 Families should be involved in awareness programs so they can support their 
family members with BC  
 
For public health researchers  
 The need for more detailed researches with larger sample size including more 
hospitals.  
 Conducting a more prospective study on diagnosis delay taking into account the 
five years‘ survival rate.  
  
   
 
 
 
 
 
 
 
 
 
 
84 
 
 
References 
American Cancer Society (2015). Cancer Facts & Figures 2015. Atlanta: American 
Cancer Society. 
American Cancer Society (2011). Global Cancer Facts & Figures 2nd Edition. Atlanta: 
American Cancer Society. 
American Cancer Society. (2016). Non-Cancerous Breast Conditions. Retrieved from. 
(http://www.cancer.org/healthy/findcancerearly/womenshealth/noncancerousbreastconditio
ns/index) 
American Cancer Society. (2016). what is breast cancer Retrieved from 
(www.cancer.org/research/cancerfactsstatistics.).  
 
American Cancer Society, (2014) Stages and survival of breast cancer  
http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-survival-by-stage).   
 
Aebi S., Davidson T., Gruber G., Cardoso F., (2011). Primary breast cancer: ESMO 
Clinical Practice Guidelines for diagnosis, treatment and follow-up. Oxford University; 
(6): vi12–vi24 
 
Abu Shmais F K., (2010) Use of Mammography Test Pattern and Percentage of Breast 
Cancer Detected in Nablus District. 
 
American Cancer Society. (2015). How is breast cancer staged? Retrieved from: 
(http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-staging) 
Alhurishi S., Lim J. N., Potrata B., (2011). West R. Factors Influencing Late Presentation 
for Breast Cancer in the Middle East: A Systematic Review. Asian Pacific J Cancer; (12): 
1597-1600  
 
Arndt V.,Sturmer T., Stegmaier C., Dhom G., Brenner H., (2002).  Patient delay and stage 
of diagnosis among breast cancer patients in Germany – a population based study. British 
Journal of Cancer;(86): 1034 – 1040  
85 
 
 
Arndt V., Sturmer T., Stegmaier C., Ziegler H., Becker A., Brenner H., (2003). Provider 
Delay Among Patients with Breast Cancer in Germany: A Population-Based Study. Journal 
of Clinical Oncology;(8): 1440-1446 
American Cancer Society (2014). What is breast cancer. Retrieved from 
(http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-what-is-breast-
cancer)  
 
Altwalbeh D., El Dahshan E. M., Yaseen R., (2015).  Factors Influencing Delayed 
Presentation of Breast Cancer among Saudi Women.  International Journal of Science and 
Research; (4): 2319-7064. 
 
Altaf A. T., Abdul R. S., Abdulghaffar A., Ali A., (2011). Late presentation of breast 
cancer: A dilemma. J Pak Med Assoc;61(7): 662-6 
 
Amin T., Al Mulhim A., Al Meqihwi A., (2009). Breast Cancer Knowledge, Risk Factors 
and Screening among Adult Saudi Women in a Primary Health Care Setting. Asian Pacific 
Journal of Cancer Prevention, 10, 133-8. 
 
Ajekigbe A. T., (1991). Fear of mastectomy: The most common factor responsible for late 
presentation of carcinoma of the breast in Nigeria. Elsevier Ltd. 3(2):78-80  
 
American Cancer Society. (2014). Mammogram basics. Retrieved from 
(http://www.cancer.org/treatment/understandingyourdiagnosis/examsandtestdescriptions/m
ammogramsandotherbreastimagingprocedures) 
 
American Cancer Society. (2014). How is breast cancer staged? Retrieved from 
(http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-staging) 
 
Azaiza F., Cohen M., Awad M., Daoud F., (2010). Factors associated with   low screening 
for breast cancer in the Palestinian authority: Relations of availability, environmental 
barriers, and cancer-related fatalism. Cancer, 116, 4646-55 
86 
 
Abu-Helalah A M., Alshraideh AH. , Al-Hanaqtah M. , Da'na M. , Al-Omari A. , Mubaidin 
R.(2016), Delay in Presentation, Diagnosis, and Treatment for Breast Cancer Patients in 
Jordan. Breast J;22(2):213-7.  
Burgess C. C., Ramirez A. J., Richards M. A., Love S B., (1998). Who and what influences 
delayed presentation in breast cancer. British Joumal of Cancer; 77(8):1343-1348. 
 
Barlow W. E.,  Lehman C. D., Zheng Y., Barbash R., Yankaskas B. C., Cutter G. R., 
Carney P. A., Geller B. M., Rosenberg R.,  Kerlikowske K.,  Weaver D. L., Taplin S. H., 
(2002). Performance of Diagnostic Mammography for Women with Signs or Symptoms of 
Breast Cancer. Journal of the National Cancer Institute; (1600): 98101-1448 
 
Bittar J., (2011). Breast cancer is the most prevalent in Palestine, early detection raises cure 
rates to high rates. Available from: (http://www.wafa.ps)  
Canadian Cancer Society. (2015). Risk factors for breast cancer. Retrieved from 
(http://www.cancer.ca) 
Cancer Research UK. (2014). Breast cancer symptoms.  Retrieved from 
(http://www.cancerresearchuk.org)  
Caplan L., (2014). Delay in breast cancer: implications for stage at diagnosis and survival. 
Frontiers in public health. doi: 10.3389/fpubh.2014.00087. 
Consedine S. N., Magai C., Krivoshekova S. Y., Ryzewicz L., Neugut I. A., (2004). Fear, 
Anxiety, Worry, and Breast Cancer Screening Behavior: A Critical Review. Epidemiol 
Biomarkers Prev; (4): 501–510. 
 
Chintamani, Tuteja A., Khandelwal R., Tandon M., Bamal R.,Jain S., Narayan N., Srinivas 
S., Kumar Y., (2011). Patient and provider delays in breast cancer patients attending a 
tertiary care centre: a prospective study.J R Soc Med Sh Rep;2:76  
 
Center to Advance Palliative Care. (2011) Public Opinion Research on Palliative Care. 
https://goo.gl/2jojcU, 2016. 
 
87 
 
Donnelly T., Al-Khater Al., Al-Kuwari M., Al-Meer N., Al-Bader S.B., Malik M., Singh 
R. and Jong F.C. (2011). Study exploring breast cancer screening practices amongst Arab 
women living in the state of Qatar. Avicenna, 2011, 1-9 
 
Donnelly T., Al Khater A., Al-Bader S., Al Kuwari M., Al-Meer N., Singh R., Jong F., 
Arab Women‘s Breast Cancer Screening Practices. Asian Pac J Cancer Prev, 14 (8), 4519-
4528  
Darweesh A. (2009) Risk Factors of Breast Cancer among Palestinian Women in North 
West Bank. 46(1-65)     
Davis E., Schechtel M., Rugge B., HickamD., (2010). Reducing the Risk of Breast Cancer 
With Medicine.Eisenberg Center:The Agency for Healthcare Research and Quality, 
09(10)-EHC028-A. 
Donnelly T. T., Al Khater A., Al-Bader S. B., Al Kuwari M. G., Al-Meer N., Malik M., 
Singh R., Chaudhry S., Fung T., (2013). Beliefs and attitudes about breast cancer and 
screening practices among Arab women living in Qatar: a cross-sectional study. BMC 
Women's Health;( 13:49):1472-6874 
 
Elobaid Y. E., Aw T C, Grivna M., Nagelkerke N., (2014). Breast Cancer Screening 
Awareness, Knowledge, and Practice among Arab Women in the United Arab Emirates: A 
Cross-Sectional Survey. PLoS ONE; 9(9): e105783 
 
El Saghir N., Khalil M. Eid T., El Kinge A., Charafeddine M., Geara F., Seoud M., 
Shamseddine A., (2007). Trends in epidemiology and management of breast cancer in 
developing Arab countries. International Journal of Surgery, (5):225-233. 
ElSaghir N., Abulkhair O., (2010). Epidemiology, prevention and management guidelines 
for breast cancer in Arab countries.cancer care in the arab world, (2):12-18 
Ermiah E., Abdalla A., Buhmeida A., Larbesh A., Pyrhönen S., Collan Y., (2012). 
Diagnosis delay in Libyan female breast cancer. BMC Research Notes 5:452. 
EL Saghir S N., (2008). Responding to the Challenges of Breast Cancer in Egypt and 
Other Arab Countries. Journal of the Egyptian; Vol. 20, No. 4, December: 309-312, 2008 
88 
 
 
 
Elzawawy A.M., Elbahaie A. M., Dawood S. M., Elbahaie H. M., Badran A., (2008) Delay 
in Seeking Medical Advice and Late Presentation of Female Breast Cancer Patients in 
Most of the World.Breast Care;( 3):37–41  
 
Freitas A.G., Weller M., (2015). Patient delays and system delays in breast cancer 
treatment in developed and developing countries. CienSaude Colet;20(10):3177-89   
Facione NC., (1993) Delay versus help seeking for breast cancer symptoms: a critical 
review of the literature on patient and provider delay. SocSci Med; 36(12):1521-34 
 
Gilani S. I., Khurram M., Mazhar T., Mir S. T., Ali S., Tariq S., Malik A. Z., (2010). 
Knowledge, attitude and practice of a Pakistani female cohort towards breast cancer. J Pak 
Med Assoc; 60(3): 205- 208.   
 
Goncalves L. L., Travassos G. L., Almeida A. M., Guimaraes A. M., Gois C. F., (2014). 
Barriers in health care to breast cancer: perception of women. Rev Esc Enferm USP; 
48(3):394-400    
 
Grunfeld E. A., Ramirez A.J., Richards M.A., (2002). Women‘s knowledge and beliefs 
regarding breast cancer. British Journal of Cancer;(86): 1373 – 1378 
 
Gullatte M M., Phillips J M., Gibson L M., (2006) Factors Associated with Delays in 
Screening of Self-Detected Breast Changes in African American Women. Journal of 
National Black Nurses Association; 17(1): 45–50.  
Gnerlich L. J., Deshpande D. A., PhD, Jeffe B. D., AllisonSweet A., MPH3, White N., 
Margenthaler A. J., (2009). Elevated Breast Cancer Mortality in Young Women (<40 
Years) Compared with Older Women Is Attributed to Poorer Survival in Early Stage 
Disease. J Am CollSurg; (3): 341–347. 
 
Hazboun A., Glennon A. C., (2011) Cultural Influences on Health Care in Palestine. 
Clinical Journal of Oncology Nursing; 10.1188/11.CJON.281-286. 
 
89 
 
Hirko K. A., (2013). The global profile of breast cancer: exploring the disease 
epidemiology among international and migrant populations. Epidemiological Science;(4) 
Hadi M., Hassali M., Shafie A., Awaisu A., (2010). Evaluation of breast cancer awareness 
among female university students in Malaysia., (1):29-34 
Harris M. D., Miller E. J., Davis M. D., (2003). Racial Differences in Breast Cancer 
Screening, Knowledge and Compliance. J Natl Med Assoc; (95): 693-701 
International Agency for Research on Cancer. (2013).Latest world cancer statistics 
Retrieved from http://globocan.iarc.fr. 
Innos K., Padrik P., Valvere V., Eelma E., KUtner R., Lehtsaar J., Tekkel M., (2013). 
Identifying women at risk for delayed presentation of breast cancer: a cross-sectional study 
in Estonia. BMC Public Health, 13:947 
 
Ismail M. G., Abd El Hamid A. Z., AbdElNaby G. A., (2013). Assessment of Factors that 
Hinder Early Detection of Breast Cancer among Females at Cairo University Hospital. 
World Applied Sciences Journal; (1): 99-108.   
 
Jassem J., Ozmen V., Bacanu F., Drobniene M., Eglitis J., Lakshmaiah K. C., Kahan Z., 
Mardiak J., kowski T. P., Semiglazova T., Stamatovic L., Timcheva C., Vasovic S., 
Vrbanec D., Zaborek P., (2013). Delays in diagnosis and treatment of breast cancer:a 
multinational analysis. European Journal of Public Health; (7): 80-211 
 
Jemal A., Bray F., Center M., Ferlay J., Ward E., Forman D., (2011). Global Cancer 
Statistics. Cancer Journal for Clinicians;(61): 69–90 
Johnson M. N., (2006). Young Women's Perceptions of Breast Cancer. School of Health 
and Environment. Breast Cancer Network Australia Newsletter; (3): 1-8. 
 
Jones E. C., Maben J., Jack H. R., Davies A. E., Forbes J. L., Lucas G., Ream E., (2014).  
A systematic review of barriers to early presentation and diagnosis with breast cancer 
among black women. BMJ Open; (4): e004076. 
 
90 
 
Khatib O. M., (2006). Guidelines for the early detection and screening of breast 
cancer.United States of America: World Health Organization, 30the ed. 
Kanaga C. K., Nithiya J., Shatirah N., (2011). Awareness of Breast Cancer and Screening 
Procedures Among Malaysian Women. Asian Pacific J Cancer Prev; (12): 1965-1967 
 
Khazaee M., Majlessi F., Foroushani A. R., Montazeri A., Nedjat S., Shojaeizadeh D., 
Salimzadeh H., (2014). Perception of Breast Cancer Screening among Iranian Women 
without Experience of Mammography: A Qualitative Study. Asian Pac J Cancer Prev; 15 
(9): 3965-3971 
 
Khakbazan Z., Taghipour A., Roudsari L. R., Mohammadi E., (2014). Help Seeking 
Behavior of Women with Self-Discovered Breast Cancer Symptoms: A Meta-
Ethnographic Synthesis of Patient Delay. PLoS ONE; 9(12): e110262.  
 
Krieger N., (2002). Is Breast Cancer a Disease of Affluence, Poverty, or Both? The Case of 
African American Women. American Journal of Public Health; 92(4): 611- 613   
 
Khokher S., Qureshi U. M., Fatima W., Mahmood S., Saleem A., (2015). Impact of a 
Breast Health Awareness Activity on the Knowledge Level of the Participants and its 
Association with Socio- Demographic Features. Asian Pac J Cancer Prev; 16 (14): 5817-
5822 
 
Kothari, A., Fentiman, I., (2003). Diagnostic delays in breast cancer and impact 
on survival. Int J ClinPract, 57(3), 200-203.  
 
Karbani G., Lim N. G., Hewison J., Atkin K., Horgan K., Lansdown M., Chu E. C., 
(2011). Culture, Attitude and Knowledge about Breast Cancer and Preventive Measures: A 
Qualitative Study of South Asian Breast Cancer Patients in the UK. Asian Pacific J 
Cancer; (12): 1619-1626.  
 
Linsell L., Burgess C., Ramirez A., (2008). Breast cancer awareness among older women. 
British Journal of Cancer; (99): 1221 – 1225. 
 
91 
 
Linsell L., Forbes L., Kapari M., Burgess C., Tucke L., Ramirez A., (2009). A randomised 
controlled trial of an intervention to promoteearly presentation of breast cancer in older 
women: effect on breast cancer awareness. British Journal of Cancer; (101): S40 – S48  
 
Lamptey et al., (2009). Why Do Breast Cancer Patients Report Late or Abscond During 
Treatment In Ghana? A Pilot Study. Ghana Medical Journal Volume 43, Number 3 
 
Magrath, I. (2010). Cancer in low and middle income countries retrieved 2016 from 
(http://www.inctr.org) 
 
Mclaughlin J M., Anderson R T., Ferketich A K., Seiber E E., Balkrishnan R., Paskett ED. 
(2012) Effect on Survival of Longer Intervals Between Confirmed Diagnosis and 
Treatment Initiation Among Low-Income Women with Breast Cancer. J ClinOncol 
30:4493-4500. VOLUME 30 _ NUMBER 36 
Mclafferty S., Wang F., Luo L., Butler J., (2011). Rural – urban inequalities in late-stage 
breast cancer: spatial and social dimensions of risk and access. Environ Plann B Plann 
Des.; 38(4): 724–740.   
 
Meechan G.1., Collins J., Petrie K.J., (2003). The relationship of symptoms and 
psychological factors to delay in seeking medical care for breast symptoms, 36(3):374-8. 
 
Montazeri A., Ebrahimi M., Mehrdad N., Ansari M., Akram S., (2003). Delayed 
presentation in breast cancer: a study in Iranian women.BMC Women's Health;(3:4): 1472-
6874 
 
Macleod U., Mitchell E. D., Burgess C., Macdonald S., Ramirez A. J., (2009) Risk factors 
for delayed presentation and referral of symptomatic cancer: evidence for common 
cancers. British Journal of Cancer; (101): S92 – S101  
 
Marcus S. T., Lunda S., Fernandez L., (2013). Delayed breast cancer presentation: hospital 
data should inform proactive primary care. Afr J Prm Health Care Fam Med; 5(1), Art. 
#503, 7 pages. 
 
92 
 
Mayo Clinic. (2016). Breast self-exam for breast awareness. Retrieved from 
(http://www.mayoclinic.org/tests-procedures/breast-exam/basics/definition) 
 
Musmar S., Abu Shmais F K., (2010). Pattern of mammography test use among women in 
Nablus/Palestine: A cross sectional study. ANU Medical and Health Sciences Journal; Vol. 
1 Iss. 1 
 
Mousa S. M., Seifeldin I. A., Hablas A., Elbana E. S., Soliman A. S., (2011).  Patterns of 
seeking medical care among Egyptian breast cancer patients: Relationship to late-stage 
presentation. Elsevier Ltd; 1-7 
 
Nissan A., Spira R M., Hamburger T., Badrriyah M., Prus D., Cohen T., Hubert A., Freund 
H R., Peretz T. (2004). Clinical profile of breast cancer in Arab and Jewish women in the 
Jerusalem area. The American Journal of Surgery ;188 :62–67 
 
Najjar H., Easson., (2010). Age at diagnosis of breast cancer in Arab nations. International 
Journal of Surgery; 8: 448-452   
 
National Breast Cancer Foundation. (2015). Clinical Breast Exam. Retrieved from 
(http://www.nationalbreastcancer.org/clinical-breast-exam) 
 
National Breast Cancer Foundation. (2015). Breast Cancer Stages. Retrieved from 
(http://www.nationalbreastcancer.org/breast-cancer-stages) 
 
National Breast Cancer Foundation. (2015). What is Breast Cancer.  Retrieved from 
(http://www.nationalbreastcancer.org/what-is-breast-cancer) 
 
National Breast Cancer Foundation. (2015). Early Detection Program .Retrieved from:  
http://www.earlydetectionplan.org.. 
 
Nurleli, Petpichetchian W., Maneewat K., (2014). Patient delay in consulting a medical 
doctor among Aceh women with breast cancer. Songklanagarind Journal of Nursing; (34): 
1-11 
93 
 
Norsa‘adah B., Rampal K. G., Rahmah M. A.,Naming N., Biswal B. M., (2011) Diagnosis 
delay of breast cancer and its associated factors in Malaysian women.BMC Cancer, 
(11:141): 1471-2407 
 
Neal R. D., Allgar V. L., (2005). Sociodemographic factors and delays in the diagnosis of 
six cancers: analysis of data from the ‗National Survey of NHS Patients:Cancer'. British 
Journal of Cancer, (92); 1971 – 1975 
 
Naroozi A., Tahmasebi R., (2011). Factors influencing breast cancer screening behavior 
among Iranian Women. Asian pac j. cancer prev; 12(5): 1239-44 
 
National Cancer Institute. (2009) Staging as the process where breast cancer spread within 
or to other parts of the body.  
 
Osborne C., Ostir G.V., Du X., Peek M.K., Goodwin J.S.,(2005). The influence of marital 
status on the stage at diagnosis, treatment, and survival of older women with breast cancer. 
Breast Cancer Res Treat; 93(1):41-7. 
Otaghvar A. H., Hosseini M., Tizmaghz A., Shabestanipour G., Noori H.,( 2015).  A 
review on metastatic breast cancer in Iran. Asian Pac J Trop Biomed; 5(6): 429–433. 
 
OzmenV., Boylu S., Ok E., Canturk N. Z., Varol Celik5, Kapkac M., Girgin S., Tireli M., 
Ihtiyar E., OrhanDemircan O., Baskan M. S., Koyuncu A., Tasdelen I., Dumanli E., 
Ozdener F., Zaborek P., (2014). Factors affecting breast cancer treatment delay in Turkey: 
a study from Turkish Federation of Breast Diseases Societies. European Journal of Public 
Health:( 1–6) doi:10.1093/eurpub/cku086 
 
Odongo J., Makumbi T., Kalungi S., Galukande M., (2015).  Patient delay factors in 
women presenting with breast cancer in a low income country. BMC Res Notes () 8:467 
 
PCBS.(2013). Annual report 2013. Retrieved from http://www.pcbs.gov.ps. 
Pineros M., Sanchez A., Cendales R., Perry F., Ocampo R., (2009). Patient delay among 
Colombian women with breast cancer, (51): 372-380  
 
94 
 
Partridge A. H., Hughes M.  E., Ottesen R. A., Won G. Y., Edge S. B., Theriault R. L., 
Blayney D. W., Niland J. C., Winer E. P., Weeks J. C., Tamimi R. M., (2012). The Effect 
of Age on Delay in Diagnosis and Stage of Breast Cancer.The Oncologist, (17):775–782 
 
Parkin M., Pisani P., Ferlay J., (1999). Global Cancer Statistics. cancer Journal for 
Clinicians, (4 9): 3 3 - 6 4. 
 
Parkash D., (2014). breast cancer, Nuclear Medicine. India :(143). 
PHIC (2014). Health Annual Report Palestine.  
 
Pack G T., Gallo J S., (1938) The Culpability for delay in the treatment of cancer. Am J 
Cancer; 33:443-462. 
 
Poum A., Promthet A., Duffy S., Parkin D. M., (2014).  Factors Associated with Delayed 
Diagnosis of Breast Cancer in Northeast Thailand. J Epidemiol;24(2):102-108 
 
Petro-Nustus W., Mikhail B.I., (2002). Factors associated with breast self- examination 
among Jordanian women. Public Health Nursing, vol. 19, 263-71.  
 
Qabaha K., Abu Hassan W., Bsharat A., Mousa M., Horani Y., (2015). Demographic and 
clinical predictors of breast cancer among Palestinian women. International Research 
Journal of Medicine and Medical Sciences; 3(2): 35-39 
 
Rezaianzadeh A., Peacock J., Reidpath D., Talei A., Hosseini V. A., Mehrabani D., 
(2009). Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran. 
BMC Cancer; 9(168): 1471-2407. 
 
Richards M., Westcombe A., Love S., Littlejohns P., Ramirez A., (1999). Influence of 
delay on survival in patients with breast cancer. a systematic review, (9159):1119-26 
Radi M. A., (2013). Breast Cancer Awareness among Saudi Females in Jeddah. Asian Pac 
J Cancer; 14 (7): 4307-4312 
 
95 
 
Rauscher G. H., Ferrans C. E., Kaiser K., Campbell R., Calhoun E., Warnecke R. B., 
(2010). Misconceptions about breast lumps and delayed medical presentation in urban 
breast cancer patients. Cancer Epidemiol Biomarkers Prev.;19(3): 640–647. 
 
Ruddy J. K., Gelber S., Tamimi M. R., Schapira L., Come E. S.,,Meyer E., M, Winer P. E., 
Partridge H. A., (2014). Breast Cancer Presentation and Diagnostic Delays in 
YoungWomen. American Cancer Society; (120):20-5. 
 
Rastad H., Khanjani N., Khandani K. B., (2013). Causes of Delay in Seeking Treatment in 
Patients with Breast Cancer in Iran: A Qualitative Content Analysis Study. Asian Pacific J 
Cancer Prev; (9): 4511-4515.  
 
Shaheen R., Slanetz P.J., Raza S., Rosen M.P., (2011). Barriers and opportunities for early 
detection of breast cancer in Gaza women. 
 
Statistics Canada (2009) An update on mammography use in Canada. Available: 
http://www.statcan.gc.ca/pub/82-003-x/2009003/article/10873-eng.htm Accessed 
15 February 2013. 
 
Seedhom E. A., Kamal N., (2011) Factors Affecting Survival of Women Diagnosed with 
Breast Cancer in El-Minia Governorate, Egypt. Int J Prev;3:(131–138).  
 
Stapleton J. M., Mullan P. B., Dey S., Hablas A., Gaafar R., Seifeldin I. B., Banerjee M., 
Soliman A. S., (2011). Patient-mediated factors predicting early- and late-stage 
presentation of breast cancer in Egypt. Psychooncology; 20(5): 532–537 
 
Saldana K. U.,Castaneda C. I., (2009). Delay of medical care for symptomatic breast 
cancer: A literature review ;(2): S270-S285 
 
Saldana U. K., (2014). Challenges to the early diagnosis and treatment of breast cancer in 
developing countries. World J ClinOncol; 5(3): 465-477. 
 
96 
 
Seif Y. N., Aziz A. M., (2000).  effect of breast self-examination training program on 
knowledge, attitude, and practice of a group of working women. Journal of Egyptian Nat; 
(12): 105-115. 
 
Soskolne V., Marie S., Manor O., (2006). Beliefs, recommendations and intentions are 
important explanatory factors of mammography screening behavior among Muslim Arab 
women in Israel. Oxford University Press; 22(5): 665–676. 
 
Stapleton M. J., Mullan B. P., Dey S., Hablas A., Gaafar R., Seifeldin A. I., Banerjee M., 
Soliman S. A.,(2015).  Patient-mediated factors predicting early- and late-stage 
presentation of breast cancer in Egypt. PMC; 20(5): 532–537.  
 
Shaheen R., Slanetz P. J., Raza S., Rosen M. P., (2011). Barriers and opportunities for 
early detection of breast cancer in Gaza women. The Breast, (20: S30-S34 
Saldana K. U.,Castaneda C. I., (2009). Delay of medical care for symptomatic breast 
cancer: A literature review ;(2): S270-S285 
 
Taha H., Al-Qutob R., Nystrom L., Wahlstrom R., Berggren V., (2012). Voices of Fear 
and Safety‖ Women‘s ambivalence towards breast cancer and breast health: a qualitative 
study from Jordan.BMC Women's Health;( 12:21): 1472-6874 
 
Tabar L. Falun Meeting, Falun, Sweden, O. C. a. C. (1996), Breast-cancer screening with 
mammography in women aged 40–49 years. Int. J. Cancer, 68: 693–699 
 
Taplin S. H., Ichikawa L., Yood M. U., Manos M., Geiger A. M., Weinmann S., Gilbert J., 
Mouchawar J., Leyden W. A., Altaras R., Beverly R. K., Casso D., Westbrook E. O., 
Bischoff K., Zapka J. G., Barlow W. E., (2004). Reason for Late-Stage Breast Cancer: 
Absence of Screening or Detection, or Breakdown in Follow-up?.J Natl Cancer 
Inst;(96):1518–27  
 
Tfayli A., Temraz S., AbouMrad R., Shamseddine A., (2010). Breast Cancer in Low and 
Middle-Income Countries: An Emerging and Challenging Epidemic. Journal of Oncology, 
(5) doi:10.1155/2010/490631  
97 
 
 
Tartter P. I., Pace D., Frost M.,Bernstein J. L., (1999). Delay in Diagnosis of Breast 
Cancer. Annals of Surgery; 229(1): 91-96  
 
Unger-Saldaña K., Infante-Castañeda C., (2008) Delay of Medical Care for Symptomatic 
Breast Cancer: A Literature Review. SaludPublica de Mexico 5: 270–85. 
WHO. (2014). Early detection of cancer.  Retrieved from http://www.who.int. 
WebMD. (2014). understanding breast cancer.Retrieved from (http://www.webmd.com).  
WHO. (2015). Retrieved from. Breast cancer burden 
(http://www.who.int/cancer/detection/breastcancer/en) 
Weller D. P., Campell C., (2009). Uptake in cancer screening programmes: a priority in 
cancer control. Br J Cancer; (101): 55-59 
 
World Health Organization (2008) World Health Statistics. Available: http:// 
www.who.int/whosis/whostat/EN_WHS08_Full.pdf Accessed 
 
Williams F., (2015). Assessment of Breast Cancer Treatment Delay Impact on Prognosis 
and Survival: A Look at the Evidence from Systematic Analysis of the Literature. J Cancer 
Biol Res; 3(4): 1071.6 
 
WHO. (2016). Breast cancer: prevention and control. Retrieved from 
(http://www.who.int/cancer/detection/breastcancerl) 
 
Wikipedia. (2016). Health belief model. Retrieved from 
(https://en.wikipedia.org/wiki/Health_belief_model) 
 
 
 
 
 89
 
 
  mroF tnesnoC .1 xennA
 
 اقرار بالموافقة على المشاركة فً البحث
 eriannoitseuQ ro yevruS htiw hcraeseR rof tnesnoC demrofnI
 عنوان البحث:
ٌتعالجن  للاتًوا سرطان الثدي عند النساء الفلسطٌنٌات العوامل المرتبطة فً تأجٌل تشخٌص     
 لحم.بٌت  –فً مستشفى بٌت جالا الحكومً 
 هدف البحث:
كانت متعلقة  إذاسرطان الثدي ومعرفة أسباب التأجٌل فٌما  دراسة جمٌع العوامل المتعلقة فً تأجٌل تشخٌص     
مدى انتشار هذه الظاهرة بٌن النساء الفلسطٌنٌات اللاتً ٌتعالجن  ،بالمرٌض نفسه او ناجمه عن مقدم الرعاٌة الصحٌة
   الورم.حجم  ،مرحلة السرطان ،على صحة المرٌض تأثٌر هذا الـتأجٌل مدى وما ،فً مستشفى بٌت جالا الحكومً
 :البحث من الغرض
 من بنجاعة العلاج فً ٌساهم المبكر الكشف ان متأخرا كما اكتشافها ٌتم فلسطٌن فً الثدي سرطان حالات معظم ان
 .)1102 الفلسطٌنٌة، الصحة وزارة% (04 تفوق بنسبه منه والشفاء المرض هذا
ة والدقٌقة تمكنننا من فهم العواملل المرتبطلة فلً تأجٌلل تشلخٌص ٌان مساعدتنا فً الحصول على المعلومات الصح    
ترتبلة علٌله، وٌزٌلد ملن لمسرطان الثدي، وهذا بدوره ٌساهم فً العلاج المبكر مما ٌخفف من حدة الملرض والعواقلب ا
النتائج ستتم التوصٌات لإنشاء برامج توعوٌة للنسلاء  ىبناءا علو نسبة الشفاء بٌن هذه الشرٌحة من المجتمع الفلسطٌنً،
الفلسطٌنٌات حول أهمٌة فحص الثدي الدوري لاكتشاف المرض فً مراحله المبكرة، كما ٌساهم هذا البحث فلً تسللٌط 
   الثدي.المساهمة بالكشف المبكر لسرطان  ودورهم فًالضوء على مقدمً الرعاٌة الصحٌة 
عبئة هلذا الاسلتبٌان بدقلة وصلراحة، علملا ان جمٌلع المعلوملات التلً سلوف تلدلٌن بهلا سلوف تعاملل ارجو تعاونك فً ت
 بسرٌة ولأغراض البحث العلمً فقط.
 والعرفان الشكر جزٌل مع
 
 الطالب: عبد الناصر بدوي    
 المشرف: د. سمٌة الصاٌج
 توقٌع المشتركة/اختٌاري:
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 eriannoitseuq cibarA .2 XENNA                                                 ................الرقم المتسلسل للاستبٌان: 
   
 .تارٌخ الٌوم: ...............................
 الرقم الطبً: ..............................
 
 الجزء الأول: 
 ىيَوٝغ.ٕنا اىغيء ٝزؼَِ اىقظبئض الاعزَبػٞخ ٗاىلَٝ٘غوافٞخ 
   ٍْخ .اىؼَو: .................... 1
   .اىَٞلاك: ............ربهٝـ  6
  ٍقٌٞ  □  قوٝخ □    ٍلْٝخ □ اىَنِ:ٍنبُ  0
   .ٍفظو: ...............................................................ػْ٘اُ  1
   اٍٜ □ 7اىزؼيَٜٞاىََز٘ٙ  2
 ٍيٌ (رقوأ ٗرنزت) □
 اثزلائٜ □
 اػلاكٛ□ 
  صبّ٘ٛ □
 كثيً٘ ٍزٍ٘ؾ□ 
 ثنبى٘هًٝ٘ فأػيٚ □
  ٍزيٗعخ □ ػيثبء □ اىيٗعٞخ:اىؾبىخ  6
 
  اهٍيخ□  ٍطيقخ □
  ٍْخ ........... اىؼَو ػْل اىيٗاط: 7
 اىَْٖخ: 5
  هثخ ثٞذ □
 .ٍزقبػلٓ. ٍب ٕٜ ٗظٞفزل اىَبثقخ: ..................... □
  .اىؾبىٞخ: ....................... ٍب ٕٜ ٗظٞفزل خٍ٘ظف □
 امموٛ ......................................... مىل،غٞو □
   ...................... اىَبػٞخ:اىَْٖخ فلاه اىقََخ اػ٘اً  6
اىلفو اىشٖوٛ ىيؼبئيخ  31
 ثبىشٞنو:
 0003ٍِ  أمضو □ 0003-1002□ 0002-1001 □ 0001اقو ٍِ □
 001
 
 
 الثانً:الجزء 
 المعلومات المتعلقة بالتارٌخ الصحً لك وللعائلة، والعادات المتبعة بشأن فحص الثدي والمتابعة الدورٌة لاكتشاف سرطان الثدي.
 هل عانٌت او تعانٌن من الامراض المزمنة التالٌة او امراض اخرى: 1
 
 لا اعرف لا نعم
 □ □ □ ارتفاع ضغط الدم                     1 
 □ □ □ السكري 6 
 □ □ □ الربو    3 
 □ □ □ أي نوع من انواع الحساسٌة 1 
 □ □ □ التهاب المفاصل المزمن او الحاد   2 
 □ □ □ امراض الجهاز الهضمً  3 
 □ □ □ امراض القلب والاوعٌة الدموٌة    4 
 □ □ □ )، الخروماتٌزم المفاصل ،الذئبة الحمراءمثل ( امراض الجهاز المناعً الذاتٌة. 5 
 □ □ □ عدوات متكررة  6 
 □ □ □ امراض عصبٌة او نفسٌة 31 
 □ □ □ الثدي)اماكن اخرى فً الجسم (غٌر  خبٌثة فًاورام  11 
 
 
 6
 
 اىزبهٝـ اىظؾٜ ىل ٗىيؼبئيخ 
   
 فٜ اىَوؽيخ اىزٜ ٍجقذ امزشبف اىَوع ىلٝل ٕو ػبّٞذ ٍِ ٗع٘ك مزيخ، 1 
 اٗ اىزٖبة فٜ اىضلٛ؟ أمٞبً ىٞفٞخ، افواىاد ؽيٞجٞٔ
 لا اذكر □ □لا □ نعم □
 أؽلٕو قَذ فلاه اىقٌَ ٍْ٘اد اىزٜ ٍجقذ امزشبف اىَوؽبُ ثيٝبهح  2 
 ؟ىغََلالاؽجبء / اىطجٞجبد ٗمىل ٍِ اعو اىقٞبً ثفؾ٘طبد شبٍيخ 
 لا اذكر □ □لا □ نعم □
 3 
 
 الأخت) أصٌب بسرطان الثدي؟ الام،من افراد العائلة ( ٌوجد أحدهل 
  لم اسمع عنه ٌوما□ لا □ نعم □
بنت الخال/ة)  ة،بنت العم/ الجدة، الخالة، (العمه،من الاقارب  أحدهل ٌوجد  4 
 الثدي؟أصٌب بسرطان 
 لا اعرف□ لا□ نعم□
 لا اعرف□ لا□ نعم□  من افراد العائلة او الاقارب بأي نوع اخر من السرطانات؟ أحدهل اصٌب  5 
    فؾض اىضلٛاىؼبكاد اىَزجؼخ ثشأُ  0
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 لا اػوف□ لا□ نعم□ للثدي؟قبل تشخٌص المرض لدٌك، هل تعرفٌن كٌفٌة اجراء الفحص الذاتً  1 
    كانت اجابتك نعم من اٌن مصدر معلوماتك؟ إذا 2 
   □ التوعٌة المقدمة من الطواقم الطبٌة  .1  
   □ الانترنت  .2  
   □ التلفاز .3  
   □ ...) اختً،امً،  زوجً،(العائلة من افراد  أحد .4  
   □ اذكري......................... ذلك،غٌر  .5  
 قبل تشخٌص المرض لدٌك، هل سبق وان قمت بالفحص الذاتً للثدي؟  3 
 
 ىٌ اٍَغ ػْٔ ٍٝ٘ب□ لا□ نعم□
 وفق ما ذسَىه مىاسة √)(اشازخ ضع  ،وعمماود اجاترل  إذا  
 ثٖب ثبىفؾض اىنارٜ ىيضلٛ؟ قَذػلك اىَواد اىزٜ 
   
   □ اقً٘ ثؼَو اىفؾض اىنارٜ ىيضلٛ ٍوٓ مو شٖو..1  
   □ ٍواد ٍْ٘ٝب. أهثغاقً٘ ثؼَو اىفؾض اىنارٜ ىيضلٛ ٍِ صلاس اىٚ .2  
   □ .ٍْخاقً٘ ثؼَو اىفؾض اىنارٜ ىيضلٛ ٍوٓ مو .3  
   □ غٞو مىل، امموٛ ............4  
      
 لم اسمع عنه ٌوما□ لا□ نعم□ ٕو رؼوفِٞ ٍب ٕ٘ اىزظ٘ٝو الاشؼبػٜ ىيضلٛ؟ قجو رشقٞض اىَوع ىلٝل،  4 
قجو رشقٞض اىَوع ىلٝل، ٕو ٍجق ٗاُ قَذ ثؼَو ط٘هح شؼبػٞخ ىيضلٛ؟ 5 
  
 لم اسمع عنه ٌوما□ لا□ نعم□
 وفق ما ترٌنه مناسب √)(اشارت ضع  ،نعمكانت اجابتك  إذا  
 بها بعمل صوره شعاعٌة للثدي؟ قمتالمرات التً 
 
   
   □ مره كل سنة. الثدي الشعاعٌة.اقوم بعمل صوره 1  
   □ مره كل سنتٌن. الثدي الشعاعٌة.اقوم بعمل صوره 2  
   □ سنوات. أربعمره كل ثلاث الى  الثدي الشعاعٌة.اقوم بعمل صوره 3  
   □ .غٌر ذلك، اذكري ...........4  
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اىَوع ىلٝل، ٕو ٍجق ٗاُ ىهد اىطجٞت/ٓ ىؼَو اىفؾض قجو رشقٞض  6 
 اىَوٝوٛ ىيضلٛ؟
 لم اسمع عنه ٌوما□ لا□ نعم□
    وفق ما ذسَىه مىاسة √)(اشازخ ضع  ،نعمكانت اجابتك  إذا  
    ح؟اىَواد اىزٜ قَذ ثٖب ثؼَو اىفؾض اىَوٝوٛ ىيضلٛ ػْل اىطجٞت/  
   □ ٍْخاقً٘ ثؼَو اىفؾض اىَوٝوٛ ىيضلٛ ٍوح مو .1  
   □ اقً٘ ثؼَو اىفؾض اىَوٝوٛ ىيضلٛ ٍوح مو ٍْزِٞ.2  
   □ ٍْ٘اد أهثغاقً٘ ثؼَو اىفؾض اىَوٝوٛ ىيضلٛ ٍوح مو صلاس اىٚ .3  
   □ امموٛ .......... مىل.غٞو .4  
 
 7 الجصء الثالث
اىَؼيٍ٘بد اىَزؼيقخ ثبلأػواع الاٗىٚ ىَوؽبُ اىضلٛ ػْلك، اىشقض اىنٛ امزشف ٕنٓ الاػواع، ٍجت اىزأفٞو ٍب ثِٞ امزشبف 
 ٕنٓ الاػواع اىٚ ىٝبهح اىطجٞت، ٍٗجت اىزأفٞو فٜ ٗػغ اىزشقٞض اىْٖبئٜ ثؼل ىٝبهح اىطجٞت.  
 1
 
 ٞخ؟ٍب ٕٜ اىؼلاٍخ اىزٜ ظٖود ػْلك ٗكفؼزل ىيجؾش ػِ اىَش٘هح اىظؾ
 اىضلٛ)اىزؾنٝوٝخ ىَوؽبُ  (الاػواع
 
 لا اعرف لا نعم
 □ □ □ اىطجٞت؟ٍَب كفؼل ىيٝبهح  ِٞاىضلٝ أؽل ٍإىَٔ فٜٕو ظٖو مزيخ غٞو  1 
 □ □ □ اىؾيَخ؟ٕو ؽلس رغٞو ٍٗشبمو فٜ  2 
 □ □ □ اىضلٛ؟ٕو ؽلس اىٌ فٜ  3 
 □ □ □ ٕو ؽلس رغٞو فٜ شنو ٗؽغٌ اىضلٛ 4 
 □ □ □ الاثؾ؟ٕو ؽلس اّزفبؿ اٗ ثوٗى ىيغلك اىيَٞفبٗٝخ رؾذ  5 
 □ □ □ ٕو ؽلس ٗاُ مبُ ْٕبك افواىاد ماد ؽجٞؼخ غوٝجخ ٍِ اىضلٛ 6 
 □ □ □ اىضلٛ؟ٕو ؽلس اّزفبؿ فٜ  7 
 6
 
 ٍب ٕٜ اٗه الاػواع اىَبثقخ اىزٜ ظٖود ىلٝل؟ الاعبثخ...................  
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 0
 
 )؟اىضلٛ ػْلك الأٗىٚ ىَوؽبُاىؼلاٍخ ٍِ امزشف اىؼوع / الاػواع اىزٜ قَذ ثبلإكلاء ثٖب ثبلأٍئيخ اىَبثقخ، (أٛ 
 
   □  ّفَٔ) (اىَوٝغاّذ  1 
   □ اىطجٞت/ اىطجٞجخ 2 
   □ ) ٗثلُٗ رؾ٘ٝو ٍِ اىطجٞتyhpargommamٍِ فلاه اىظ٘هح اىشؼبػٞخ ( 3 
   □ ............ ؽلكٛ ،مىلغٞو  4 
 
 4
 
 ػْل ظٖ٘ه أؽل ٕنٓ الاػواع اىَبثقخ ٕو قَذ ثبىزؾلس اىٚ؟ 
 
   □ ىٌ ارؾلس لاؽل  1 
   □ قَذ ثافجبه ىٗعٜ  2 
   □ افواك اىؼبئيخ  أؽلافجود  3 
   □ رٜ بطلٝقاؽلٙ افجود  4 
 5
 
مٌ رأفود ٍِ اىيٍِ ٍْن ظٖ٘ه الاػواع ىلٝل ٗاىٚ ؽِٞ ىٝبهح اىطجٞت لإفجبهٓ ثزيل الاػواع ػيَب ثبّٖب مبّذ اىجلاٝخ 
 اهع٘ رؾلٝل اىفزوح اىيٍْٞخ ثغبّت الاعبثخ اىزٜ رقزبهْٖٝب)(لامزشبف اىَوع؟ 
 
   (اذكري عدد الاٌام..............)                      □اقل من شهر                        1 
    .....)                     .....(امموٛ ػلك الاٝبً....□ ما بٌن شهر الى ثلاث أشهر       2 
  (اذكري عدد الأشهر او السنوات................)                      □أكثر من ثلاث أشهر               3 
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ػغ  المسض72 ما سثة الرأخُس لصَازج الطثُة مىر ظهىز الاعساض فٍ الثدٌ الً شَازج الطثُة الاولً لامرشاف 3
ٍ٘افق  ٍ٘افق، غٞوغٞو  ،أكهٙلا  ثشلٓ، ٍ٘افق، (ٍ٘افقٗفقب ىَقٞبً ىٞنود اىقَبٍٜ  ٍْبٍت،رؾذ ٍب روْٝٔ (√) اشبهح 
 ثشلٓ)
 
 ما سثة الرأخُس لصَازج
 
 
موافق 
 بشده
غٌر  أدرىلا  موافق
 موافق
غٌر 
موافق 
 بشده
الاعتقاد بأن هذه الاعراض  جدي،لم اخذ الامر بشكل  1
 تزول؟سوف 
     
      لدي؟عدم وجود الوقت الكافً  2
      ؟الثديلفحص  امرأةعدم وجود طبٌبه او اخصائٌة  3
      ؟بذلكلا ٌسمح  للؤسرة الوضع الاقتصادي 4
      زٌارة الطبٌب وفحص الثدي؟الخجل من  5
      ؟الخوف من تشخٌص سرطان الثدي 6
      ؟جراحٌةالخوف من اجراء عملٌة  7
      ؟منةالخوف من ازالة الثدي او جزء  8
، بفقدان الثدي او جزء التأثٌر على وضعً كأنثى او زوجه 9
 ؟منه
     
      عدم تلقً الدعم من العائلة؟ 01
      ؟تلقً الدعم من الزوجعدم  11
مصاب بسرطان الثدي النساء من افراد العائلة  أحدوجود  21
 ؟ولا ارٌد ان اعانً مثله
     
الاعتقاد بأن العلاج المتوفر لسرطان الثدي ٌؤدي الى  31
 ؟الموت السرٌع
     
الرفض للتوجه الى طبٌب واعتبار ذلك تسلٌم للقدر مهما  41
 الثدي؟كانت نتائج سرطان 
     
      ؟بالأعشابالسعً لاستخدام الطب البدٌل مثل المداواة  51
 
مان  إذا2 ما هى السثة السئُسٍ مه الاسثاب الساتقح لرأخُسك لصَازج الطثُة مىر ظهىز الاعساض لدَل فٍ الثدٌ او 5
  ................................................................................................ اخسي؟لدَل اسثاب 
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) عند المربع   √(من اجابة بوضع  أكثرٌمكن اختٌار ما هو السبب الذي دفعك للاستشارة الطبٌة بعد الانتظار؟ (  4
 )المناسب
 اػوفلا  □ لا □ نعم □ اٍزَواه الاػواع 1 
 ئمابىق٘ف ثبُ رنُ٘ اػواع ىَوؽبُ اىضلٛ ٗاُ رظجؼ اٍ٘ء ثاىشؼ٘ه  2 
 رومذ ثلُٗ ػلاط
 □ □ □
 □ □ □ مبّذ ٕٜ اػواع ٍوؽبُ اىضلٛ ئمااىفؼ٘ه  3 
 □ □ □ ّظٞؾخ ٍِ الاٍوح ٗالاقبهة  4 
 □ □ □  ءاٍ٘ أمضواطجؾذ الاػواع  5 
 □ □ □ ................ امموٛاٍجبة افوٙ/  6 
الاطباء / الطبٌبات وذلك قبل  أحدمنذ ظهور الاعراض لدٌك، هل قمت بزٌارة  5
 الحكومً؟زٌارة مستشفى بٌت جالا 
 نعم□
 
 لا□
 
 لا اعرف□
 
 
 
 
  11ارجو الانتقال للسؤال  لاكانت  وإذاارجو الاجابة عن السؤالٌن التالٌٌن  نعمكانت اجابتك  إذا
من الطبٌب / الطبٌبة الذي قمت بمراجعته منذ ظهور الاعراض لدٌك وقبل زٌارة  6
 الحكومً؟مستشفى بٌت جالا 
   
   □ عام /ةطبٌب 1 
   □ نسائٌةطبٌب/ة  2 
   □ اورام /ةطبٌب 3 
   □ جراحه /ةطبٌب 4 
 حددي ......... ذلك،غٌر  5 
 
   □
ثَبما ػْل ىٝبهرل اىطجٞت ىيَوح الأٗىٚ ثؼل ظٖ٘ه اىؼوع الأٗه ىَوؽبُ اىضلٛ،  31
 ر٘عٖٞل، ٗمىل قجو ىٝبهح ٍَزشفٚ ثٞذ عبلا اىؾنٍٜ٘؟ رٌ
   
   □ طلب منً عمل صورة شعاعٌة للثدي 1 
   □ لاستكمال الفحوصات الاورام،تم تحوٌلً لمستشفى بٌت جالا /عٌادة  2 
   □ لاستكمال الفحوصات.تحوٌلً لمستشفى اخر  3 
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   □ تشخٌصً بغٌر سرطان الثدي، مثل التهاب فً الثدي 4 
 غٌر ذلك؟ اذكري ....................................... 5 
 
  □
 
 
مٌ  ٍِ اى٘قذ  الاٗهاً،ٍ٘ػل ىؼٞبكح  اىؾنٍٜ٘ لأفنػْل ىٝبهرل ىََزشفٚ ثٞذ عبلا  11
 اٍزغوقذ ىوؤٝخ اىطجٞت؟
   
   (اذكري عدد الاٌام.........)                      □اقل من اسبوع                       1 
   (اذكري عدد الاٌام ........)                      □اقل من شهر                          2 
    (اذكري عدد الأٌام /الاشهر.........)                      □أكثر من أشهر                       3 
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ؽَت مامورل، ٍب ٕٜ اىَلح اٗ اىفزوح ثِٞ اىيٝبهح الأٗىٚ ىيطجٞت، ٗاى٘ط٘ه اىٚ 
 ثأفن ػْٞخ ٍِ اىضلٛ؟  اىضلٛ ٍوٗهااىزشقٞض اىْٖبئٜ ىَوؽبُ 
 
   
   (اذكري عدد الاٌام.........)                      □اقل من اسبوع                        1 
   (اذكري عدد الاٌام ........)                      □اقل من شهر                           2 
    (اذكري عدد الأٌام /الاشهر.........)                      □أكثر من أشهر                        3 
 
 01
 
 ....................................ما هى ذازَخ ذشخُصل تسسطان الثدٌ؟  
 
   
 مه اجاتح) أمثساخرُاز  (َمنه ٍب ٕ٘ ّ٘ع اىؼلاط اىنٛ فؼؼذ ىٔ ٍْن اطبثزل ثَوؽبُ اىضلٛ؟ 11
 
 لا اعرف □ لا □ نعم □ عواؽخ لإىاىخ اىضلٛ ثأمَئ.  1 
 □ □ □ عواؽخ لإىاىخ عيء ٍِ اىضلٛ. 2 
 □ □ □ عواؽخ لإىاىخ اىنزيخ. 3 
 □ □ □ ػلاط ثبلإشؼبع. 4 
 □ □ □ ػلاط مَٞٞبئٜ. 5 
 □ □ □ ػلاط ٕوٍّٜ٘. 6 
 □ □ □ ػلاط ٍْبػٜ. 7 
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لا تهدف الرعاٌة التلطٌفٌة إلى علاج المرض، ولكنها تهدف إلى مساعدة المرٌض ومساعدة عائلته  التلطٌفٌة:الرعاٌة 
لتحسٌن حٌاته من خلال تلبٌة الاحتٌاجات الجسدٌة والعملٌة والمعنوٌة والروحٌة المرتبطة بمرضة؛ وهً تتضمن مجموعة من 
ٌركز العلاج فً الغالب على  الصلة،الصحة ذوي  الخدمات المقدمة من الفرٌق الطبً والتمرٌضً، وغٌرهم من أخصائً
 .تسببها الأدوٌة قد تخفٌف الألم أو الأعراض الناتجة عن الإصابة بالسرطان، وٌتضمن أٌضا ًعلاج للآثار الجانبٌة الجسدٌة التً
 51
 
 ٕو رٌ اهشبكك اٗ رؾ٘ٝيل ىيوػبٝخ اىزيطٞفٞخ؟
 اجب عن السؤالٌن التالٌٌن نعمكانت الاجابة  إذا
  لا □ ّؼٌ □
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 ٍِ اعبثخ) أمضو؟  (َٝنِ افزٞبه ٕو مبّذ اىوػبٝخ اىزيطٞفٞخ
   
   □ جزء من العلاج داخل المستشفى 1 
   □ )(البٌت رعاٌة منزلٌة 2 
   □ اذكري؟غٌر ذلك،  3 
وفق ما ذسَىه  √)(اشازخ َمنه اخرُاز أمثس مه اجاتح تىضع ( ؟ٍب ٕ٘ ّ٘ع اىوػبٝخ اىزيطٞفٞخ اىزٜ رٌ رقلَٝٔ ىل  41
 )مىاسة
 
 ػلاط الالاً ثبٍزقلاً اىََنْبد اىزٜ رزواٗػ ثِٞ اىََنْبد اىجَٞطخ ٍضو 1 
بهاٍٞزبٍ٘ه ، اٗ ٍَنْبد ٍزٍ٘طخ ٍضو اىزواٍبكٗه، أٗ اىََنْبد اىق٘ٝخ ٍضو ث
 اىَ٘هفِٞ .
 لا اعرف □ لا □ ّؼٌ □
ػلاط الأػواع غٞو اىَإىَخ ٍضو اىغضٞبُ ٗاىؼؼف اىؼبً ٍٗشبمو  2 
 ٗغٞوٕب.الأٍؼبءٗثؼغ طؼ٘ثبد اىزْفٌ 
 □ □ □
 □ □ □ غٞوٓ.ػلاط الامزئبة ٗاىؾيُ ٗاىزٜ قل رؾزبط ئىٚ ػلاط كٗائٜ أٗ  3 
 
ٍَبػلح ػبئيزٜ ٕٗنا ٝزؼَِ رؼيَٞبد ؽ٘ه مٞفٞخ ئػطبء اىلٗاء، ثبلإػبفخ  4 
اىنٛ اػٞش فٞٔ ٍِ فلاه رٖٞئخ ثؼغ الأشقبص اىَقوثِٞ ئىٚ رٖٞئخ اىَْيه 
 ىٜ ٗرلهٝجٌٖ ػيٚ هػبٝزٜ.
 □ □ □
ر٘فٞو الاؽزٞبعبد اىلْٝٞخ ٗٝشَو مىل كػٌ، ّٗظؼ هعبه اىلِٝ ىٜ اٗ  5 
 ىؼبئيزٜ.
 □ □ □
ػْل اىؾلٝش ػِ  ىٜ ٍِ فلاه الاٍزَبع اىٜ ر٘فٞو الاؽزٞبعبد اىوٗؽٞخ 6 
 اىغَلٝخ.ٍؼبّبرٜ اىْفَٞخ اٗ 
 □ □ □
 801
 
 
 :( لاستخدام الباحث فقط)الرابعالجزء 
 
   
    بها:المرحلة التً تم تشخٌص المرٌضة  51
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 (المعلومات التالٌة تخص وضع المرٌضة حالٌا)
 فً أي مرحلة من سرطان الثدي:  المرٌضة
   
    ىيَوٝغ:ؽغٌ اى٘هً اىَظبؽت  36
    اطبثخ اىغلك اىيَٞفبٗٝخ رؾذ الاثؾ: 12
 اىضلٛ:اّزشبه اىَوؽبُ اىٚ أػؼبء أفوٙ غٞو  22
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ANNEX 3. English questionnaire 
The serial number of the questionnaire: ................ 
Today's date: ............................................................. 
Medical Number: ................................................... 
part One: 
 
This section includes the social and demographic characteristics of the patient. 
Age: .....................years  1 
Birth date: ............. 2 
 □ camp □ Village City□    Place of residence:  3 
Detailed Title: ............................................... ............... 
 
4 
 Educational level                                                                                          
Illiterate□                                                                                           
  not (reads and writes) □ 
                         primary□ 
                   Preparatory□ 
                      secondary□ 
          Diploma Average□ 
bachelor degree or high □ 
 
5 
Widow □  divorced□  □married □ Single Marital Status. 
 
6 
 Age at marriage: ........... years 
 
7 
Occupation: 
□ housewife  
□ retired. What is the last job: ...................... 
□ employee. What is your current job: ....................... 
□ Other, Indicate ........................................? 
8 
The profession over the past five years: ...................... 9 
□ more than 3000 □ 2001-3000 □ 1001-2000 □ less than: 
1000 
Monthly income of the 
family NIS 
10 
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part:The second  
Information related to you and your family health history, and the occurrences of breast 
screening and periodic follow-up to detect breast cancer. 
I do not know No Yes  Have you had or are suffering from these chronic diseases and other 
diseases: 
 
1 
□ □ □ High blood pressure 1  
□ □ □ Diabetes 2  
□ □ □ Asthma  3  
□ □ □ Any type of allergies 4  
□ □ □ Chronic arthritis or acute 
 
5  
□ □ □ Digestive Disease 
 
6  
□ □ □ Cardiovascular disease 
 
7  
□ □ □ Self-immune system diseases. (Such as systemic lupus 
erythematosus, rheumatic arthritis, etc.) 
 
 8  
□ □ □ Recurrent infections  9  
□ □ □ Neurological or psychiatric disease 
 
10  
□ □ □ Malignant tumors elsewhere in the body (non-breast) 11  
Health history of you and your family                                                                     Yes       no     I don’t 
know 
2 
□ □ □ In the period before the discovery of the disease have you had the 
presence of mass, fibrous bags, milky secretions or inflammation 
in the breast? 
1  
□ □ □ During the five years preceding the discovery of the cancer have 
you visited one of the doctors / physicians in order to carry out 
comprehensive checks to your body 
2  
□ □ □ Is there anyone of the family members (mother, sister) has or had 
breast cancer? 
3  
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□ □ □ Is there anyone of the relatives (Aunt, aunt, grandmother, uncle 
girl / H, girl Khal / e) suffering from breast cancer? 
4  
□ □ □ Is there anybody of the family members or relatives who suffers 
from any other type of cancer. 
5  
□ □ □ Usages on breast examination 3 
□ □ □ Before the diagnosis of the disease you have, do you know how to 
perform a breast self-examination? 
1  
□ □ □ If you answer is "yes", where have you got the source of your 
information? 
2  
□ □ □ 1. awareness provided by the medical staff   
□ □ □ 2. online   
□ □ □ 3. TV   
□ □ □ 4. One of the family members (my husband, my mom, my sister, 
...) 
  
□ □ □ 5. otherwise, Indicate .........................   
□ □ □ Before the diagnosis of the disease you have, have you ever 
thought of breast self-examination? 
3  
      
   If you answer is “yes”, put the mark (√) as appropriate 
according to the number of times that you have made self-
examination of the breasts? 
 
  
□ □ □ 1.I run breast self-examination once a month.   
□ □ □ 2.I run breast self-examination of three to four times a year.   
□ □ □ 3.I run breast self-examination once a year.   
   4. Others indicate .........   
□ □ □ Before the diagnosis of the disease you have, have you known 
what a mammogram is? 
4  
   Before the diagnosis of the disease you have, have you ever 
thought of performing a mammogram? 
5  
If you answered is "yes", place (√) as appropriate  
Once you have run a mammogram? 
  
□ □ □ 1.I run mammogram everyone years. 
 
  
□ □ □ 2.I run mammogram every two years.   
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□ □ □ 3. mammogram once every three to four years.                         
   4. others. Indicate ...........   
□ □ □ Before the diagnosis of the disease you have, have you ever 
visited the doctor / before you run clinical breast examination? 
6  
If you answer is "yes", place (√) as appropriate  
Once you have run the clinical breast examination when? the doctor / e? 
  
□ □ □ 1. I Perform the clinical breast examination once a year   
□ □ □ every two years. 2. I Perform the clinical breast examination   
□ □ □ 3.I perform the clinical breast examination once every three to four 
years 
  
□ □ □ 4.Others. Indicate ..........   
 
The third part: 
Information related to the first symptoms of breast cancer you have, the person who discovered these 
symptoms, the cause of the delay between the discovery of these symptoms and visiting the doctor, and 
the reason for the delay in a final diagnosis after visiting the doctor. 
    
What is the mark that appeared which urges you to search for 
health advice? (Warning symptoms of breast cancer) 
1 
  □ Does the emergence of an unpainful lump in one of breasts urge 
your t to visit the doctor? 
1  
  □ Were there changes and problems in the nipple? 2  
  □ Was there a pain in the breast? 3  
  □ Was there a change in the shape and size of breast?  4  
  □ Was there a swilling of the lymph nodes under the armpit? 5  
  □ Was there a strange nature of secretions from the breast 6  
  □ Was there a swilling in the breast itself? 7  
   What were the first symptoms that appeared earlier? The answer. 
 
 
1 
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Who discovered the symptoms that you have you have mentioned in the previous answers, (i.e. 
the first sign of breast cancer you have)? 
2 
  □ You? (the patient himself) 
 
1  
  □ The physician / doctor 2  
Through X-ray (mammography) and without conversing with the doctor. 3  
   Others. Identify ............ 4  
   Upon the emergence of these previous symptoms did you speak to? 4 
  □ I have not spoken to anyone. 1  
  □ I told my husband. 2  
  □ told a family member. 3  
  □ I told one of my friends. 4  
How long did it take you since onset of symptoms you have to visit a doctor to tell him about 
those symptoms? Knowing that it was the beginning of the discovery of the disease? (Please 
specify the time period next to the answer you choose) 
5 
   Less than a month (Indicate the number of days ..............) 1  
Between one month to three months (Indicate the number of months..............) 2  
More than three months (Indicate the number of months or years ................) 3  
 
6. What was reason for the delay to visit a doctor since the onset of symptoms in the breast to detect the 
disease: Tick (√) under the appropriate choice according to the Likert scale Quintet (Strongly Disagree, OK, I 
do not know, but OK, strongly disagree). 
 
 
  
 
 
 
 
 
The reason for the delay of the visit 
 
     I did not take things seriously, believing that 
these symptoms will go away? 
1 
     The lack of adequate time do I have? 2 
     The lack of a woman doctor or a specialist who 
can run breast examination? 
3 
     The economic situation of the family does not 
allow it? 
4 
     The embarrassment of visiting the doctor and 
breast examination? 
5 
     Fear of diagnosis of breast cancer? 6 
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     Fear of surgery? 7 
     Fear of mastectomy or part thereof? (removing) 8 
     The impact on my status as a female or spouse, 
loss of breast or part of it? 
9 
     I do not receive support from the family? 10 
     I do not receive support from the spouse 11 
     The presence of one of the family members 
suffering from breast cancer and I do not want 
to I suffer like her? 
12 
     The belief that the therapy available for breast 
cancer leads to rapid death? 
13 
     The refusal to go to a doctor and leaving to fate 
as whatever the outcome of breast cancer could 
be? 
14 
     Seeking to use alternative therapies such as 
herbal medicine? 
15 
 
8. What is the main reason, taking into consideration the previous ones, for the delay to visit a doctor 
since the onset of symptoms you have in your breast? ......................... .................................................. ... 
 
   What is the reason that urges you for medical consultation 
after the delay? (You may select more than one answer put (√) 
in the appropriate box) 
 7 
  □ symptoms persist. 1  
  □ The feeling of fear that the symptoms of breast cancer may 
become worse if left untreated. 
2   
  □ Curiosity if they are the symptoms of breast cancer. 3   
  □ Advice from family and relatives. 4   
  □ Symptoms become serious. 5   
  □ Other reasons / Mention!................ 6   
 □No □Yes Since the onset of symptoms, you have, did you visit one of the 
doctors / physicians prior to the visit of Beit Jala Governmental 
Hospital? 
 8 
 If your answer is "Yes" please answer the following two questions and if they do 
not apply, please go to question 11! 
 
 
 
 
  
115 
 
The doctors you have reviewed since the onset of symptoms and before visiting Beit 
Jala Government Hospital the first time? 
 9 
  □ A general practitioner  1   
  □ A gynecologist 2   
  □ An oncologist 3   
  □ A Surgeon 4   
  □ Others!! Mention! 5   
When you visit a doctor for the first time after the appearance of the first signs of 
breast cancer, what does he tell you to do before being directed of Beit Jala 
Governmental Hospital? 
 10 
  □ I was asked to have a mammogram  1   
  □ I have been transferred to Beit Jala Hospital / Oncology 
Clinic, to complete the tests. 
2   
  □ I have been transferred to other Hospital to complete the tests. 3   
  □ Being diagnosed as non-breast cancer case, it is only 
inflammation of the breast 
4   
  □ Others? Indicate ....................................... 5   
 When you visited BJGH, to make an appointment for the Oncology clinic, 
how long did it take to see a doctor? 
 11 
   Less than a week □ (Indicate the number of days .........) 1   
   Less than a month □ (Indicate the number of days ........) 2   
   More than a month □ (Indicate the number of days / months)  3   
 According to your memory, what is the duration and the period between the 
first visit to the doctor, and getting to the final diagnosis of breast cancer, 
through taking a sample from the breast? 
 12 
   Less than a week □ (Indicate the number of days .........) 1   
   Less than a month □ (Indicate the number of days ........) 2   
   More than a month □ (Indicate the number of days / months .. 3   
What is the time that diagnosis of breast cancer? ....................................  13 
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What is the treatment that has undergone since the time was diagnosed as breast 
cancer? (You may select more than one answer 
 14 
 
 
  □ Mastectomy. 1   
  □ Partial mastectomy.  2   
  □ Lumpectomy  3   
  □ Radiotherapy. 4   
  □ Chemotherapy. 5   
  □ Hormonal therapy. 6   
  □ Immunotherapy. 7   
Palliative care: The palliative care doesn't aim to treat the disease, but they are designed to help the 
patient and help the family to improve his life by meeting the physical and practical, moral and spiritual 
needs associated with illness; it includes a range of services provided by medical and nursing team, and 
other health professionals with relevant understanding, often focused on relieving the pain or symptoms 
resulting from cancer. It also includes the treatment of the physical side and effects of drugs that may 
be caused.                                                                                                                                                     
         
Were you guided to the Palliative Care? 
If the answer is "Yes” the two following questions. 
 15 
Was palliative care? (You may select more than one answer)  16 
  □ Part of the treatment performed in the hospital 1   
  □ Home care (home) 2   
  □ Others! Indicate! 3   
What types of palliative care, which have been submitted to you? (You may select 
more than one answer. Mark (√) as appropriate! 
 17 
The treatment of pain using painkillers, which range from simple analgesics such as 
paracetamol, or painkillers like Tramadol medium, or strong painkillers such as 
morphine. 
1   
The treatment of painful symptoms such as nausea, general weakness and problems 
related to breathing difficulties and others. 
2   
The treatment of depression, sadness and which may need different medication. 3   
The help my family and this includes instructions on how to take the medicine, in 
addition to the house in which I live through finding some close ones to be trained to 
take care of me.  
4   
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Providing religious needs that includes the support of religious men for moral-raising 
and advice.  
 
5   
Providing me with the spiritual needs by listening to and talking about my 
psychological or physical suffering.  
6   
Part IV :( For the researcher use only)   
The stage of the illness which patient are diagnosed by. 18   
(The following information concerning the current status of the patient). 18 
The stage of the illness (breast cancer) the patient is undergoing. 19   
The size of tumor-associated with the illness. 20   
The affected lymph nodes under the armpit. 21   
The spread of cancer to other organs other than the breast. 22   
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Annex 4 Factors analysis for the reasons of patient delay 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N   
1.  Did not take things seriously, believing that these symptoms will go 
away? 0.647 
2.  The embarrassment of visiting the doctor and breast examination 0.779 
3.  Do not receive support from the spouse 0.801 
4.  The economic situation of the family does not allow it 0.567 
5.  Fear of diagnosis of breast cancer 0.651 
6.  Fear of surgery 0.539 
7.  The impact on status as a female or spouse, loss of breast or part of it 0.480 
8.  one of the family members suffering from breast cancer and I do not 
want to I suffer like her 
0.535 
9.  Belief that the therapy available for breast cancer leads to rapid 
death 
0.531 
10.  Do not receive support from the family 0.599 
11.  Seeking to use alternative therapies such as herbal medicine 0.414 
12.  Fear of mastectomy or part thereof 0.475 
13.  The refusal to go to a doctor and leaving to fate as whatever the 
outcome of breast cancer  
0.542 
14.  The lack of adequate time  0.775 
15.  The lack of a woman doctor or a specialist who can run breast 
examination? 0.681 
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Annex 5 Types of palliative care 
 
 
Yes No 
Do not 
know Tot
al N 
# % # % # % 
The treatment of pain using painkillers, which 
range from simple analgesics such as 
paracetamol, or painkillers like Tramadol 
medium, or strong painkillers such as 
morphine. 
33 5423 6 
102
3 
- 323 36 
The treatment of painful symptoms such as 
nausea, general weakness and problems 
related to breathing difficulties and others. 
21 4520 12 
612
4 
- 323 36 
The treatment of depression, sadness and 
which may need different medication. 
23 4022 14 
622
3 
1 122 36 
The help my family and this includes 
instructions on how to take the medicine, in 
addition to the house in which I live through 
finding some close ones to be trained to take 
care of me. 
33 6224 0 120 - 323 36 
Providing religious needs that includes the 
support of religious men for moral-raising and 
advice. 
 
2 426 31 
662
5 
- 323 36 
Providing me with the spiritual needs by 
listening to and talking about my 
psychological or physical suffering. 
33 6224 0 120 - 323 36 
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العوامل المرتبطة فً تأجٌل تشخٌص سرطان الثدي عند النساء الفلسطٌنٌات اللاتً ٌتعالجن فً  
 لحم.بٌت  –مستشفى بٌت جالا الحكومً 
 بدوي محمود حسن اعداد: عبد الناصر
 اشراف الدكتورة: سمٌة الصاٌج
  الملخص:
 
سرطان قاتل فً صفوف  ثرأك ٌعتبر اٌضاو ،النساء بٌنإن سرطان الثدي هو أكثر أنواع السرطان شٌوعا مقدمة: 
حٌث  2102فً عام بٌن النساءوسرطان الثدي هو أكثر اسباب الوفاة بالسرطان شٌوعا مٌع أنحاء العالم، النساء فً ج
المرتبة الاولى بٌن أنواع السرطان التً تصٌب النساء  حالة وفاة. سرطان الثدي ٌأتً فً 000.225كانت هناك 
، ومعظم هؤلاء النساء تسعى إلى عناٌة 3102٪) من إجمالً حالات السرطان فً عام 4.53( ذي بلغ، والٌاتالفلسطٌن
 طبٌة فً مرحلة متأخرة.
اللاتً ٌتعالجن فً مستشفى بٌت جالا الحكومً، التشخٌص بٌن النساء  تأجٌل فًتحدٌد ما إذا كان هناك أي  الأهداف:
فً المرتبطة  الحواجز /تقٌٌم جمٌع العوامل الممكنةمن مقدم الرعاٌة الصحٌة. سواء كان التأجٌل من المرٌض نفسه او 
تأخٌر تشخٌص سرطان الثدي، للتعرف على العلاقة بٌن الخصائص الدٌمغرافٌة للمرٌض، العادات المتبعة بشأن 
للذهاب  فحص الثدي، التارٌخ الصحً للعائلة، طبٌعة ونوع الاعراض الاولٌة لسرطان الثدي وتأخٌر المرٌض
والكشف عن سرطان الثدي، التعرف على العلاقة بٌن مرحلة المرض وحجم الورم والتأخٌر فً تشخٌص سرطان 
 الثدي.
مصابة بسرطان الثدي، واللاتً ٌتعالجن فً امرأة فلسطٌنٌة  491 علىأجرٌت  مقطعٌة عبر دراسة المنهجٌة:
مستشفى بٌت جالا الحكومً، وقد تم اختٌار العٌنة من قسم الرعاٌة الٌومٌة للنساء اللاتً تأتً لتلقً العلاج الكٌمٌائً 
واٌضا من قسم الاورام ومن العٌادات الخارجٌة للنساء التً تأتً للمراجعة، وقد تم جمع البٌانات وجها لوجه مع 
 رٌضات باستخدام استبٌان منظم تم اعداده مسبقا. الم
البٌانات الدٌموغرافٌة، والمرٌض والتارٌخ الصحً للؤسرة، والمتابعة الدورٌة  وقد شمل الاستبٌان معلومات حول
والسبب فً تأخٌر  بها، لثدي، والطرٌقة التً تم اكتشافهسرطان اسرطان الثدي، الأعراض الأولٌة ل للكشف عن
بب التأخٌر بٌن اكتشاف هذه الأعراض وزٌارة الطبٌب وسبب التأخٌر فً التشخٌص النهائً بعد زٌارة التشخٌص. س
تم التحقق من مرحلة المرض لكل امرأة شاركت فً الدراسة عن طرٌق الرجوع لملف كل مرٌضه الطبٌب. وأخٌرا، 
 مسجل على الكمبٌوتر.
ٍِ  ٪1.73 ٗاُ فٜ غؼُ٘ الأشٖو اىضلاصخ الأٗىٚ.الاٍزشبهح ٍِ اىَْبء مٕجِ ىزيقٜ ٪ 71اىلهاٍخ اُاىْزبئظ: فيظذ 
ٍِ اىَْبء اىَشزومبد فٜ  ٪9.64رأفٞو اىَوٝغ). مَب اٗػؾذ اىلهاٍخ اُ صلاصخ أشٖو ( ٍِاىَْبء اّزظوُ لأمضو 
فٞو مَب اٗػؾذ اىلهاٍخ اُ اىزأفٞو اىنيٜ (رأ ).رأفٞو ٍقلً اىوػبٝخ اىظؾٞخ(اىلهاٍخ رٌ رشقٞظِٖ ثؼل أمضو ٍِ شٖو 
 (أمضو ٍِ صلاصخ أشٖو). بد فٜ اىلهاٍخ٪ ٍِ عَٞغ اىَْبء اىَشبهم8.06اىَوٝغ ٗرأفٞو ٍقلً اىوػبٝخ اىظؾٞخ) مبُ 
اىَوٝغ فٜ ىٝبهح اىطجٞت ىينشف ػِ الاػواع الاٗىٚ ىَوؽبُ اىضلٛ، رٌ اىؼض٘ه ػيٚ اىؼلٝل ٍِ الأٍجبة ىزأفٞو 
، اىؾوط ٍِ ىٝبهح اىطجٞت رْظو اىٚ ٕنٓ الاػواع ثبّٖب فطٞوٓ اىَزأفواد ىٌ٪ ٍِ اىَْبء 89 ٗمبّذ الاٍجبة مبىزبىٜ:
٘ػغ الاقزظبكٛ اى٪ ػيٚ اىز٘اىٜ. 8.77٪، 39٪. اىَوأح لا رزيقٚ كػَب ٍِ اىيٗط ٗالأٍوح 2.49ٗفؾض اىضلٛ 
٪، 6.88٪، 8.09ٍوؽبُ اىضلٛ ٗاىغواؽخ ٗاٍزئظبه اىضلٛ أٗ عيء ٍْٖب  رشقٞض ٍِاىق٘ف  ٪. 4.19ىلأٍوح
 .٪4.38 ىٗعخثظفزٜ اٍوأح أٗ  ٜٗػؼز٘اىٜ. اىزأصٞو ػيٚ يٚ اى٪ ػ2.47
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ٛ ٝإكٛ ئىٚ اىَ٘د ىَوؽبُ اىضل ثأُ اىؼلاط اىَزبػ ٪. الاػزقبك6.08ٗع٘ك أؽل أفواك الأٍوح ٝؼبّٜ ٍِ ٍوؽبُ اىضلٛ 
ٍَٖب  اىوفغ ىيز٘عٔ اىٚ اىطجٞت ٗفؾض اىضلٛ. ٪2.77 ً اىؼلاعبد اىجلٝيخ ٍضو الأكٗٝخ اىؼشجٞخاٍزقلا٪. 8.97 اىَوٝغ
 ٪.6.07خ ثَوؽبُ اىضلٛ ٍقزظٗع٘ك ؽجٞجخ  ٪. ػلً8.27٪. ػلً ٗع٘ك اى٘قذ اىنبفٜ 8.27مبّذ اىْزبئظ 
ٗقل ٗعلد اىلهاٍخ اُ ْٕبىل ػلاقخ ماد كلاىخ اؽظبئٞخ ثٞذ اىزأفٞو فٜ اىزشقٞض ٗاىؼلٝل ٍِ ٍزغٞواد اىلهاٍخ ٍِ 
ٍَز٘ٙ اىلفو  اىَزيٗعبد،ىََز٘ٙ اىزؼيَٜٞ، اىَْبء ا ٍْخ، اّقفبع) 06-64ثِٞ ( ٍبٗفظ٘طب  اىزقلً فٜ اىَِ ثْٖٞب.
 اىزٖبة فٜ اىضلٛ فٜ فزوح ٍب قجو امزشبف اىَوع. أٗىٞفٞخ  مزيخ اىَْقفغ ٗع٘ك
، ثْٖٞبٗاىؼلٝل ٍِ ٍزغٞواد اىلهاٍخ ٍِ  اىَجنو اىزشقٞض ِٗقل ٗعلد اىلهاٍخ اُ ْٕبىل ػلاقخ ماد كلاىخ اؽظبئٞخ ثٞ
ثِٞ اىَْبء اىزٜ ىاهد اىطجٞت فلاه اىقٌَ ٍْ٘اد اىزٜ ٍجقذ امزشبف اىَوع، ثِٞ اىَْبء اىزٜ ػْلٕب أؽل ٍِ افواك 
اىؼبئيخ ٍظبة اٗ قل اطٞت ثَوؽبُ اىضلٛ (الاً اٗ الافذ). ثِٞ اىَْبء اىزٜ رؼوف ٍب ٕ٘ اىفؾض اىنارٜ ىيضلٛ، 
و امزشبف اىَوع. ٗاىَْبء اىزٜ مبّذ ػْلٕب اػواع أٗىٚ ٍضو ٗاىَْبء اىزٜ رقً٘ ثؼَو اىفؾض اىنارٜ ىيضلٛ ٗمىل قج
 ظٖ٘ه مزيخ فٜ أؽل اىضلِٝٞ.  
 خ(اىَوؽيٍجنوح ٍِ ٍوؽبُ اىضلٛ ٍوؽيخ ٍِ اىَْبء اىَشزومبد فٜ اىلهاٍخ ِٕ فٜ ٪) 7.25(اٗػؾذ اىلهاٍخ اُ 
(اىَوؽيخ ٍِ ٍوؽبُ اىضلٛ  ِٕ فٜ ٍوؽيخ ٍزأفوح ٪) ٍِ اىَْبء3.74(مَب اٗػؾذ اىلهاٍخ اُ الأٗىٚ ٗاىضبّٞخ). 
ٗعلد ٕنٓ اىلهاٍخ اُ ْٕبىل ػلاقخ ق٘ٝخ ماد كلاىخ اؽظبئٞخ ثِٞ رأفٞو اىَوٝغ أمضو ٍِ صلاصخ ). اىواثؼخٗ اىضبىضخ
شٖ٘ه ىطيت اىَش٘هح اىظؾٞخ ٗرأفٞو ٍقلً اىوػبٝخ اىظؾٞخ أمضو ٍِ شٖو ىزأمٞل اىزشقٞض ٗثِٞ رقلً اىؾبىخ اىَوػٞخ 
    ٗاىيٝبكح فٜ ؽغٌ اى٘هً.
 
ػْل اىَْبء اىفيَطْٞٞبد اىلارٜ فٜ رأفٞو رشقٞض ٍوؽبُ اىضلٛ  رَبٌٕاىزٜ  ٍؼقلح ٍِ اىؼ٘اٍو ٍغَ٘ػخ الخلاصح7
ٝزؼبىغِ فٜ ٍَزشفٚ ثٞذ عبلا اىؾنٍٜ٘. فيظذ اىلهاٍخ اُ ٍؼظٌ اىَْبء اىَشبهمبد فٜ اىلهاٍخ ثلأد اىؼلاط ثؼل 
اىطجٞخ ٗرأفٞو ٍقلً اىوػبٝخ اىظؾٞخ فٜ الاٍواع فٜ  اىزأفٞو. ٗاُ ملا ٍِ رأفٞو اىَوٝغ فٜ ؽيت الاٍزشبهح
اىزشقٞض ٍورجؾ فٜ رقلً اىَوؽيخ اىَوػٞخ ػْل اىَْبء اىَظبثبد ثَوؽبُ اىضلٛ. اٗطذ اىلهاٍخ اىٚ هفغ ٍَز٘ٙ 
اى٘ػٜ ٗرؼيٝي اىنشف اىَجنو ػِ ٍوؽبُ اىضلٛ، ٗاٝؼب اىٚ اّشبء ثوّبٍظ ٗؽْٜ ىيزشقٞض ٗاىؼلاط قجو رقلً اىَوؽيخ 
ٞخ، اػبكح اىْظو ٗاطلاػ اىَٞبٍبد اىظؾٞخ اىَزؼيقخ فٜ رؼيٝي الاٍواع فٜ رشقٞض ٍوؽبُ اىضلٛ ػْل اىَْبء اىَوػ
 اىفيَطْٞٞبد ٗاىلارٜ ٝزؼبىغِ فٜ ٍَزشفٚ ثٞذ عبلا اىؾنٍٜ٘. 
 
 
